CN104334095B - Including fiber to generate the tissue thickness compensation part of elastic load - Google Patents
Including fiber to generate the tissue thickness compensation part of elastic load Download PDFInfo
- Publication number
- CN104334095B CN104334095B CN201380028097.0A CN201380028097A CN104334095B CN 104334095 B CN104334095 B CN 104334095B CN 201380028097 A CN201380028097 A CN 201380028097A CN 104334095 B CN104334095 B CN 104334095B
- Authority
- CN
- China
- Prior art keywords
- nail
- tissue thickness
- thickness compensation
- compensation part
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000835 fiber Substances 0.000 title claims description 190
- 239000000463 material Substances 0.000 claims abstract description 380
- 239000012636 effector Substances 0.000 claims abstract description 216
- 238000010304 firing Methods 0.000 claims abstract description 192
- 238000009527 percussion Methods 0.000 claims abstract description 113
- 239000013013 elastic material Substances 0.000 claims abstract description 12
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 10
- 229920000117 poly(dioxanone) Polymers 0.000 claims description 24
- 230000015572 biosynthetic process Effects 0.000 claims description 23
- 229920001577 copolymer Polymers 0.000 claims description 23
- 150000002148 esters Chemical class 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 20
- 238000003786 synthesis reaction Methods 0.000 claims description 14
- 239000004626 polylactic acid Substances 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 7
- 229920000515 polycarbonate Polymers 0.000 claims description 7
- 239000004425 Makrolon Substances 0.000 claims description 6
- 239000007767 bonding agent Substances 0.000 claims description 2
- 229920002643 polyglutamic acid Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 abstract description 145
- 230000014759 maintenance of location Effects 0.000 abstract description 115
- 229920001971 elastomer Polymers 0.000 abstract description 29
- 239000000806 elastomer Substances 0.000 abstract description 27
- 239000011159 matrix material Substances 0.000 abstract description 24
- 210000004177 elastic tissue Anatomy 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 1160
- 239000003814 drug Substances 0.000 description 123
- 239000000203 mixture Substances 0.000 description 110
- 238000007906 compression Methods 0.000 description 87
- 230000006835 compression Effects 0.000 description 87
- 239000000017 hydrogel Substances 0.000 description 84
- 238000005520 cutting process Methods 0.000 description 82
- 238000009740 moulding (composite fabrication) Methods 0.000 description 79
- 229920000954 Polyglycolide Polymers 0.000 description 70
- 239000004633 polyglycolic acid Substances 0.000 description 68
- 229940124597 therapeutic agent Drugs 0.000 description 62
- 238000000034 method Methods 0.000 description 60
- -1 poly(trimethylene carbonate) Polymers 0.000 description 59
- 229920001610 polycaprolactone Polymers 0.000 description 58
- 239000002243 precursor Substances 0.000 description 58
- 239000002585 base Substances 0.000 description 56
- 239000006260 foam Substances 0.000 description 55
- 239000004632 polycaprolactone Substances 0.000 description 55
- 238000004806 packaging method and process Methods 0.000 description 53
- 229940079593 drug Drugs 0.000 description 52
- 239000002245 particle Substances 0.000 description 41
- 229920000747 poly(lactic acid) Polymers 0.000 description 40
- 239000012530 fluid Substances 0.000 description 36
- 238000010586 diagram Methods 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 229920001059 synthetic polymer Polymers 0.000 description 26
- 239000010408 film Substances 0.000 description 25
- 239000007864 aqueous solution Substances 0.000 description 24
- 230000008569 process Effects 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- 230000008093 supporting effect Effects 0.000 description 24
- 239000007800 oxidant agent Substances 0.000 description 23
- 230000001590 oxidative effect Effects 0.000 description 23
- 102000009123 Fibrin Human genes 0.000 description 22
- 108010073385 Fibrin Proteins 0.000 description 22
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 22
- 239000003795 chemical substances by application Substances 0.000 description 22
- 229950003499 fibrin Drugs 0.000 description 22
- 239000007789 gas Substances 0.000 description 21
- 239000004627 regenerated cellulose Substances 0.000 description 21
- 239000000560 biocompatible material Substances 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 19
- 230000036961 partial effect Effects 0.000 description 19
- 238000010276 construction Methods 0.000 description 18
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 18
- 239000000622 polydioxanone Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 230000008859 change Effects 0.000 description 17
- 239000000499 gel Substances 0.000 description 17
- 229920002994 synthetic fiber Polymers 0.000 description 17
- 230000033001 locomotion Effects 0.000 description 16
- 229920001432 poly(L-lactide) Polymers 0.000 description 16
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 15
- 238000011068 loading method Methods 0.000 description 15
- 239000012779 reinforcing material Substances 0.000 description 15
- 238000001356 surgical procedure Methods 0.000 description 15
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 14
- 239000000853 adhesive Substances 0.000 description 14
- 230000001070 adhesive effect Effects 0.000 description 14
- 238000007789 sealing Methods 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000004094 surface-active agent Substances 0.000 description 14
- 108010010803 Gelatin Proteins 0.000 description 13
- 229920000159 gelatin Polymers 0.000 description 13
- 239000008273 gelatin Substances 0.000 description 13
- 229940014259 gelatin Drugs 0.000 description 13
- 235000019322 gelatine Nutrition 0.000 description 13
- 235000011852 gelatine desserts Nutrition 0.000 description 13
- 238000011065 in-situ storage Methods 0.000 description 13
- 210000004379 membrane Anatomy 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 230000000717 retained effect Effects 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 210000001124 body fluid Anatomy 0.000 description 12
- 239000010839 body fluid Substances 0.000 description 12
- 239000002874 hemostatic agent Substances 0.000 description 12
- 229920001282 polysaccharide Polymers 0.000 description 12
- 239000005017 polysaccharide Substances 0.000 description 12
- 102000008186 Collagen Human genes 0.000 description 11
- 108010035532 Collagen Proteins 0.000 description 11
- 241000238367 Mya arenaria Species 0.000 description 11
- 230000003115 biocidal effect Effects 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- 239000003431 cross linking reagent Substances 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 11
- 210000000515 tooth Anatomy 0.000 description 11
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 10
- 230000003213 activating effect Effects 0.000 description 10
- 229930002875 chlorophyll Natural products 0.000 description 10
- 235000019804 chlorophyll Nutrition 0.000 description 10
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 125000000524 functional group Chemical group 0.000 description 10
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 10
- 229920003023 plastic Polymers 0.000 description 10
- 239000004033 plastic Substances 0.000 description 10
- 229910052697 platinum Inorganic materials 0.000 description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000002202 Polyethylene glycol Substances 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000013270 controlled release Methods 0.000 description 9
- 238000005755 formation reaction Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 238000012856 packing Methods 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 8
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 8
- 239000012190 activator Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 description 8
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 8
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 8
- 229940105329 carboxymethylcellulose Drugs 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 8
- 239000001913 cellulose Substances 0.000 description 8
- 235000010980 cellulose Nutrition 0.000 description 8
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 8
- 229920002674 hyaluronan Polymers 0.000 description 8
- 229960003160 hyaluronic acid Drugs 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 8
- 238000009941 weaving Methods 0.000 description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 7
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 7
- SCRCZNMJAVGGEI-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;oxepan-2-one Chemical compound O=C1COC(=O)CO1.O=C1CCCCCO1 SCRCZNMJAVGGEI-UHFFFAOYSA-N 0.000 description 7
- 108010014258 Elastin Proteins 0.000 description 7
- 102000016942 Elastin Human genes 0.000 description 7
- 102000007547 Laminin Human genes 0.000 description 7
- 108010085895 Laminin Proteins 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000002246 antineoplastic agent Substances 0.000 description 7
- 238000005452 bending Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 238000007334 copolymerization reaction Methods 0.000 description 7
- 229920002549 elastin Polymers 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000002513 implantation Methods 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 238000007493 shaping process Methods 0.000 description 7
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 6
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 6
- 229930192392 Mitomycin Natural products 0.000 description 6
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 6
- 102000016611 Proteoglycans Human genes 0.000 description 6
- 108010067787 Proteoglycans Proteins 0.000 description 6
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 6
- 229940048053 acrylate Drugs 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 238000005266 casting Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 6
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 6
- 230000009021 linear effect Effects 0.000 description 6
- 229960004857 mitomycin Drugs 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 229960003500 triclosan Drugs 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 5
- 208000011231 Crohn disease Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 5
- 229930182566 Gentamicin Natural products 0.000 description 5
- 102000003886 Glycoproteins Human genes 0.000 description 5
- 108090000288 Glycoproteins Proteins 0.000 description 5
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 5
- 108010093965 Polymyxin B Proteins 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 229960001138 acetylsalicylic acid Drugs 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 229940009456 adriamycin Drugs 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 5
- 239000003124 biologic agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 229960002518 gentamicin Drugs 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 229960000890 hydrocortisone Drugs 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 229960002009 naproxen Drugs 0.000 description 5
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000004584 polyacrylic acid Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920000024 polymyxin B Polymers 0.000 description 5
- 229960005266 polymyxin b Drugs 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 5
- 229960000894 sulindac Drugs 0.000 description 5
- 230000005532 trapping Effects 0.000 description 5
- 230000010148 water-pollination Effects 0.000 description 5
- 230000003313 weakening effect Effects 0.000 description 5
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 4
- 108010049003 Fibrinogen Proteins 0.000 description 4
- 102000008946 Fibrinogen Human genes 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 239000004952 Polyamide Substances 0.000 description 4
- 229920001710 Polyorthoester Polymers 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 238000006065 biodegradation reaction Methods 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 238000003490 calendering Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 238000002788 crimping Methods 0.000 description 4
- 229960001259 diclofenac Drugs 0.000 description 4
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 229940012952 fibrinogen Drugs 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000009940 knitting Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 230000000269 nucleophilic effect Effects 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 235000006408 oxalic acid Nutrition 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- YYPNJNDODFVZLE-UHFFFAOYSA-N 3-methylbut-2-enoic acid Chemical compound CC(C)=CC(O)=O YYPNJNDODFVZLE-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229920003232 aliphatic polyester Polymers 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 108010066657 azoreductase Proteins 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000011443 conventional therapy Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000002168 ethanoic acid esters Chemical class 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229960000598 infliximab Drugs 0.000 description 3
- 238000001459 lithography Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 3
- IRDAKMLOSKOTRQ-UHFFFAOYSA-N phosphane piperazine Chemical compound N1CCNCC1.P IRDAKMLOSKOTRQ-UHFFFAOYSA-N 0.000 description 3
- 229920001308 poly(aminoacid) Polymers 0.000 description 3
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 3
- 239000002745 poly(ortho ester) Substances 0.000 description 3
- 229920002627 poly(phosphazenes) Polymers 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000009958 sewing Methods 0.000 description 3
- 229940009188 silver Drugs 0.000 description 3
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 3
- 239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical class NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000193163 Clostridioides difficile Species 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000008961 HMPL-004 Substances 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 241000218194 Laurales Species 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 229920002732 Polyanhydride Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000002152 aqueous-organic solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 210000000080 chela (arthropods) Anatomy 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 238000000748 compression moulding Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000881 depressing effect Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 229960004963 mesalazine Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 208000026721 nail disease Diseases 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229950010732 poliglecaprone Drugs 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920002620 polyvinyl fluoride Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012783 reinforcing fiber Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical group OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 2
- 229960003040 rifaximin Drugs 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960002317 succinimide Drugs 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000003856 thermoforming Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004127 vitreous body Anatomy 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AASBXERNXVFUEJ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) propanoate Chemical compound CCC(=O)ON1C(=O)CCC1=O AASBXERNXVFUEJ-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- OQANPHBRHBJGNZ-FYJGNVAPSA-N (3e)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid Chemical compound C1=CC(=O)C(C(=O)O)=C\C1=N\NC1=CC=C(S(=O)(=O)NC=2N=CC=CC=2)C=C1 OQANPHBRHBJGNZ-FYJGNVAPSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- WVAFEFUPWRPQSY-UHFFFAOYSA-N 1,2,3-tris(ethenyl)benzene Chemical compound C=CC1=CC=CC(C=C)=C1C=C WVAFEFUPWRPQSY-UHFFFAOYSA-N 0.000 description 1
- MYWOJODOMFBVCB-UHFFFAOYSA-N 1,2,6-trimethylphenanthrene Chemical compound CC1=CC=C2C3=CC(C)=CC=C3C=CC2=C1C MYWOJODOMFBVCB-UHFFFAOYSA-N 0.000 description 1
- MFRCZYUUKMFJQJ-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1COC(=O)CO1 MFRCZYUUKMFJQJ-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- ARKDCHXUGNPHJU-UHFFFAOYSA-N 2,7-dimethylocta-2,6-dienediamide Chemical compound NC(=O)C(C)=CCCC=C(C)C(N)=O ARKDCHXUGNPHJU-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- HIWGDJVTAWTBNH-UHFFFAOYSA-N 2-methylidene-5-sulfopentanoic acid Chemical compound OC(=O)C(=C)CCCS(O)(=O)=O HIWGDJVTAWTBNH-UHFFFAOYSA-N 0.000 description 1
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 1
- QXZGLTYKKZKGLN-UHFFFAOYSA-N 4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)ON1C(=O)CCC1=O QXZGLTYKKZKGLN-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- JRWROCIMSDXGOZ-UHFFFAOYSA-N 4-tert-butyl-n-[4-chloro-2-(1-oxidopyridin-1-ium-4-carbonyl)phenyl]benzenesulfonamide Chemical compound C1=CC(C(C)(C)C)=CC=C1S(=O)(=O)NC1=CC=C(Cl)C=C1C(=O)C1=CC=[N+]([O-])C=C1 JRWROCIMSDXGOZ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical class CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229910001094 6061 aluminium alloy Inorganic materials 0.000 description 1
- 229910001008 7075 aluminium alloy Inorganic materials 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229940122444 Chemokine receptor antagonist Drugs 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 229920004937 Dexon® Polymers 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- IWDQPCIQCXRBQP-UHFFFAOYSA-M Fenaminosulf Chemical compound [Na+].CN(C)C1=CC=C(N=NS([O-])(=O)=O)C=C1 IWDQPCIQCXRBQP-UHFFFAOYSA-M 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 229930195503 Fortimicin Natural products 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 229920001944 Plastisol Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
- 241000321728 Tritogonia verrucosa Species 0.000 description 1
- 239000004775 Tyvek Substances 0.000 description 1
- 229920000690 Tyvek Polymers 0.000 description 1
- 229920004738 ULTEM® Polymers 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FHLPGTXWCFQMIU-UHFFFAOYSA-N [4-[2-(4-prop-2-enoyloxyphenyl)propan-2-yl]phenyl] prop-2-enoate Chemical compound C=1C=C(OC(=O)C=C)C=CC=1C(C)(C)C1=CC=C(OC(=O)C=C)C=C1 FHLPGTXWCFQMIU-UHFFFAOYSA-N 0.000 description 1
- CLDKAKLHMYILJA-UHFFFAOYSA-N [S].C1=NC=C2NC=NC2=N1 Chemical compound [S].C1=NC=C2NC=NC2=N1 CLDKAKLHMYILJA-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- BIDUPMYXGFNAEJ-APGVDKLISA-N astromicin Chemical compound O[C@@H]1[C@H](N(C)C(=O)CN)[C@@H](OC)[C@@H](O)[C@H](N)[C@H]1O[C@@H]1[C@H](N)CC[C@@H]([C@H](C)N)O1 BIDUPMYXGFNAEJ-APGVDKLISA-N 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960004168 balsalazide Drugs 0.000 description 1
- IPOKCKJONYRRHP-FMQUCBEESA-N balsalazide Chemical compound C1=CC(C(=O)NCCC(=O)O)=CC=C1\N=N\C1=CC=C(O)C(C(O)=O)=C1 IPOKCKJONYRRHP-FMQUCBEESA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000002599 biostatic effect Effects 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002559 chemokine receptor antagonist Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000002305 electric material Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- IQIJRJNHZYUQSD-UHFFFAOYSA-N ethenyl(phenyl)diazene Chemical compound C=CN=NC1=CC=CC=C1 IQIJRJNHZYUQSD-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940032950 ferric sulfate Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229940063190 flagyl Drugs 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000008348 humoral response Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940073062 imuran Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- GDPKWKCLDUOTMP-UHFFFAOYSA-B iron(3+);dihydroxide;pentasulfate Chemical compound [OH-].[OH-].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GDPKWKCLDUOTMP-UHFFFAOYSA-B 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940013926 lialda Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000012978 minimally invasive surgical procedure Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000272 myelencephalon Anatomy 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-N n-Decanedioic acid Natural products OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
- 229960005027 natalizumab Drugs 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QQBDLJCYGRGAKP-FOCLMDBBSA-N olsalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=C(C(O)=CC=2)C(O)=O)=C1 QQBDLJCYGRGAKP-FOCLMDBBSA-N 0.000 description 1
- 229960004110 olsalazine Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004999 plastisol Substances 0.000 description 1
- 229920001245 poly(D,L-lactide-co-caprolactone) Polymers 0.000 description 1
- 229920001693 poly(ether-ester) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000006903 response to temperature Effects 0.000 description 1
- 238000007761 roller coating Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229960005076 sodium hypochlorite Drugs 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007155 step growth polymerization reaction Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 238000009965 tatting Methods 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 229960000575 trastuzumab Drugs 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229960000834 vinyl ether Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0643—Surgical staples, i.e. penetrating the tissue with separate closing member, e.g. for interlocking with staple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/0682—Surgical staplers, e.g. containing multiple staples or clamps for applying U-shaped staples or clamps, e.g. without a forming anvil
- A61B17/0684—Surgical staplers, e.g. containing multiple staples or clamps for applying U-shaped staples or clamps, e.g. without a forming anvil having a forming anvil staying above the tissue during stapling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07207—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously the staples being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07292—Reinforcements for staple line, e.g. pledgets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B17/115—Staplers for performing anastomosis, e.g. in a single operation
- A61B17/1155—Circular staplers comprising a plurality of staples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00477—Coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00491—Surgical glue applicators
- A61B2017/00495—Surgical glue applicators for two-component glue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00526—Methods of manufacturing
- A61B2017/0053—Loading magazines or sutures into applying tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00818—Treatment of the gastro-intestinal system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00884—Material properties enhancing wound closure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00889—Material properties antimicrobial, disinfectant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00893—Material properties pharmaceutically effective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00898—Material properties expandable upon contact with fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07228—Arrangement of the staples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07235—Stapler heads containing different staples, e.g. staples of different shapes, sizes or materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07242—Stapler heads achieving different staple heights during the same shot, e.g. using an anvil anvil having different heights or staples of different sizes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/0725—Stapler heads with settable gap between anvil and cartridge, e.g. for different staple heights at different shots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07257—Stapler heads characterised by its anvil
- A61B2017/07264—Stapler heads characterised by its anvil characterised by its staple forming cavities, e.g. geometry or material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07271—Stapler heads characterised by its cartridge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07278—Stapler heads characterised by its sled or its staple holder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B2017/07214—Stapler heads
- A61B2017/07285—Stapler heads characterised by its cutter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2901—Details of shaft
- A61B2017/2908—Multiple segments connected by articulations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2912—Handles transmission of forces to actuating rod or piston
- A61B2017/2919—Handles transmission of forces to actuating rod or piston details of linkages or pivot points
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2912—Handles transmission of forces to actuating rod or piston
- A61B2017/2923—Toothed members, e.g. rack and pinion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2927—Details of heads or jaws the angular position of the head being adjustable with respect to the shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2932—Transmission of forces to jaw members
- A61B2017/2933—Transmission of forces to jaw members camming or guiding means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2932—Transmission of forces to jaw members
- A61B2017/2933—Transmission of forces to jaw members camming or guiding means
- A61B2017/2936—Pins in guiding slots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2946—Locking means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B2017/320052—Guides for cutting instruments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a kind of non-woven compensating part (20020), it is used for the end effector of surgical instruments and can includes more elastomers (20082) being dispersed in the entire non-woven compensating part.The non-woven compensating part can be positioned in the adjacent end effector of the platform surface such as with fastener cartridge, and the fastener cartridge is positioned in the end effector.When the fastener from the fastener cartridge moves to firing position from initial position, the fastener can engage the non-woven compensating part.The fastener can compress a part for the non-woven compensating part in the nail retention region limited by the percussion nail.The elastomer in the non-woven compensating part may include elastic material, and can be deformed when a part for non-woven compensating part described in the fasteners compress.In addition, the non-woven compensating part may include non-elastic fiber, hemostatic material and/or uniform absorbable polymer matrix.
Description
Cross reference to related applications
The patent application of this non-transitory is entitled according to submitting 29 days April in 2011 of 35 U.S.C. § 120
“Tissue Thickness Compensator For A Surgical Stapler Comprising An Adjustable
The part continuation application of the U.S. Patent Application Serial Number 13/097,891 of Anvil ", the U.S. Patent application are according to 35
U.S.C. entitled " the Selectively Orientable Implantable that the Septembers in 2010 of § 120 are submitted on the 30th
The part continuation application of the U.S. Patent Application Serial Number 12/894,377 of Fastener Cartridge ", above-mentioned patent application
Complete disclosure be hereby incorporated by reference.
Background technology
The present invention relates to surgical instruments, and in various embodiments, and the present invention relates to be designed to cut and stitch
It is combined the surgery cuts knitted and suture instruments and its nail bin.
Invention content
It is the incomplete row of claimed or possible claimed invention embodiment below
Table.
1. a kind of fastener cartridge assembly for surgical instruments, the fastener cartridge assembly include:
Support section, the support section include securing member chamber;
Non-woven compensating part, the non-woven compensating part are positioned relative to the support section, wherein the non-woven benefit
It includes more elastomers being scattered in everywhere to repay part;With
Fastener, the fastener can move between initial position and firing position, wherein at the fastener
When its initial position, the fastener is positioned at least partially in the securing member chamber, and wherein when the fastener
When being moved between its initial position and its firing position, the fastener can compress the non-woven compensating part.
2. according to fastener cartridge assembly described in embodiment 1, wherein at least one elastomer includes elastic material, and
Wherein described in the fasteners compress when non-woven compensating part, the elastomer deformation.
3. according to the fastener cartridge assembly described in embodiment 1 or embodiment 2, wherein the fastener includes:
Base portion;
First leg, first leg extend from the base portion;With
Second leg, second leg extend from the base portion, wherein when the fastener moves to its firing position
When, first leg and second leg can be towards the base curves;
Wherein when the fastener moves to its firing position, the fastener is in first leg and described second
A part for the non-woven compensating part is captured between at least one of leg and the base portion.
4. according to fastener cartridge assembly described in embodiment 3, further include:
Slit, the slit extend through at least part of the support section;With
Firing member, the firing member can translate in the slit, wherein the firing member can be described
Firing member engages the base portion of the fastener when translating so that the fastener is projected from the securing member chamber.
5. the fastener cartridge assembly according to any one of previous embodiment is glued wherein the non-woven compensating part passes through
Mixture is releasably attached to the platform of the support section.
6. the fastener cartridge assembly according to any one of previous embodiment, wherein the elastomer is entire described
Random dispersion and random orientation in non-woven compensating part.
7. the fastener cartridge assembly according to any one of previous embodiment, wherein the non-woven compensating part includes more
Root non-elastic fiber.
8. the fastener cartridge assembly according to any one of previous embodiment, wherein the elastomer includes synthesis
Bioabsorbable material.
9. the fastener cartridge assembly according to any one of previous embodiment, wherein the elastomer includes selected from packet
Include the material of the group of following substance:Poly- (dioxanone) (PDO), polylactic acid (PLA), polyglycolide (PGA), polycaprolactone
(PCL), makrolon and their copolymer.
10. the fastener cartridge assembly according to any one of previous embodiment, wherein the elastomer thermoforming
To keep the shape of substantially coiled type.
11. the fastener cartridge assembly according to any one of previous embodiment, wherein the non-woven compensating part is needle
Thorn and include hemostatic material.
12. a kind of fastener cartridge for surgical instruments, the fastener cartridge include:
Main body, the main body includes the first main part and the second main part, wherein first main part includes
Securing member chamber, wherein second main part includes compressible part, wherein the compressible part includes being scattered in
More elastomers everywhere, and the wherein described elastomer is at least partially elasticity;With
Fastener, wherein each fastener is aligned with the securing member chamber of first main part.
13. according to the fastener cartridge described in embodiment 12, wherein at least one fastener can be in initial position and percussion
Moved between position, and wherein when the fastener moves to its firing position, the fastener can compress it is described can
A part for the part of compression.
14. according to described in embodiment 13 fastener cartridge, wherein the compressible part includes the absorbable of homogenization
Polymeric matrix.
15. according to the fastener cartridge described in any one of embodiment 12-14, further include:
Slit, the slit extend through at least part of first main part;With
Firing member, the firing member can translate in the slit, wherein the firing member can be described
Firing member engages at least one fastener when translating so that the firing member is by least one fastener from described the
One main part projects.
16. a kind of end effector assembly for surgical instruments, the end effector assembly include:
Anvil block;
Fastener cartridge, the fastener cartridge include:
Warehouse, the warehouse include securing member chamber;And fastener, wherein when the fastener is in initial position, institute
Fastener is stated to be positioned at least partially in securing member chamber;And
Non-woven compensating part, the non-woven compensating part are located among the fastener cartridge and the anvil block, wherein institute
It includes more elastomers being scattered in everywhere to state non-woven compensating part, and the wherein described elastomer is at least partially
Elasticity.
17. according to the end effector assembly described in embodiment 16, wherein the non-woven compensating part is releasedly consolidated
Surely at least one of the fastener cartridge and the anvil block are arrived, and the wherein described non-woven compensating part includes non-woven material
Material.
18. according to the end effector assembly described in embodiment 17, wherein the fastener can be transported from its initial position
Firing position is moved, and wherein when the fastener moves to its firing position, the fastener can compress described non-
Weave a part for compensating part.
19. according to the end effector assembly described in embodiment 18, wherein the anvil block includes being located at tissue contacting surface
In forming pit, and wherein when the fastener moves to its firing position from its initial position, the forming pit
The fastener is set to deform.
20. according to the end effector assembly described in embodiment 18 or embodiment 19, wherein when the fasteners compress institute
When stating the part of non-woven compensating part, the non-woven compensating part can be detached from the end effector assembly.
Description of the drawings
Refer to the following explanation of the embodiment of the present invention, feature of the invention and advantage and its acquisition side in conjunction with the accompanying drawings
Method will become more apparent, and be better understood invention itself, wherein:
Fig. 1 is the sectional view of surgical instrument embodiment;
Figure 1A is the perspective view of one embodiment of implanted nail bin;
Figure 1B -1E show the multiple portions for the end effector that tissue is clamped and sutured with implanted nail bin;
Fig. 2 is the partial cross-sectional side view of another end effector of the part for being connected to surgical instruments, wherein
End effector supports surgery nail bin and its anvil block is in an open position;
Fig. 3 is end effector shown in Fig. 2 another partial cross-sectional side view in the close position;
Fig. 4 is that Fig. 2 and end effector shown in Fig. 3 begin to pass another part cross when end effector promotes in knife bar
Side cross-sectional view;
Fig. 5 is Fig. 2 horizontal to another part of the end effector shown in Fig. 4 when knife bar is partly advanced through wherein
Side cross-sectional view;
Fig. 6 A- Fig. 6 D describe the deformation that the surgical staples in staple cartridge body are located according at least one embodiment;
Fig. 7 A are to show to be located in the schematic diagram that can be crushed the nail in staple cartridge body;
Fig. 7 B are the schematic diagram for being crushed staple cartridge body and being crushed by anvil block for showing Fig. 7 A;
Fig. 7 C are the schematic diagram for being crushed staple cartridge body and being further crushed by anvil block for showing Fig. 7 A;
Fig. 7 D are to show nail and Fig. 7 A in complete conquassation condition in Fig. 7 A in configuration are fully formed
The schematic diagram of nail bin can be crushed;
Fig. 8 is according to the top view of the nail bin of at least one embodiment, which includes in embedded staple cartridge body
Nail;
Fig. 9 is the front view of the nail bin of Fig. 8;
Figure 10 is the decomposition perspective view of the alternative embodiment of compressible nail bin, which includes nail and be used for
The system for driving nail against anvil block;
Figure 10 A are the partial sectional view of the alternative embodiment of the nail bin of Figure 10;
Figure 11 is the sectional view of the nail bin of Figure 10;
Figure 12 is the front view that can be traversed the nail bin of Figure 10 and make the sliding part that nail moves towards anvil block;
Figure 13 is the schematic diagram for the staple drivers that can be lifted towards anvil block by the sliding part of Figure 12;
Figure 14 is the perspective view of the nail bin of at least one embodiment according to the present invention, which includes for being stitched with surgery
The rigid support portion and compressible tissue thickness compensation part that clutch tool is used together;
Figure 15 is the partial exploded view of the nail bin of Figure 14;
Figure 16 is the complete exploded view of the nail bin of Figure 14;
Figure 17 is another exploded view of the nail bin of Figure 14, which is not covered with the wrappage of tissue thickness compensation part;
Figure 18 is the warehouse of the nail bin of Figure 14 or the perspective view of support section;
Figure 19 is the top perspective of sliding part, which can move in the nail bin of Figure 14, to be followed closely from cartridge deployment;
Figure 20 is the bottom perspective view of the sliding part of Figure 19;
Figure 21 is the front view of the sliding part of Figure 19;
Figure 22 is the top perspective of driver, which can support one or more nails, and by the sliding of Figure 19
Part is lifted up to be projected with that will follow closely from nail bin;
Figure 23 is the bottom perspective view of the driver of Figure 22;
Figure 24 is can be at least partly around the wrappage of the compressible tissue thickness compensation part of nail bin;
Figure 25 is the partial sectional view of nail bin, which includes rigid support portion and the compensation of compressible tissue thickness
Part shows that never firing position moves to firing position to nail during First ray;
Figure 26 is the front view of the nail bin of Figure 25;
Figure 27 is the thin portion front view of the nail bin of Figure 25;
Figure 28 is the section end view of the nail bin of Figure 25;
Figure 29 is the bottom view of the nail bin of Figure 25;
Figure 30 is the thin portion bottom view of the nail bin of Figure 25;
Figure 31 is the longitudinal sectional drawing of nail bin and anvil block in the close position, which includes rigid support portion and can
The tissue thickness compensation part of compression shows that never firing position moves to firing position to nail during First ray;
Figure 32 is the anvil block of Figure 31 and another sectional view of nail bin, in opening after being completed it illustrates percussion sequence
The anvil block of position;
Figure 33 is the local detail drawing of the nail bin of Figure 31, and it illustrates the nails in non-firing position;
Figure 34 is the cross-section front view of nail bin, which includes rigid support portion and the compensation of compressible tissue thickness
Part shows the nail in non-firing position;
Figure 35 is the detail drawing of the nail bin of Figure 34;
Figure 36 is the front view of nail bin and anvil block in an open position, which includes rigid support portion and compressible
Tissue thickness compensation part, show the nail in non-firing position;
Figure 37 is the front view of nail bin and anvil block in the close position, which includes rigid support portion and compressible
Tissue thickness compensation part, show in non-firing position nail and be trapped between anvil block and tissue thickness compensation part
Tissue;
Figure 38 is the anvil block of Figure 37 and the detail drawing of nail bin;
Figure 39 is the front view of nail bin and anvil block in the close position, which includes rigid support portion and compressible
Tissue thickness compensation part, show the nail in non-firing position, show be positioned in it is thicker between anvil block and nail bin
Tissue;
Figure 40 is the anvil block of Figure 39 and the detail drawing of nail bin;
Figure 41 is the anvil block of Figure 39 and the front view of nail bin, shows to be positioned between anvil block and nail bin have difference
The tissue of thickness;
Figure 42 is the anvil block of Figure 39 and the detail drawing of nail bin, as shown in figure 41;
Figure 43 is to show the tissue thickness compensation part compensated to the different tissues thickness being trapped in different nails
Schematic diagram;
Figure 44 is to show that tissue thickness compensation part applies compression pressure to by one or more crosscutting blood vessel of staple line
Schematic diagram;
Figure 45 is the schematic diagram for being shown in which one or more nails imappropriate the case where shaping;
Figure 46 is the schematic diagram for showing the tissue thickness compensation part that can compensate for imappropriate forming nail;
Figure 47 is the schematic diagram for showing the tissue thickness compensation part being positioned in the tissue regions of multiple staple line intersections;
Figure 48 is the schematic diagram for showing the tissue being trapped in nail;
Figure 49 is the schematic diagram for showing the tissue and tissue thickness compensation part that are trapped in nail;
Figure 50 is the schematic diagram for showing the tissue being trapped in nail;
Figure 51 is the schematic diagram for showing the thick tissue and tissue thickness compensation part that are trapped in nail;
Figure 52 is the schematic diagram for showing the thin tissue and tissue thickness compensation part that are trapped in nail;
Figure 53 is the signal for showing the tissue thickness compensation part being trapped in nail and the tissue with interior thickness
Figure;
Figure 54 is to show the tissue thickness compensation part being trapped in nail and the tissue with another interior thickness
Schematic diagram;
Figure 55 is the schematic diagram for showing the thick tissue and tissue thickness compensation part that are trapped in nail;
Figure 56 is the partial cutaway view of the end effector of surgery suturing appliance, is shown in retraction, non-firing position
Trigger shaft and nail percussion sliding part;
Figure 57 is another partial cutaway view of the end effector of Figure 56, shows the percussion that position is promoted in part
Bar and nail percussion sliding part;
Figure 58 is the sectional view of the end effector of Figure 56, is shown in being fully advanced or the trigger shaft of firing position;
Figure 59 is the sectional view of the end effector of Figure 56, show after being fired in retraction position trigger shaft with
And stay in the nail percussion sliding part of its complete firing position;
Figure 60 is the detail drawing of the trigger shaft in retraction position of Figure 59;
Figure 61 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 62 is the detail drawing of the non-woven material of the tissue thickness compensation part of Figure 61;
Figure 63 is the tissue thickness compensation part of Figure 61 for showing to be implanted against tissue and discharge from end effector
Front view;
Figure 64 is the detail drawing of the non-woven material of tissue thickness compensation part according at least one embodiment;
Figure 65 is the schematic diagram according at least one cluster for implementing to be illustrated randomly-oriented crimped fibre;
Figure 66 is the schematic diagram according at least one cluster for implementing to be illustrated randomly-oriented crimped fibre;
Figure 67 is the schematic diagram according at least one construction for implementing to be illustrated crimped fibre;
Figure 68 is the schematic diagram according at least one construction for implementing to be illustrated crimped fibre;
Figure 69 is the schematic diagram according at least one construction for implementing to be illustrated crimped fibre;
Figure 70 is the section plan of the coiled fiber in tissue thickness compensation part according at least one embodiment;
Figure 70 A are the section plans of the coiled fiber of Figure 70;
Figure 70 B are the cross-sectional details figures of the tissue thickness compensation part of Figure 70;
Figure 71 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 72 is the schematic diagram of the deformation for the tissue thickness compensation part for showing Figure 71;
Figure 73 is the schematic diagram of the weaving suture loading of tissue thickness compensation part according at least one embodiment, it illustrates
Weaving suture loading in loading configuration;
Figure 74 is the schematic diagram of the weaving suture loading of Figure 73, and it illustrates the weaving suture loadings in release configuration;
Figure 75 be surgical instruments end effector in the weaving suture loading with Figure 73 tissue thickness compensation part it is flat
Face figure;
Figure 76 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 77 is the partial plan layout of the tissue thickness compensation part of Figure 76;
Figure 78 is the exploded view of the end effector of Figure 61 and the fastener cartridge assembly of tissue thickness compensation part;
Figure 79 is the partial sectional view of the fastener cartridge assembly of Figure 78, and it illustrates do not fire, partly fire and fire
Fastener;
Figure 80 is the front view of the fastener cartridge assembly of Figure 78, and it illustrates drivers to fire fastener from fastener cartridge group
The nail cavity of part enters tissue thickness compensation part;
Figure 81 is the detail drawing of the fastener cartridge assembly of Figure 80;
Figure 82 is the front view of the tissue of the tissue thickness compensation part and capture of Figure 61 in percussion fastener;
Figure 83 is the front view of the tissue of the tissue thickness compensation part and capture of Figure 61 in percussion fastener;
Figure 84 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 85 is the schematic diagram of the deformation of the deformable tube for the tissue thickness compensation part for showing Figure 84;
Figure 86 is the detail drawing of the deformable tube of the tissue thickness compensation part of Figure 84;
Figure 87 is the schematic diagram according to the deformation of at least one deformable tube for implementing to exemplify tissue thickness compensation part;
Figure 88 is the front view of tissue thickness compensation part according at least one embodiment, which includes
Against the tubular element of tissue implantation;
Figure 89 is the front view of tissue thickness compensation part according at least one embodiment, which includes
Against the tubular element of tissue implantation;
Figure 90 is the local perspective view for the deformable tube for including according at least one embodiment tubulose lattice;
Figure 91 is the front view of the tubulose strand of the deformable tube of Figure 90.
Figure 92 is the front view of the deformable tube of Figure 90;
Figure 93 is the front view of more tubulose strands of the deformable tube for Figure 90 according to various embodiments;
Figure 94 is the front view against the tubulose lattice of Figure 90 of tissue implantation;
Figure 95 is the local perspective view of deformable tube according at least one embodiment;
Figure 96 is the local perspective view of deformable tube according at least one embodiment;
Figure 97 is the local perspective view of deformable tube according at least one embodiment;
Figure 98 is the front view of the deformable tube of Figure 97;
Figure 99 is the local perspective view of deformable tube according at least one embodiment;
Figure 100 is the local perspective view of deformable tube according at least one embodiment;
Figure 101 is the local perspective view of deformable tube according at least one embodiment;
Figure 102 is the perspective view of tissue thickness compensation part according at least one embodiment, and the tissue thickness compensation part is fixed
Position is in the end effector of surgical instruments;
Figure 103 is the front view of the tubular element of the tissue thickness compensation part of Figure 102;
Figure 104 is the tissue thickness compensation part of Figure 102 and the positive view of end effector, and it illustrates in not clamping
The end effector of configuration;
Figure 105 is the tissue thickness compensation part of Figure 102 and the positive view of end effector, it illustrates in clamping and
The end effector of percussion configuration;
Figure 106 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
It is located in the end effector of surgical instruments;
Figure 107 is the tissue thickness compensation part of Figure 106 and the positive view of end effector, it illustrates in clamping and
The end effector of percussion configuration;
Figure 108 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Positive view;
Figure 109 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
It is located in the end effector of surgical instruments;
Figure 110 is the tissue thickness compensation part of Figure 109 and the positive view of end effector, it illustrates in clamping and
The end effector of percussion configuration;
Figure 111 is the perspective view of tissue thickness compensation part according at least one embodiment, and the tissue thickness compensation part is fixed
Position is in the end effector of surgical instruments;
Figure 112 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
It is located in the end effector of surgical instruments;
Figure 113 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
It is located in the end effector of surgical instruments;
Figure 114 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
It is located in the end effector of surgical instruments;
Figure 115 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
It is located in the end effector of surgical instruments;
Figure 116 is the partial plan layout of tissue thickness compensation part according at least one embodiment, tissue thickness compensation
Part is located in the end effector of surgical instruments;
Figure 117 is the partial plan layout of tissue thickness compensation part according at least one embodiment, tissue thickness compensation
Part is located in the end effector of surgical instruments;
Figure 118 is the tissue thickness compensation part of Figure 116 and the local positive view of end effector, and it illustrates in not
The end effector of clamping configuration;
Figure 119 is the tissue thickness compensation part of Figure 116 and the local positive view of end effector, and it illustrates in folder
The end effector of tight configuration;
Figure 120 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 121 is the tissue thickness compensation part of Figure 120 and the front view of end effector;
Figure 122 is the tissue thickness compensation part of Figure 120 and the perspective view of end effector, and it illustrates towards clamping configuration
The anvil block of the end effector of movement;
Figure 123 is the tissue thickness compensation part of Figure 120 and the front view of end effector, and it illustrates in clamping configuration
End effector;
Figure 124 is the positive view of the tubular element of the tissue thickness compensation part of Figure 120 in not deformed configuration;
Figure 125 is the positive view of the tubular element of the tissue thickness compensation part of Figure 120 in deformed configuration;
Figure 126 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 127 is the tissue thickness compensation part of Figure 126 and the positive view of end effector, and it illustrates in clamping structure
The end effector of type;
Figure 128 is the tissue thickness compensation part of Figure 126 and the positive view of end effector, it illustrates in percussion and
The end effector of the non-clamping configuration in part;
Figure 129 is the perspective view of tissue thickness compensation part according at least one embodiment, and the tissue thickness compensation part is fixed
Position is in the end effector of surgical instruments;
Figure 130 is the positive view of tissue thickness compensation part according at least one embodiment, the tissue thickness compensation part
Anvil block fixed to surgical end effectors;
Figure 131 is the tissue thickness compensation part of Figure 130 and the positive view of end effector, and it illustrates in clamping structure
The end effector of type;
Figure 132 is the tissue thickness compensation part of Figure 130 and the positive view of end effector, it illustrates in percussion and
The end effector of the non-clamping configuration in part;
Figure 133 is the tissue thickness compensation part of Figure 132 and the detail drawing of end effector;
Figure 134 is the tissue thickness's compensation being clamped according at least one embodiment in the end effector of surgical instruments
The positive view of part, it illustrates dispose to follow closely by nail percussion sliding part;
Figure 135 is the tissue thickness compensation part of Figure 134 and the positive view of end effector, and it illustrates in clamping structure
The end effector of type;
Figure 136 is the tissue thickness compensation part of Figure 134 and the positive view of end effector, and it illustrates in percussion structure
The end effector of type;
Figure 137 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 138 is the perspective view of the tubular element of the tissue thickness compensation part of Figure 137;
Figure 139 is the perspective view of the tubular element for the Figure 138 being cut off between first end and second end;
Figure 140 is the perspective view of the tissue thickness compensation part of Figure 137, and it illustrates the cuttings of cut-out tissue thickness compensation part
Element and the nail for engaging tissue thickness compensation part;
Figure 141 is the perspective of the frame for the tissue thickness compensation part that Figure 137 can be made according at least one embodiment
Figure;
Figure 142 is the positive view of the frame of Figure 141, and it illustrates the tissue thickness of cured Figure 137 in the frame benefits
Repay part;
Figure 143 is the group for being removed from the frame of Figure 142 and being prepared for being trimmed by least one cutting device
Knit the positive view of thickness compensation part;
Figure 144 is that the tissue of Figure 143 after at least one cutting device trims tissue thickness compensation part is thick
Spend the positive view of compensating part;
Figure 145 is the positive view of the tissue thickness compensation part formed in the frame of Figure 142, and it illustrates with various
The cut-off tube of cross-sectional geometry;
Figure 146 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective view;
Figure 147 is the detail drawing of the tissue thickness compensation part of Figure 146 according at least one embodiment;
Figure 148 is the local perspective view of tissue thickness compensation part according at least one embodiment;
Figure 149 is the local perspective view of tissue thickness compensation part according at least one embodiment;
Figure 150 A are the tissue thickness compensation part of Figure 146 and the positive view of end effector, and it illustrates in not pressing from both sides
The end effector of tight configuration;
Figure 150 B are the tissue thickness compensation part of Figure 146 and the positive view of end effector, and it illustrates in clamping
The end effector of configuration;
Figure 150 C are the tissue thickness compensation part of Figure 146 and the positive view of end effector, and it illustrates in clamping
With the end effector of percussion configuration;
Figure 150 D are the positive views for the tissue thickness compensation part for capturing Figure 146 in percussion nail;
Figure 150 E are the positive views for the tissue thickness compensation part for capturing Figure 146 in percussion nail, and it illustrates tissues
Thickness compensation part further expands;
Figure 151 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective cut-away schematic view;
Figure 152 is the partial elevation view for the tissue thickness compensation part for capturing Figure 151 in percussion nail;
Figure 153 is the front view of the deformable tube of the tissue thickness compensation part of Figure 151;
Figure 154 is the front view of deformable tube according at least one embodiment;
Figure 155 is the perspective cut-away schematic view of the tissue thickness compensation part of Figure 151;
Figure 156 is the tissue thickness compensation part in the end effector of surgical instruments according at least one embodiment
Perspective cut-away schematic view;
Figure 157 is the perspective view of tissue thickness compensation part according at least one embodiment;
Figure 158 is the local positive view of the tissue thickness compensation part of Figure 157, and it illustrates thick with tissue and with tissue
Spend the fastener of compensating part engagement;
Figure 159 is the perspective cut-away schematic view of tissue thickness compensation part according at least one embodiment;
Figure 160 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 161 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 162 is the front view of tissue thickness compensation part according at least one embodiment, and the tissue thickness compensation part is fixed
Position is in the rounded ends actuator of surgical instruments;
Figure 163 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 164 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 165 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 166 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 167 is the front view of tissue thickness compensation part according at least one embodiment;
Figure 168 is the local perspective view of tissue thickness compensation part according at least one embodiment;
Figure 169 is the local perspective view of tissue thickness compensation part according at least one embodiment, tissue thickness compensation
Part is located in the end effector of surgical instruments;
Figure 170 is the local perspective view of tissue thickness compensation part according at least one embodiment, tissue thickness compensation
Part has the fastener being located in its hole;
Figure 171 is the local perspective view of the tissue thickness compensation part of Figure 169, and it illustrates the tissues in not deformed configuration
Thickness compensation part;
Figure 172 is the local perspective view of the tissue thickness compensation part of Figure 169, and it illustrates the groups in part deformed configuration
Knit thickness compensation part;
Figure 173 is the local perspective view of the tissue thickness compensation part of Figure 169, and it is thick that it illustrates the tissues in deformed configuration
Spend compensating part;
Figure 174 is the perspective view of tissue thickness compensation part according at least one embodiment;
Figure 175 is the perspective of the end effector for the suture instruments for including according at least one embodiment anvil block and nail bin
Figure;
Figure 176 is the sectional view of the end effector of Figure 175, and it illustrates be located in nail bin to be in non-cock
Nail and include the tissue thickness compensation part in the sealing container for not piercing through state, wherein for illustrative purposes, container
It is illustrated as its part to be removed;
Figure 177 is the sectional view of the end effector of Figure 175, and it illustrates Figure 176 at least partly cock
Nail and at least partly pierce through state container;
Figure 178 is the perspective of the end effector for the suture instruments for including according at least one embodiment anvil block and nail bin
Figure;
Figure 179 is the sectional view of the end effector of Figure 178, and it illustrates be located in nail bin to be in non-cock
Nail and be located in the tissue thickness compensation part of nail bin in not piercing through the sealing container of state, wherein in order to illustrate
Purpose, container are illustrated as its part and are removed;
Figure 180 is the sectional view of the end effector of Figure 178, and it illustrates Figure 179 at least partly cock
Nail and nail bin at least partly pierce through state container;
Figure 181 is the suture including anvil block and the sealing container for being attached to anvil block according at least one alternative embodiment
The perspective view of the end effector of instrument, wherein for illustrative purposes, container is illustrated as its part and is removed;
Figure 182 is the sectional view of the end effector of Figure 181, it illustrates at least partly from nail bin fire nail and
It is attached to the container at least partly puncture state of anvil block;
Figure 183 is attached to the sectional view of the container of the anvil block of Figure 181 shown in extended mode;
Figure 184 is attached to the detail drawing of the container of the anvil block of Figure 183 shown in extended mode;
Figure 185 is shown in the container upwardly extended transverse to the side of staple line;
Figure 186 is shown in the multiple containers upwardly extended transverse to the side of staple line;
Figure 187 is the sectional view of nail bin according to various embodiments;
Figure 188 is the partial sectional view of Figure 187 under implantation condition;
Figure 189 A are local perspective view of the tissue thickness compensation part before extension;
Figure 189 B are local perspective view of the tissue thickness compensation part in extending period of Figure 189;
Figure 190 is that the part of the tissue thickness compensation part comprising the swollen composition of fluid-soluble according to various embodiments is saturating
View;
Figure 191 is the sectional view for being oriented the tissue adjacent with tissue thickness compensation part according to various embodiments;
Figure 192 is the partial sectional view of Figure 191 after nail bin is fired;
Figure 193 is the schematic diagram of the tissue thickness compensation part for the Figure 191 for showing with organizing adjacent implantation;
Figure 194 is the local perspective view of tissue thickness compensation part according to various embodiments;
Figure 195 is the perspective view of the jaw for the tissue thickness compensation part that can receive Figure 194;
Figure 196 is the partial sectional view of nail bin, and it illustrates the nails from cartridge deployment;
Figure 197 is located at Top tissue thickness compensation part and lower part tissue thickness in the actuator of disposable loading unit
Spend the perspective view of compensating part;
Figure 198 A are the section views of the Lower tissue thickness compensation part of Figure 197 manufactured in a mold according to various embodiments
Figure;
Figure 198 B are the sectional views of the three-layer weave thickness compensation part manufactured in a mold according to various embodiments;
Figure 199 is the sectional view of anvil block according to various embodiments, which includes the tissue thickness for including reinforcing material
Compensating part;
Figure 200 is the sectional view of tissue according to various embodiments, the tissue be located in Top tissue thickness compensation part with
Among Lower tissue thickness compensation part;
Figure 20 1 is the sectional view of Figure 200, and it illustrates the nails from cartridge deployment;
Figure 20 2 is the sectional view of Figure 200 after nail bin is fired;
Figure 20 3A show needle according to various embodiments, which can deliver a fluid to the tissue thickness for being attached to nail bin
Spend compensating part;
Figure 20 3B are the sectional views for the nail bin for including tissue thickness compensation part, which can receive figure
The needle of 203A;
The method that Figure 20 4 shows manufacture tissue thickness compensation part according to various embodiments;
Figure 20 5 is the schematic diagram and method of the thickness compensation part of formation extension according to various embodiments;
Figure 20 6 shows the micella comprising hydrogel precursor;And
Figure 20 7 is the schematic diagram of surgical instruments according to various embodiments, which includes tissue thickness compensation part
And the fluid of tissue thickness compensation part can be delivered to;
Figure 20 8 is the local perspective view of tissue thickness compensation part according at least one embodiment, tissue thickness compensation
Part is fixed to the anvil block of the end effector of surgical instruments.
Figure 20 9 is the perspective view of the tubular element of the tissue thickness compensation part of Figure 20 8.
Figure 21 0 is the perspective view of the tubular element of Figure 20 9, it illustrates the tubular element for being cut into two halves and each
The fluid of contact hydroaropic substance in half.
Figure 21 1 is the perspective view of the half of the cut-out tubular element of Figure 21 0, and it illustrates the extensions of cut-out tubular element.
Through multiple views, corresponding reference mark indicates corresponding component.Example shown in this article shows in one form
Certain embodiments of the present invention, and the range that such example should not be construed as in any way limiting the present invention are gone out.
Specific implementation mode
Present applicant also possesses U.S. Patent application below, these patent applications are respectively complete by reference
It is incorporated herein entirely:
The U.S. of entitled " SURGICAL INSTRUMENTS WITH RECONFIGURABLE SHAFT SEGMENTS "
Patent application serial number 12/894,311 (attorney number END6734USNP/100058);
Entitled " SURGICAL STAPLE CARTRIDGES SUPPORTING NON-LINEARLY ARRANGED
STAPLES AND SURGICAL STAPLING INSTRUMENTS WITH COMMON STAPLE-FORMING POCKETS”
U.S. Patent Application Serial Number 12/894,340 (attorney number END6735USNP/100059);
The United States Patent (USP) Shen of entitled " JAW CLOSURE ARRANGEMENTS FOR SURGICALINSTRUMENTS "
It please sequence number 12/894,327 (attorney number END6736USNP/100060);
Entitled " SURGICAL CUTTING AND FASTENING INSTRUMENTS WITH SEPARATE AND
The U.S. Patent Application Serial Number of DISTINCT FASTENER DEPLOYMENT AND TISSUE CUTTING SYSTEMS "
12/894,351 (attorney number END6839USNP/100524);
Entitled " IMPLANTABLE FASTENER CARTRIDGE HAVING A NON-UNIFORM
The U.S. Patent Application Serial Number 12/894,338 (attorney number END6840USNP/100525) of ARRANGEMENT ";
Entitled " IMPLANTABLE FASTENER CARTRIDGE COMPRISING A SUPPORT RETAINER "
U.S. Patent Application Serial Number 12/894,369 (attorney number END6841USNP/100526);
The U.S. of entitled " IMPLANTABLE FASTENER CARTRIDGE COMPRISING MULTIPLE LAYERS "
State's patent application serial number 12/894,312 (attorney number END6842USNP/100527);
The U.S. of entitled " SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE " is special
Sharp patent application serial numbers 12/894,377 (attorney number END6843USNP/100528);
Entitled " SURGICAL STAPLING INSTRUMENT WITH COMPACT ARTICULATION CONTROL
The U.S. Patent Application Serial Number 12/894,339 (attorney number END6847USNP/100532) of ARRANGEMENT ";
Entitled " SURGICAL STAPLING INSTRUMENT WITH A VARIABLE STAPLE FORMING
The U.S. Patent Application Serial Number 12/894,360 (attorney number END6848USNP/100533) of SYSTEM ";
Entitled " SURGICAL STAPLING INSTRUMENT WITH INTERCHANGEABLE STAPLE
12/894,322 (the attorney number of U.S. Patent Application Serial Number of CARTRIDGE ARRANGEMENTS "
END6849USNP/100534);
Entitled " SURGICAL STAPLE CARTRIDGES WITH DETACHABLE SUPPORT STRUCTURES
AND SURGICAL STAPLING INSTRUMENTS WITH SYSTEMS FOR PREVENTING ACTUATION
12/894,350 (the agent of U.S. Patent Application Serial Number of MOTIONS WHEN ACARTRIDGE IS NOT PRESENT "
File number END6855USNP/100540);
Entitled " IMPLANTABLE FASTENER CARTRIDGE COMPRISING BIOABSORBABLE
The U.S. Patent Application Serial Number 12/894,383 (attorney number END6856USNP/100541) of LAYERS ";
The U.S. Patent Application Serial Number 12/894,389 of entitled " COMPRESSIBLE FASTENER CARTRIDGE "
(attorney number END6857USNP/100542);
The United States Patent (USP) of entitled " FASTENERS SUPPORTED BY A FASTENER CARTRIDGE SUPPORT "
Patent application serial numbers 12/894,345 (attorney number END6858USNP/100543);
The U.S. Patent Application Serial Number 12/894,306 of entitled " COLLAPSIBLE FASTENER CARTRIDGE "
(attorney number END6859USNP/100544);
Entitled " FASTENER SYSTEM COMPRISING A PLURALITY OF CONNECTED RETENTION
(the attorney number END6860USNP/ of U.S. Patent Application Serial Number 12/894,318 of MATRIX ELEMENTS "
100546);
Entitled " FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND AN ALIGNMENT
The U.S. Patent Application Serial Number 12/894,330 (attorney number END6861USNP/100547) of MATRIX ";
The U.S. Patent application sequence of entitled " FASTENER SYSTEM COMPRISING A RETENTION MATRIX "
Row number 12/894,361 (attorney number END6862USNP/100548);
Entitled " FASTENING INSTRUMENT FOR DEPLOYING A FASTENER SYSTEM
12/894,367 (the attorney number of U.S. Patent Application Serial Number of COMPRISING A RETENTION MATRIX "
END6863USNP/100549);
The U.S. of entitled " FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND A COVER "
State's patent application serial number 12/894,388 (attorney number END6864USNP/100550);
Entitled " FASTENER SYSTEM COMPRISING A PLURALITY OF FASTENER CARTRIDGES "
U.S. Patent Application Serial Number 12/894,376 (attorney number END6865USNP/100551);
Entitled " SURGICAL STAPLER ANVIL COMPRISING A PLURALITY OF FORMING
The U.S. Patent Application Serial Number 13/097,865 (attorney number END6735USCIP1/100059CIP1) of POCKETS ";
The United States Patent (USP) of entitled " TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER "
Patent application serial numbers 13/097,936 (attorney number END6736USCIP1/100060CIP1);
Entitled " STAPLE CARTRIDGE COMPRISING A VARIABLE THICKNESS COMPRESSIBLE
The U.S. Patent Application Serial Number 13/097,954 (attorney number END6840USCIP1/100525CIP1) of PORTION ";
Entitled " STAPLE CARTRIDGE COMPRISING STAPLES POSITIONED WITHIN A
13/097,856 (the attorney number of U.S. Patent Application Serial Number of COMPRESSIBLE PORTION THEREOF "
END6841USCIP1/100526CIP1);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING DETACHABLE PORTIONS's "
U.S. Patent Application Serial Number 13/097,928 (attorney number END6842USCIP1/100527CIP1);
Entitled " TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER COMPRISING
(the attorney number END6843USCIP1/ of U.S. Patent Application Serial Number 13/097,891 of AN ADJUSTABLE ANVIL "
100528CIP1);
The U.S. of entitled " STAPLE CARTRIDGE COMPRISING AN ADJUSTABLE DISTAL PORTION "
State's patent application serial number 13/097,948 (attorney number END6847USCIP1/100532CIP1);
The U.S. Patent Application Serial Number 13/ of entitled " COMPRESSIBLE STAPLE CARTRIDGE ASSEMBLY "
097,907 (attorney number END6848USCIP1/100533CIP1);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING PORTIONS HAVING
13/097,861 (the attorney number of U.S. Patent Application Serial Number of DIFFERENT PROPERTIES "
END6849USCIP1/100534CIP1);
The U.S. Patent Application Serial Number 13/097 of entitled " STAPLE CARTRIDGE LOADING ASSEMBLY ",
869 (attorney number END6855USCIP1/100540CIP1);
Entitled " COMPRESSIBLE STAPLE CARTRIDGE COMPRISING ALIGNMENT MEMBERS's "
U.S. Patent Application Serial Number 13/097,917 (attorney number END6856USCIP1/100541CIP1);
The United States Patent (USP) Shen of entitled " STAPLE CARTRIDGE COMPRISING A RELEASABLE PORTION "
It please sequence number 13/097,873 (attorney number END6857USCIP1/100542CIP1);
Entitled " STAPLE CARTRIDGE COMPRISING COMPRESSIBLE DISTORTION RESISTANT
(the attorney number END6858USCIP1/ of U.S. Patent Application Serial Number 13/097,938 of COMPONENTS "
100543CIP1);
Entitled " STAPLE CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR's "
U.S. Patent Application Serial Number 13/097,924 (attorney number END6859USCIP1/100544CIP1);
The U.S. Patent Application Serial Number 13/ of entitled " SURGICAL STAPLER WITH FLOATING ANVIL "
242,029 (attorney number END6841USCIP2/100526CIP2);
The U.S. Patent application sequence of entitled " CURVED END EFFECTOR FOR A STAPLING INSTRUMENT "
Row number 13/242,066 (attorney number END6841USCIP3/100526CIP3);
The U.S. Patent Application Serial of entitled " STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK "
Number 13/242,086 (attorney number END7020USNP/110374);
The U.S. of entitled " STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK ARRANGEMENT "
Patent application serial number 13/241,912 (attorney number END7019USNP/110375);
The U.S. Patent application of entitled " SURGICAL STAPLER WITH STATIONARY STAPLE DRIVERS "
Sequence number 13/241,922 (attorney number END7013USNP/110377);
Entitled " SURGICAL INSTRUMENT WITH TRIGGER ASSEMBLY FOR GENERATING
13/241,637 (the attorney number of U.S. Patent Application Serial Number of MULTIPLE ACTUATION MOTIONS "
END6888USNP3/110378);And
Entitled " SURGICAL INSTRUMENT WITH SELECTIVELY ARTICULATABLE END
The U.S. Patent Application Serial Number 13/241,629 (attorney number END6888USNP2/110379) of EFFECTOR ".
Present applicant also possesses U.S. Patent application below, these patent applications carry on the same day with the application
It hands over, and each is respectively integrally incorporated herein by reference:
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING APLURALITY OF
The U.S. Patent Application Serial Number of CAPSULES " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6864USCIP1/
100550CIP1);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING APLURALITY OF LAYERS "
U.S. Patent Application Serial Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6864USCIP2/100550CIP2);
The U.S. Patent Application Serial of entitled " EXPANDABLE TISSUE THICKNESS COMPENSATOR "
Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP2/100528CIP2).
The United States Patent (USP) of entitled " TISSUE THICKNESS COMPENSATOR COMPRISING ARESERVOIR "
Patent application serial numbers _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP3/100528CIP3);
Entitled " RETAINER ASSEMBLY INCLUDING A TISSUE THICKNESS COMPENSATOR's "
U.S. Patent Application Serial Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP4/100528CIP4);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING ATLEAST ONE
The U.S. Patent Application Serial Number of MEDICAMENT " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP5/
100528CIP5);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING CONTROLLED RELEASE AND
The U.S. Patent Application Serial Number of EXPANSION " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP6/
100528CIP6);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING STRUCTURE TO PRODUCE A
The U.S. Patent Application Serial Number of RESILIENT LOAD " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP8/
100528CIP8);
The U.S. of entitled " TISSUE THICKNESS COMPENSATOR COMPRISING RESILIENT MEMBERS "
State's patent application serial number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP9/100528CIP9);
Entitled " METHODS FOR FORMING TISSUE THICKNESS COMPENSATOR ARRANGEMENTS
The U.S. Patent Application Serial Number of FOR SURGICAL STAPLERS " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number
END6843USCIP10/100528CP10);
The U.S. Patent Application Serial of entitled " TISSUE THICKNESS COMPENSATORS "
Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP11/100528CP11);
The U.S. Patent Application Serial of entitled " LAYERED TISSUE THICKNESS COMPENSATOR "
Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP12/100528CP12);
Entitled " TISSUE THICKNESS COMPENSATORS FOR CIRCULAR SURGICAL STAPLERS "
U.S. Patent Application Serial Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END6843USCIP13/100528CP13);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING CAPSULES DEFINING A
The U.S. Patent Application Serial Number of LOW PRESSURE ENVIRONMENT " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number
END7100USNP/110601);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISED OF APLURALITY OF
The U.S. Patent Application Serial Number of MATERIALS " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7101USNP/
110602);
Entitled " MOVABLE MEMBER FOR USE WITH A TISSUE THICKNESS COMPENSATOR's "
U.S. Patent Application Serial Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7107USNP/110603);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING APLURALITY OF
The U.S. Patent Application Serial Number of MEDICAMENTS " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7102USNP/
110604);
Entitled " TISSUE THICKNESS COMPENSATOR AND METHOD FOR MAKING THE SAME's "
U.S. Patent Application Serial Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7103USNP/110605);
The United States Patent (USP) Shen of entitled " TISSUE THICKNESS COMPENSATOR COMPRISING CHANNELS "
Please sequence number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7104USNP/110606);
Entitled " TISSUE THICKNESS COMPENSATOR COMPRISING TISSUE INGROWTH
The U.S. Patent Application Serial Number of FEATURES " _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7105USNP/110607);
And
Entitled " DEVICES AND METHODS FOR ATTACHING TISSUE THICKNESS
The U.S. Patent Application Serial of COMPENSATING MATERIALS TO SURGICAL STAPLING INSTRUMENTS "
Number _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ (attorney number END7106USNP/110608).
Certain exemplary embodiments will now be described, to understand the knot of apparatus and method as disclosed herein on the whole
Structure, function, manufacture and purposes.One or more examples of these embodiments are shown in the accompanying drawings.The ordinary skill people of this field
Member it should be appreciated that specifically describe and be illustrated in the exemplary embodiment that the device and method in attached drawing are unrestricted herein.
With regard to the feature that an exemplary embodiment is illustrated or described, can be combined with the feature of other embodiment.It is such
Modifications and variations are included within the scope of the invention.
Can be used it is disclosed herein or it is claimed for manufacture, formed or in other words article of manufacture or
Any of method of product manufactures, is formed or in other words produced whole or the portion of considered product or product
Point, and using the manufacture of such method, formation or the in other words part of the considered product or product of production,
Can the rest part of article of manufacture or product in any way, including by using disclosed herein and claimed
For manufacturing, being formed or in other words any of other methods of article of manufacture or product, and can be with any side
Formula combines the various pieces so produced.Similarly, disclosed herein or claimed any product or product
Can individualism, or combined presence or as its entirety portion with so disclosed any other product or product compatible
Divide and exists.Therefore, can will combine a kind of a particular feature, structure, or characteristic shown or described in product, product or method all or
It is unlimitedly combined with the feature or characteristic of other one or more biocompatible articles, product or method part.Such modification and change
Type is included within the scope of the invention.
With reference to certain figures or otherwise, the specific embodiment in invention disclosed herein or certain systems
In the case that product, product or method may include certain structures, characteristic or feature, reader should be appreciated that this indicates those structures, spy
Property or feature structure can be embodied in any compatible combination in considered product, product or method.In particular, multiple optional
Such disclosure of structure, characteristic or feature should be understood as in addition disclose in combination all that structure, characteristic or
Feature, but as disclosed in alternate forms each other structure, characteristic or the case where feature except.In this class formation, characteristic or spy
In the case that sign is used as disclosed in alternate forms each other, this should be understood as disclosing those alternate forms as mutual
It replaces.
Terms used herein " nearside " and " distal side " be relative to manipulate surgical instruments handle portions clinician and
Speech.Term " nearside " refers near the part of clinician, and term " distal side " refers to the part far from clinician.Also answer
Work as understanding, for the sake of succinct and is clear, such as "vertical", "horizontal", "up" and "down" etc can be used in conjunction with attached drawing herein
Spatial terminology.However, surgical instruments uses in many directions and position, and these terms and it is unrestricted and/or
Absolute.
Various exemplary means and method are provided to execute laparoscopic type and minimally invasive surgical procedures.However, reader
Will be apparent from, various method and apparatus disclosed herein can be used for many surgical procedures and application (including with opening
The application that formula surgical procedures are combined) in.With continued reference to present embodiment, reader will be further understood that, this paper institutes
Disclosed various instruments can be inserted into body in any way, such as pass through natural cavity, the notch by being formed in tissue
Or puncturing hole etc..The working portion or end effector portion of instrument can be plugged directly into patient body or can be by with works
Make entering device and being inserted into for channel, the end effector and the axis of elongation of surgical instruments can be promoted by the service aisle.
Attached drawing is gone to, wherein in multiple views, the similar component of similar digital representation, Fig. 1, which is shown, to be put into practice
The surgical instruments 10 of several unique benefits.Surgery suturing appliance 10 is designed to manipulate and/or activate operationally to be attached
To the various forms of surgery suturing appliance 10 and the end effector 12 of size.In Fig. 1-Fig. 1 E, such as end effector 12
Including elongated channel 14, which forms the lower jaw 13 of end effector 12.Elongated channel 14 can support " implantable
" nail bin 30 and also movably support as end effector 12 upper jaw 15 anvil block 20.
Elongated channel 14 can be made of such as 300&400 series, 17-4&17-7 stainless steels, titanium etc., and can be formed with interval
Side wall 16.Anvil block 20 by 300&400 series 17-4&17-7 stainless steels, titanium under it can be process, and can have nail to shape
Surface, the nail shaped lower face are generally indicated as 22 and are formed with multiple nail shapes pits 23.Referring to Figure 1B -1E.
In addition, anvil block 20 have from anvil block 20 to nearside it is raised be divided into two-part slide assemblies 24.Anvil block pin 26 is from slide assemblies
24 each horizontal lateral process, to receive in respective slots or opening 18 in the side wall 16 of elongated channel 14, to be conducive to
By anvil block pin 26 movably or be attached pivotally to the respective slots or opening 18.
Various forms of implanted nail bins can be used together with surgical instruments disclosed herein.It will discuss in more detail below
State specific nail bin configuration and construction.However, in figure 1A, showing implanted nail bin 30.Nail bin 30 has main part 31,
The main part is by compressible hemostatic material (such as oxidized regenerated cellulose (" ORC ") or bioabsorbable foam) structure
At wherein being supported by the unfashioned peg of multirow 32.For anti-non-magnetic shim it is impacted and prevent hemostatic material introduce and position
It is activated during process, entire storehouse can be coated with or be enclosed with biodegradable film 38, such as with trade markIt sells
Six cyclic ketones films or polyglycerol sebacate (PGS) film (are gathered in oneself by PGA (polyglycolic acid is sold with trade mark Vicryl), PCL
Ester), PLA or PLLA (polylactic acid), PHA (polyhydroxyalkanoatefrom), PGCL (Poliglecaprone 25 is sold with trade mark Monocryl)
Or other biodegradable films that the compound of PGA, PCL, PLA, PDS are formed, the film are only just permeable in rupture.
The ontology 31 of nail bin 30 is sized to removedly be supported in elongated channel 14 as shown in the figure so that when anvil block 20
It is driven to when being contacted with the formation of nail bin 30, each of which nail 32 is aligned with corresponding nail shapes pit 23.
In use, once end effector 12 is positioned adjacent to target tissue, end effector 12 is just manipulated to target group
It knits capture or is clamped between the upper surface 36 of nail bin 30 and the staple forming surface 22 of anvil block 20.Nail 32 in the following way at
Shape:Anvil block 20 is set to be moved in the path for being arranged essentially parallel to elongated channel 14, so as to staple forming surface 22 and more specifically make
Nail shapes pit 23 therein substantially simultaneously contacts the top surface 36 of nail bin 30.As anvil block 20 continues to move in nail bin 30,
The leg 34 of nail 32 contacts corresponding nail shapes pit 23 in anvil block 20, nail shapes pit 23 for making nail leg 34 be bent so that
Nail 32 is configured to " B shapes ".The further movement of anvil block 20 towards elongated channel 14 will compress further nail 32 and its forming made to schedule to last
The final forming height " FF " hoped.
Above-mentioned nail forming process is generally described in Figure 1B -1E.For example, Figure 1B shows end effector 12, wherein target group
" T " is knitted to be located between anvil block 20 and the top surface 36 of implantable nail bin 30.Fig. 1 C show the initial clamped position of anvil block 20, wherein anvil
Seat 20 is closed up to target tissue " T ", and target tissue " T " is clamped between anvil block 20 and the top surface 36 of nail bin 30.Fig. 1 D
It shows initially to follow closely forming, wherein anvil block 20 has started to compress nail bin 30 so that follows closely 32 leg 34 and begins through in anvil block 20
Nail shapes pit 23 and shape.Fig. 1 E show the nail 32 that final shaped state is in across target tissue " T ", for clarity
Remove anvil block 20.Once nail 32 shapes and is fastened to target tissue " T ", surgeon just makes anvil block 20 move to open position, with
Warehouse 31 and nail 32 is set to remain attached to target tissue when withdrawing from end effector 12 from patient.When two jaws 13,15
When common clamping, end effector 12 makes all nails while shaping.Remaining " is crushed " bulk material 31 and is used as hemostat
(ORC) and staple line reinforcing agent (other film compositions 38 of PGA, PDS or any of above).Further, since nail 32 during forming not
Warehouse 31 must be left, therefore follows closely the possibility that 32 become deformity during forming and is minimized.As used herein, term " implantation
Formula " refers in addition to nail, and the warehouse material of support nail also would be held in patient body and can finally be absorbed by patient body.
Such implanted nail bin is different from previous nail bin structure, which has been fired later still completely at it
It is located in end effector.
In various specific implementations, end effector 12 can be connected to the elongation assembly from 100 protrusion of handle assembly
40.End effector 12 (when being closed) and elongation assembly 40 can have similar cross-sectional shape, and its size is set
It is fixed at passing through trocar tube or service aisle with another access instruments formal operations.As used herein, term is " operationally
Across " to refer at least part of end effector and elongation assembly can be inserted into or may pass through channel by channel or tube opening
Or tube opening, and it can be manipulated to complete surgery stitching operation if necessary in channel or tube opening.When in closure
When position, the jaw 13 of end effector 12 and 15 can provide the cross-sectional shape of substantial circular in favor of it for end effector
Across circular access/opening.It is contemplated, however, that be provided with other transversal for the end effector and elongation assembly of the present invention
Face shape passes through entering path and opening with non-circular transverse cross-section so as to other modes.Therefore, the end of closure
The overall dimension of the cross section of portion's actuator by end effector by across channel or the size of opening it is related.Therefore, one
A end effector is for example referred to alternatively as " 5mm " end effector, this, which refers to it, operationally to pass through diameter at least big
The opening of about 5mm.
Elongation assembly 40 can have the outer diameter of substantially equal with the outer diameter of end effector 12 in the close position.Example
Such as, 5mm end effectors can be connected to the elongation assembly 40 with 5mm cross-sectional diameters.However, specific real with continued reference to this
Apply mode, it will be apparent that, the present invention can be effectively combined various sizes of end effector and use.For example, the ends 10mm
Portion's actuator could attach to the axis of elongation with 5mm cross-sectional diameters.On the contrary, being opened for the entrance for wherein providing 10mm or bigger
For the application in mouth or channel, elongation assembly 40 can be with the cross-sectional diameter of 10mm (or bigger), but can also activate 5mm
Or 10mm end effectors.Therefore, the outer diameter of outer shaft 40 can be with the outer diameter of the end effector 12 for the closure for being attached to outer shaft 40
It is identical or different.
As shown, elongation assembly 40 is distally extending substantially along straight line from handle assembly 100, to limit longitudinal direction
Axis A-A.For example, elongation assembly 40 may be about 9-16 inches (229-406mm) length.However, elongation assembly 40 can be set
Connector can be had or can otherwise be conducive to end effector 12 relatively by being set in other length or elongation assembly
Joint motions are carried out in the other parts of axis or handle assembly, following article will be discussed in more detail.Elongation assembly 40 includes ridge
Component 50, the ridge component extend to end effector 12 from handle assembly 100.The nearside of the elongated channel 14 of end effector 12
End, which has from a pair of of its protrusion, keeps trunnion 17, this is sized to receive in the remote of ridge component 50 to holding trunnion
In corresponding trunnion opening or holder 52 provided in the end of side, so that end effector 12 can removedly couple elongation
Shaft assembly 40.Ridge component 50 can be made of such as 6061 or 7075 aluminium, stainless steel, titanium etc..
Handle assembly 100 includes pistol grasping type shell, which can be made into for assembling purpose
Two or more parts.For example, handle assembly 100 as shown in the figure include by polymer or plastic material molding or in other words
Made of saying and it is designed to the right hand housing member being combined together 102 and left hand housing member (not shown).Can by
It wherein molds or the snap feature structure, bolt and the pod that are in other words formed, and/or will be such by adhesive, screw etc.
Housing member is attached together.There is ridge component 50 proximal extremity 54, the proximal extremity to have flange 56 formed thereon.It is convex
Edge 56 can be rotationally supported in groove 106, and the groove is from from housing member 102, each of 104 to inner process
The formation of fit ribs 108.This structure is conducive to ridge component 50 and is attached to handle assembly 100, while keeping ridge component 50 opposite
It is rotated around longitudinal axis A-A along 360 ° of paths in handle assembly 100.
As in Fig. 1 it can further be shown that ridge component 50 passes through axle bush 60 and is supported by axle bush 60, the installation
Bushing 60 is pivotally attached to handle assembly 100.Axle bush 60 have proximal flange 62 and distal lip 64, the nearside convex
Edge and distal lip limit rotated trench 65, which can rotatably connect the leading edge portion 101 of handle assembly 100
It is received in therebetween.This structure enables axle bush 60 to be rotated around longitudinal axis A-A relative to handle assembly 100.Ridge component 50
By ridge pin 66 non-rotatably pin joint to axle bush 60.In addition, turn knob 70 is attached to axle bush 60.For example, rotation
There is button 70 hollow mounting flange portion 72, the hollow mounting flange portion to be sized to connect a part for axle bush 60
It is received in wherein.Knob 70 can by such as glass or carbon filled nylon, makrolon,Etc. being made, and also by ridge pin
66 are attached to axle bush 60.In addition, being formed in mounting flange portion 72 and can extend to the reservation flange 74 of inner process
It is formed in the radial groove 68 in axle bush 60.Therefore, surgeon can be by firmly grasping turn knob 70 and keeping it opposite
It is rotated in handle assembly 100, and ridge component 50 (and being attached to the end effector 12 of ridge component 50) is made to surround longitudinal axis A-A
It is rotated along 360 ° of paths.
Anvil block 20 is maintained at open position by anvil block spring 21 and/or another biased configuration.By being substantially marked as
109 trigger system, anvil block 20 can selectively move to various closures or clamped position and firing position from open position.
Trigger system 109 includes " firing member " 110 comprising hollow firing tube 110.Hollow firing tube 110 can be in ridge component 50
It moves axially, therefore forms the outside of elongation assembly 40.Firing tube 110 can be by polymer or other suitable material systems
At, and with the proximal extremity for the percussion yoke 114 for being attached to trigger system 109.For example, percussion yoke 114 is moldable to arrive firing tube
110 proximal extremity.However, other fasteners construction can also be used.
As can be seen in Figure 1, percussion yoke 114 can be pivotally supported in support lining ring 120, the support lining ring energy
It is enough to be axially moved in handle assembly 100.Support lining ring 120 has a pair of fin extended laterally, which sets
It is fixed at being slidably received in the fin slit being formed in left hand housing member and right hand housing member.Therefore, support lining
Circle 120 can slide axially in shank shell 100, while enable percussion yoke 114 and firing tube 110 relative to support lining ring
120 around longitudinal axis A-A rotations.According to the present invention, firing tube 110 is passed through to provide longitudinal slit, so that ridge pin 66 can be worn
It crosses longitudinal slit to extend in ridge component 50, while being conducive to firing tube 110 and axially advancing in ridge component 50.
Trigger system 109 further includes firing trigger 130, and the firing trigger is for controlling firing tube 110 in ridge component
Axial movement on 50.Referring to Fig. 1.Such moved to along distal direction of firing tube 110 carries out percussion phase interaction with anvil block 20
Axial movement is referred to herein as " percussion movement ".As can be seen in Figure 1, firing trigger 130 passes through pivot pin
132 movably or are pivotally coupled to handle assembly 100.It is separate that firing trigger 130 is biased using torsionspring 135
The pistol grip portion 107 of handle assembly 100 and reach " opening " or the initial position not activated.As can be seen in Figure 1, it hits
Sending out trigger 130, there is top 134, the top to be movably attached (pin joint) and arrive percussion chain link 136, and the percussion chain link is movable
Ground is attached (pin joint) and arrives support lining ring 120.Therefore, firing trigger 130 is from initial position (Fig. 1) towards adjacent shank component
The movement of the firing trigger 130 of the end position of 100 pistol-grip portion 107 will make percussion yoke 114 and firing tube 110
The movement in distal direction " DD ".The movement of pistol grip portion 107 of the firing trigger 130 far from handle assembly 100 (is being turned round
Under the biasing for turning spring 135) it will be so that percussion yoke 114 and firing tube 110 be moved in 50 upper edge proximal direction " PD " of ridge component.
The present invention can be used together from different sizes with the implanted nail bin of configuration.For example, when combining the first percussion to be connected
Son 140 is in use, surgical instruments 10 can be held with the ends 5mm of the about 20mm long (or with other length) of support implanted nail bin 30
Row device 12 is used together.This end effector size can be particularly well-suited in for example realizing dissection and the blood vessel of opposite fine
Processing.However, following article institute is described in more detail, such as also can be by the way that the first percussion adapter 140 is changed to the second percussion rank
It connects son and surgical instruments 10 is used in combination with the end effector of other sizes and nail bin.As other alternate forms, stretch
Long axis component 40 can be attached to the end effector of only a kind of form or size.
A kind of method that end effector 12 is removedly connected to ridge component 50 will be illustrated now.It is logical by that will extend
Start connection process in the trunnion mounting 52 that holding trunnion 17 on road 14 is inserted into ridge component 50.Then, surgeon will
The pistol grip 107 of firing trigger 130 towards casing assembly 100 promotes, by firing tube 110 and the first percussion adapter
140 are advanced distally on the proximal end portions 47 of elongated channel 14, to which trunnion 17 is maintained at its respective holder
In 52.The position of the first percussion adapter 140 above trunnion 17 is referred to here as " coupled position ".The present invention can also have
End effector locked component, for locking firing trigger 130 just after being attached to ridge component 50 in end effector 12
Position.
More particularly, one embodiment of end effector locked component 160 includes retaining pin 162, the retaining pin quilt
It is movably supported in the top 134 of firing trigger 130.As described above, firing tube 110 must be distad pushed into first
To coupled position, wherein the holding trunnion 17 of end effector 12 is maintained in ridge component 50 by the first percussion adapter 140
In trunnion mounting 52.Surgeon is held in the mouth percussion by pulling firing trigger 130 towards pistol grip 107 from initial position
It connects son 140 and is advanced distally into the coupled position.When firing trigger 130 is activated first, retaining pin 162 is distad transported
Dynamic, until the first percussion adapter 140 is advanced to coupled position by firing tube 110, retaining pin 162, which is biased to, at this time is formed in
In latch well 164 in housing member.Optionally, when retaining pin 162 enters in latch well 164, pin 162 can send out audible
" clicker " sound or other sound, and for surgeon provide end effector 12 be " locked " in ridge component 50 touch
Feel instruction.As long as in addition, retaining pin 162 is not intentionally biased out latch well 164, surgeon just will not activate unintentionally and hit
Trigger 130 is sent out to start to make the nail 32 in end effector 12 to shape.Similarly, if surgeon's release is in connection position
The firing trigger 130 set, then retaining pin 162 can make firing trigger 130 keep in the position, to prevent firing trigger
130 are back to initial position and therefore discharge end effector 12 from ridge component 50.
The present invention may also include trigger system locking press button 137, and the trigger system locking press button is with can be pivotably
It is attached to handle assembly 100.In one form, trigger system locking press button 137 has the door bolt formed in its distal end
Lock 138, the latch are oriented to the latch 138 when firing release button and being in the first latch position and engage percussion yoke 114.Such as exist
It can be seen that in Fig. 1, late spring 139 is used to trigger system locking press button 137 being biased to the first latch position.In various situations
Under, latch 138 is used to engage percussion yoke 114 at following point:At this point, the position pair of the percussion yoke 114 in ridge component 50
Ying Yu wherein the first percussion adapters 140 will be advanced to the point in the clamping slideway 28 on anvil block 20 towards distal side.It should be appreciated that
As the first percussion adapter 140 is promoted in clamping slideway 28 in an axial direction, anvil block 20 will be moved along path so that nail forming table
Face 22 is arranged essentially parallel to the top surface 36 of nail bin 30.
After end effector 12 is connected to ridge component 50, opened by depressing trigger system locking press button 137 first
Begin nail forming process, so that percussion yoke 114 can further move toward the far side in ridge component 50 and finally compress anvil block 20
Into nail bin 30.After depressing trigger system locking press button 137, surgeon, which continues to activate towards pistol grip 107, to be fired
Trigger 130, to shape on slideway 29 driving of first nail lining ring 140 to corresponding nail, to force anvil block 20 and nail bin
32 shaping contact of nail in 30.Trigger system locking press button 137 prevents before surgeon is ready to start to follow closely forming process
Unintentionally shape nail 32.In such embodiments, surgeon must be before firing trigger 130 can be further actuated
Pressure trigger system locking press button 137 is to start to follow closely forming process.
Surgical instruments 10 can be used only as tissue apposition device as needed.However, the present invention may also comprise tissue cutting
System, the tissue diced system are substantially marked as 170.In at least one form, tissue diced system 170 includes cutter component
172, it can be by activating cutter traveling trigger 200 by the cutter component selectively from the nearside of adjacent side terminal part actuator 12 end
The unactuated position at end is advanced to actuated position.Cutter component 172 is movably supported in ridge component 50, and is attached to knife bar
180 or in other words from 180 protrusion of knife bar.Cutter component 172 can be by for example with the hardness more than 38HRC (Rockwell hardness C grade)
420 or 440 stainless steels be made, and can have and be formed in tissue cutting edge 176 in its distal end 174, and can
The slit in anvil block 20 and the slit being centrally located in nail bin 30 33 are slidably extended through, end is clamped in cut through and holds
Tissue in row device 12.Knife bar 180 extends through ridge component 50 and with the proximal extremity with Cutter conveyer transmission handing-over
Part, the Cutter conveyer are operably attached to cutter traveling trigger 200.Cutter traveling trigger 200 is attached to pivot pin
132 so that it can be pivoted without activating firing trigger 130 or in other words activated.According to this hair
Bright, first cutter tooth wheel 192 is also attached to pivot pin 132 so that the actuating of cutter traveling trigger 200 also makes first cutter tooth wheel 192
It pivots.Percussion return spring 202 is attached between first cutter tooth wheel 192 and shank shell 100, by knife actuating trigger 200
It is biased to initial position or unactuated position.
Cutter conveyer further includes the second cutter tooth wheel 194, which is pivotally supported on second gear axis
And it is engaged with first cutter tooth wheel 192.Second cutter tooth wheel 194 is engaged with the 3rd gear shaft 196 being supported on third gear shaft.The
Four cutter tooth wheels 198 are also supported on third gear shaft 195.4th cutter tooth wheel 198 can be driven the nearside for being bonded on knife bar 180
A series of gear teeths on end or ring.Therefore, this structure enable 4th cutter tooth wheel 198 along distal direction " DD " or
Proximal direction " PD " axially trigger shaft 180, while making trigger shaft 180 relative to 4th cutter tooth wheel 198 around longitudinal axis A-A
Rotation.Therefore, surgeon can make to hit by pulling knife actuating trigger 200 towards the pistol grip 107 of handle assembly 100
Hair bar 180 axially promotes and most all morning distal side pushes cutter component 172.
The invention also includes cutter locking system 210, which prevents the propulsion of cutter component 172, unless percussion is touched
Hair device 130 has been pulled to complete firing position.Therefore, this structure will prevent the activation of knife propulsion system 170, unless nail is
It is fired or is formed in tissue first.As can be seen in Figure 1, the various specific implementations of cutter locking system 210 include knife lock
Fixed pole 211, the cutter securing rod 211 are pivotally supported in the pistol grip portion 107 of handle assembly 100.Cutter securing rod 211
With activated end 212, when firing trigger 130 is in complete firing position, activated end 212 can be by firing trigger 130
Engagement.Keep suspension hook 214, the holding suspension hook that can be engaged in a manner of suspension hook in addition, cutter securing rod 211 has on the other end thereof
Latch bar 216 on first cutting gear 192.Cutter securing rod 211 is biased to by " locking " position using Lock spring 218
It sets.In " locking " position, the holding of suspension hook 214 is kept to be engaged with latch bar 216, to prevent knife actuating trigger 200
Actuating, unless firing trigger 130 is in complete firing position.
After nail is " fired " in (forming) to target tissue, surgeon can depress percussion trigger release button 167,
So that firing trigger 130 can be back to initial position under the bias of torsionspring 135, to enable anvil block 20
Open position is biased downwards into the bias of spring 21.When in open position, surgeon can withdraw from end effector
12 and leave implantable nail bin 30 and nail 32.End effector is across channel, service aisle etc. wherein and what is be inserted into answers
In, surgeon will make anvil block 20 be back to closed position by activating firing trigger 130, so that end effector 12
It can be withdrawn by by the channel or service aisle.However, if surgeon wants to cut target tissue after percussion nail,
Then surgeon activates cutter traveling trigger 200 in the above described manner, passes through target tissue to reach end effector with trigger shaft 172
End.Then, the releasable cutter traveling trigger 200 of surgeon, so that percussion return spring 202 can make percussion transmission dress
It sets and knife bar 172 is back to starting (does not activate) position.Once knife bar 172 is back to initial position, surgeon can open
Implanted storehouse 30 is released to patient's body and then withdraws from end execution from patient's body by end effector jaw 13,15
Device 12.Therefore, such surgical instruments is conducive to small using that can be inserted by relatively small service aisle and channel
Implanted nail bin, while providing following selection for surgeon:The percussion nail or if necessary in hitting in the case where not cutting tissue
Tissue is also cut after hair nail.
The various unique and new embodiments of the present invention use compressible nail bin, the compressible nail bin support to be in
Substantially fixed position is for by the nail of anvil block shaping contact.During anvil block driving is followed closely to unshaped, wherein for example being reached
Nail forming degree depend on anvil block be driven to follow closely in how far.Such construct, which allows a surgeon to adjust, is applied to nail
Forming or percussion pressure amount, to change the final forming height of nail.In other aspects of the present invention, surgical stapling construction
Nail driving element can be used, which can lift nail towards anvil block.These descriptions in greater detail below.
Optionally, the actuating of firing trigger is depended on reference to the amount for above, being applied to the firing action of movable anvil block
Degree.For example, if surgeon go for only part forming nail, only need towards pistol grip 107 partly to
Interior pressure firing trigger.To obtain more nail formings, surgeon only needs further to compress firing trigger so that anvil
Seat is further driven to be contacted with being formed with nail.As used herein, term " shaping contact " refers to staple forming surface or nail
Forming pit has contacted the end of nail leg and has started to shape leg or be bent to shaping position.The degree of nail forming refers to nail
Degree that leg is folded and refer to finally nail referred to above forming height.Those skilled in the art will be into one
Step understands that, because when applying percussion movement to anvil block 20, anvil block 20 is moved with the relationship substantially parallel with nail bin,
So nail substantially simultaneously shapes and has basically the same forming height.
Fig. 2 and Fig. 3 show alternative end effectors 12 ", except the following difference that can accommodate knife bar 172 '
Except, end effector 12 " is similar to above-mentioned end effector 12 '.Knife bar 172 ' is connected to knife bar 180 or prominent from knife bar 180
It rises, and is in addition to this operated in a manner of above in connection with described in knife bar 172.However, in this embodiment, knife stick
172 ' long enoughs do not use individual distal blade to traverse the whole length of end effector 12 " in end effector 12 "
Component.Knife stick 172 ' has upper cross member 173 ' and lower cross member 175 ' formed thereon.173 ' quilt of upper cross member
It is orientated to and slideably traverses corresponding elongated slot 250 in anvil block 20 ", and lower cross member 175 ' is oriented to traverse end
Elongated slot 252 in the elongated channel 14 " of portion's actuator 12 ".It is also equipped in anvil block 20 " and is detached from slit (not shown), made
When proper knife bar 172 ' is driven to the end position in end effector 12 ", upper cross member 173 ' passes through corresponding slit
And fall, so that anvil block 20 " can move to open position, to be detached from the tissue for suturing and cutting.Anvil block 20 " can remove
It is identical as above-mentioned anvil block 20 except this, and elongated channel 14 " can be in addition to this identical as above-mentioned elongated channel 14.
In these embodiments, anvil block 20 " is biased to fully open position by spring or other Unclosing structure (not shown)
(Fig. 2).Anvil block 20 " is by the axial direction that percussion adapter 150 carries out in the above described manner is advanced in open position and clamping completely
It is moved between position.Once percussion adapter 150 is advanced into fully clamped position (Fig. 3), surgeon can be then with above-mentioned
Mode promotes knife bar 172 " towards distal side.If surgeon wants end effector carrying out manipulating tissue as grasp device,
Percussion adapter can proximally be moved, to allow anvil block 20 " to be moved far from elongated channel 14 ", as shown in phantom in figure 4.
In this embodiment, when shelves cutter rod 172 " moves toward the far side, upper cross member 173 ' and lower cross member 175 ' while anvil is pulled
Seat 20 " and elongated channel 14 " realize desired nail to reach when knife stick 172 " is promoted across end effector 12 " towards distal side
Forming.Referring to Fig. 5.Therefore, in this embodiment, nail forming is to occur simultaneously with tissue cutting, but nail itself can be in knife bar
172 " sequentially shape when being driven towards distal side.
The various surgery nail bins of the present invention and unique and novel feature of surgical instruments enable the nail in the nail bin
It is arranged in one or more line linearly or nonlinearly.A plurality of this staple line can be provided on each side of elongated slot, it is described to stretch
Long slit is centrally arranged in nail bin, for receiving the tissue cutting element across the elongated slot.In a kind of arrangement
In mode, such as nail into a line can be substantially parallel to the nail in adjacent staple line but deviate with it.As other
Alternate forms, one or more staple line can be essentially nonlinear.In other words, the base portion of at least one of staple line nail can edge
Substantially the axis crosscutting with the base portion of other nails in same staple line extends.For example, the staple line on every side of elongated slot
There can be sawtooth appearance.
According to the present invention, nail bin may include warehouse and multiple nails for being stored in warehouse.In use, nail bin can be introduced
In operative site and it is located on the side of handled tissue.In addition, can be by nail forming anvil positioning in the opposite of tissue
On side.Anvil block can be carried by the first jaw and nail bin can be carried by the second jaw, wherein the first jaw and/or the second jaw can
It is moved towards another jaw.Once nail bin and anvil block are positioned relative to tissue, then nail can be projected from staple cartridge body so that nail can
It pierces through tissue and contact stud shapes anvil block.Once disposing nail from staple cartridge body, then staple cartridge body can be removed from operative site.Nail
Can plant at least part of storehouse or nail bin has nail.For example, following article is more fully described, nail bin may include warehouse, when
When anvil block moves to closed position from open position, which can be compressed, crushes and/or be collapsed by anvil block.When warehouse compressed,
When being crushed and/or collapsing, the nail in warehouse can be deformed by anvil block.Alternately, the pincers of nail bin are used to support
Mouth can move to closed position towards anvil block.Two kinds of situations it is any in, when nail is positioned at least partially in warehouse, nail
It is deformable.In some cases, nail can not be projected from nail bin, and in other cases, nail can be together with a part for warehouse
It is emitted from nail bin.
Referring now to Fig. 6 A- Fig. 6 D, compressible nail bin (such as nail bin 1000) for example may include compressible implanted storehouse
Body 1010, and multiple nails 1020 for being positioned in addition in compressible warehouse 1010, but Fig. 6 A- Fig. 6 D only show a nail
1020.Fig. 6 A show that the nail bin 1000 supported by nail bin supporting member or staple cartridge channel 1030, wherein nail bin 1000 are shown as locating
In uncompressed condition.In this uncompressed condition, anvil block 1040 is accessible or does not contact tissue T.In use, anvil block 1040
Contact tissue T can be moved to from open position, as shown in Figure 6B, and tissue T is positioned against warehouse 1010.Even if anvil block 1040
The tissue contacting surface 1019 of tissue T against staple cartridge body 1010 can be positioned, however referring again to Fig. 6 B, staple cartridge body 1010 is at this time
Can by few (if any) compressing force or pressure, and follow closely 1020 be positively retained at unshaped or do not fire under the conditions of.
As shown in Figure 6 A and 6 B, staple cartridge body 1010 may include one or more layers, and the nail leg 1021 of nail 1020 may pass through these
Layer upwardly extends.Warehouse 1010 may include first layer 1011, the second layer 1012, third layer 1013 and the 4th layer 1014, wherein
Can be positioned on for two layer 1012 among first layer 1011 and third layer 1013, wherein third layer 1013 can be positioned on the second layer 1012 with
Among 4th layer 1014.For example, the base portion 1022 of nail 1020 can be positioned in the cavity 1015 in the 4th layer 1014, and nail leg
1021 can upwardly extend from base portion 1022 and across the 4th layer 1014, third layer 1013 and the second layer 1012.Optionally, each
Deformable leg 1021 may include top, such as sharp top 1023, such as when nail bin 1000 is in uncompressed condition, the cutting edge of a knife or a sword
The top of profit can be positioned in the second layer 1012.For example, top 1023 can be not extend to and/or pass through first layer 1011, wherein
When nail bin 1000 is in uncompressed condition, top 1023 not projecting can pass through tissue contacting surface 1019.When nail bin is in not
When contractive condition, sharp top 1023 can be positioned in third layer 1013 and/or any other suitable layer.As another kind
The warehouse of selection, nail bin can have any suitable number of layers, such as less than four layers or more than four layers.
Optionally, following article is more fully described, and first layer 1011 can be (all by buttress material and/or plastic material
Such as polydioxanone (PDS) and/or polyglycolic acid (PGA)) it constitutes, and the second layer 1012 can be by bioabsorbable bubble
Foam material and/or compressible hemostatic material (such as oxidized regenerated cellulose (ORC)) are constituted.Optionally, first layer 1011, second
Nail 1020 can be maintained in staple cartridge body 1010 by layer 1012, third layer 1013 and the 4th layer one or more of 1014, and
The holding of nail 1020 can in addition be mutually aligned.Third layer 1013 can be by buttress material or quite incompressible or non-resilient material
Material is constituted, which can be held in place the nail leg 1021 for following closely 1020 relative to each other.In addition, being located at third layer
The second layer 1012 in 1013 opposite sides and the 4th layer of 1014 movement that can stablize or reduce nail 1020, even if the second layer
1012 and the 4th layer 1014 may include compressible foam or elastic material.The screw top end 1023 of nail leg 1021 can be at least partly
In embedded first layer 1011.For example, first layer 1011 and third layer 1013 can be collaboratively and firmly by nail legs 1021
It is held in place.First layer 1011 and third layer 1013 can be respectively by such as bioabsorbable material (such as with trade name
Polyglycolic acid (PGA), polylactic acid (PLA or PLLA), polydioxanone (PDS), the poly (hydroxy alkanoate) of Vicryl sales
Ester (PHA), the Poliglecaprone 25 (PGCL), polycaprolactone (PCL), and/or the PGA, PLA that are sold with trade name Monocryl,
The compound of PDS, PHA, PGCL and/or PCL) thin slice constitute, and the second layer 1012 and the 4th layer 1014 can be respectively by extremely
A kind of few hemostatic material or hemostat are constituted.
Although first layer 1011 can be compressible, the second layer 1012 substantially can be pressed more than first layer 1011
Contracting.For example, the compressibility of the second layer 1012 can be first layer 1011 about twice, about three times, about four times, about five times and/or
About ten times.In other words, for given power, the compression degree of the second layer 1012 can be the about twice of first layer 1011, about three times,
About four times, about five times, and/or about ten times.The compressibility of the second layer 1012 for example can first layer 1011 approximately twice as with
Between about ten times.The second layer 1012 may include being defined in multiple air gaps therein, the wherein amount of the air gap in the second layer 1012
And/or size can be controlled to provide the expectation compressibility of the second layer 1012.It is similar to the above, although third layer 1013 can be
It is compressible, however the 4th layer 1014 can substantially have more compressibility than third layer 1013.For example, the 4th layer 1014 can
Compressibility can be third layer 1013 about twice, about three times, about four times, about five times, and/or about ten times.In other words, for given
Power, the 4th layer 1014 of compression degree can be the about twice of third layer 1013, about three times, about four times, about five times, and/or about
Ten times.4th layer 1014 of compressibility can be between third layer 1013 be approximately twice as about ten times.4th layer 1014 can
Including being defined in multiple air gaps therein, wherein the amount and/or size of air gap in the 4th layer 1014 can be controlled to provide
4th layer 1014 of expectation compressibility.It in various scenarios, can be by compression ratio (that is, the power that layer is directed to given size is pressed
The distance of contracting) express the compressibility of warehouse or warehouse layer.For example, compared with the layer compared with little compressible, there is high pressure
The layer of shrinkage will compress the distance of bigger for the compressing force for the given size for being applied to this layer.For so, the second layer 1012
There is higher compression ratio than first layer 1011;Similarly, there is higher compression than third layer 1013 for the 4th layer 1014
Rate.The second layer 1012 and the 4th layer 1014 can be made of identical material and can compression ratios having the same.The second layer 1012
It can be made of the material with different compression ratios with the 4th layer 1014.Similarly, first layer 1011 and third layer 1013 may include
Identical material simultaneously can compression ratio having the same.First layer 1011 and third layer 1013 can be by the materials with different compression ratios
It constitutes.
When anvil block 1040 is moved towards its closed position, anvil block 1040 can contact tissue T and be applied to tissue T and nail bin 1000
Compressive forces, as shown in Figure 6 C.In this case, anvil block 1040 can push down on warehouse 1010 towards nail bin supporting member 1030
Top surface or tissue contacting surface 1019.Nail bin supporting member 1030 may include storehouse stayed surface 1031, can be in 1000 quilt of nail bin
It is compressed in support nail cartridge 1000 when between storehouse stayed surface 1031 and the tissue contacting surface 1041 of anvil block 1040.Due to anvil block
1040 pressure applied, warehouse 1010, which can be compressed, and anvil block 1040 is accessible follows closely 1020.More particularly, warehouse 1010
The first layer for moving downward the puncture of top 1023 warehouse 1010 that can make nail leg 1021 of compression and tissue contacting surface 1019
1011, it pierces through tissue T and enters in the forming pit 1042 in anvil block 1040.When warehouse 1010 is further pressed by anvil block 1040
When contracting, the accessible wall for limiting forming pit 1042 in top 1023, and therefore, leg 1021 can be deformed inward or crimp, such as
As shown in Figure 6 C.Same as shown in Figure 6 C as nail leg 1021 deforms, the base portion 1022 for following closely 1020 can contact nail bin support
Part 1030 is supported by nail bin supporting member 1030.Optionally, as described in greater detail below, nail bin supporting member 1030 may include more
A support construction, such as nail support trenches, slit or slot 1032, such as the multiple support construction can be deformed in nail 1020
When support nail 1020 or at least nail 1020 base portion 1022.It is same as shown in Figure 6 C, cavity 1015 in the 4th layer 1014 can be by
It collapses in the compressing force for being applied to staple cartridge body 1010.In addition to chamber 1015, staple cartridge body 1010 may also include one or more
Gap (such as gap 1016), such as can be located in one or more of gaps or no-fix has the part of nail, it is described
One or more gaps can allow for warehouse 1010 to collapse.Cavity 1015 and/or gap 1016 can collapse so that limit cavity
And/or the wall of wall deflects down and contacts storehouse stayed surface 1031 and/or contact warehouse 1010 and is positioned at cavity and/or gap
The layer of lower section.
In relatively Fig. 6 B and Fig. 6 C, it is clear that the second layer 1012 and the 4th layer 1014 are substantially applied by anvil block 1040
The compression pressure compression added.It may also be noted that first layer 1011 and third layer 1013 are also compressed.It is closed when anvil block 1040 moves to it
When closing position, anvil block 1040 can continue further to press by pushing down on tissue contacting surface 1019 towards nail bin supporting member 1030
Contracting warehouse 1010.As warehouse 1010 is further compressed, anvil block 1040 can make nail 1020 be deformed to it to be fully formed shape, such as
Shown in Fig. 6 D.Referring to Fig. 6 D, the leg 1021 of each nail 1020 can downwards be deformed towards the base portion 1022 of each nail 1020, so as to by group
T, first layer 1011, the second layer 1012, third layer 1013 and the 4th layer 1014 at least part is knitted to capture in deformable leg
Between 1021 and base portion 1022.In relatively Fig. 6 C and Fig. 6 D, more obviously, the second layer 1012 and the 4th layer 1014 substantially by
The compression pressure that anvil block 1040 is applied further compresses.In relatively Fig. 6 C and Fig. 6 D it may also be noted that arriving, 1011 He of first layer
Third layer 1013 has also been further compressed.After nail 1020 is fully shaped completely or at least, anvil block 1040 can be separate
Tissue T and be lifted, and nail bin supporting member 1030 can it is separate and/or be detached from nail bin 1000 move.As shown in Figure 6 D, as with
It is upper described as a result, warehouse 1010 is implantable nail 1020.In various embodiments, the warehouse 1010 being implanted can be along staple line branch
Support tissue.In some cases, the hemostat and/or any other suitable medicine for including in the warehouse 1010 of implantation can
Handle tissue as time goes by.Hemostat as described above can reduce the tissue bleeding of suture and/or cutting, be bonded simultaneously
Agent or tissue adhesive can provide intensity for tissue as time goes by.The warehouse 1010 being implanted into can (oxidation be again by such as ORC
Raw cellulose), extracellular protein (such as collagen), the polyglycolic acid (PGA) sold with trade name Vicryl, polylactic acid (PLA or
PLLA), polydioxanone (PDS), polyhydroxyalkanoatefrom (PHA), the Poliglecaprone sold with trade name Monocryl
The material of the compound of 25 (PGCL), polycaprolactone (PCL), and/or PGA, PLA, PDS, PHA, PGCL and/or PCL is constituted.?
In certain situations, warehouse 1010 may include the antibiosis and/or anti-biotic material that can reduce the possibility of surgical site infection, such as
Collargol and/or triclosan.
The layer of warehouse 1010 can be connected with each other.For example, using at least one adhesive (such as fibrin and/or
Protein hydrogel) second layer 1012 is adhered to first layer 1011, third layer 1013 is adhered to the second layer 1012, and by
It is adhered to third layer 1013 for four layer 1014.Although being not shown, the layer of warehouse 1010 can be connected by interlocking machine feature structure
Together.For example, first layer 1011 and the second layer 1012 can include respectively corresponding interlocking features structure, such as tenon groove structure
And/or dovetail structure.Similarly, the second layer 1012 and third layer 1013 can include respectively corresponding interlocking features structure,
Third layer 1013 and the 4th layer 1014 can include respectively corresponding interlocking features structure simultaneously.Although being not shown, nail bin
1000 may include that for example one or more rivets, the one or more rivet can extend across the one or more of warehouse 1010
Layer.For example, each rivet may include the first end that adjacent first layer 1011 positions or head and it is neighbouring 4th layer 1014 and
Second head of positioning, the 4th layer of second end that can be assembled into rivet or is formed by the second end of rivet.For example, by
In the compressible character of warehouse 1010, rivet compressible warehouse 1010 so that the head of rivet can be relative to the group of warehouse 1010
It knits contact surface 1019 and/or bottom surface 1018 is recessed.For example, rivet can be by bioabsorbable material (such as with commodity
Polyglycolic acid (PGA), polylactic acid (PLA or PLLA), polydioxanone (PDS), the poly- hydroxyalkanoate that name Vicryl is sold
Acid esters (PHA), the Poliglecaprone 25 (PGCL), polycaprolactone (PCL), and/or the PGA, PLA that are sold with trade name Monocryl,
The compound of PDS, PHA, PGCL and/or PCL) it constitutes.In addition to by the nail 1020 accommodated in warehouse 1010, warehouse 1010
Layer can not be connected to each other.For example, the frictional engagement between nail leg 1021 and warehouse 1010 can for example protect the layer of warehouse 1010
It holds together, and once nail forming, then the layer can be trapped in nail 1020.At least part of nail leg 1021 may include
The roughened surface or rough coatings of the frictional force between nail 1020 and warehouse 1010 can be increased.
As described above, surgical instruments may include that the first jaw and the second jaw, the first jaw include nail bin supporting member 1030,
Second jaw includes anvil block 1040.Optionally, described in greater detail below, nail bin 1000 may include that one or more holdings are special
Structure is levied, which keeps feature structure that can engage nail bin supporting member 1030, and therefore can release nail bin 1000
Remain to nail bin supporting member 1030 with putting.For example, at least one adhesive (such as, fibrin and/or albumen water can be passed through
Gel) nail bin 1000 adhered into nail bin supporting member 1030.In use, at least one situation, especially in laparoscope
In formula and/or endoscopic surgery, such as the second jaw is moveable to the closed position opposite with the first jaw so that the first pincers
Mouth and the second jaw can be inserted by trochar in operative site.For example, trochar can limit hole or the intubation of about 5mm,
First jaw and the second jaw can be inserted by its.Second jaw is moveable in an open position between closed position
Partial closed position, which allows the first jaw and the second jaw to be inserted into across trochar, without
The nail 1020 accommodated in staple cartridge body 1010 is set to deform.For example, when the second jaw is in the centre position of its part closure, anvil
Seat 1040 can not apply staple cartridge body 1010 compressing force, and when the second jaw is in the centre position of its part closure, anvil block
1040 can compress staple cartridge body 1010.Although the compressible nail bin ontology 1010 when anvil block 1040 is in this centre position, so
And anvil block 1040 can incompletely compress staple cartridge body 1010, so that 1040 contact stud 1020 of anvil block and/or so that 1020 quilts of nail
Anvil block 1040 deforms.Once the first jaw and the second jaw are inserted by trochar in operative site, then the second jaw can
It is opened again, and anvil block 1040 and nail bin 1000 can be positioned relative to target tissue as described above.
Referring now to Fig. 7 A- Fig. 7 D, the end effector of surgical stapling device may include being positioned at anvil block 1140 and nail bin branch
Implanted nail bin 1100 among support member 1130.Similar to the above, anvil block 1140 may include tissue contacting surface 1141, nail bin
1100 may include tissue contacting surface 1119, and nail bin supporting member 1130 may include the support surface for capableing of support nail cartridge 1100
1131.Referring to Fig. 7 A, anvil block 1140 can be utilized to position the tissue contacting surface 1119 of tissue T against nail bin 1100 without making
Nail bin 1100 deforms, and when anvil block 1140 is in this position, tissue contacting surface 1141 can be positioned so that and nail bin branch
1131 distance 1101a of surface is supportted, and tissue contacting surface 1119 can be oriented and 1131 phase of nail bin support surface
Away from distance 1102a.Then, when anvil block 1140 is moved towards nail bin supporting member 1130, referring now to Fig. 7 B, anvil block 1140 can be downward
Push the top surface or tissue contacting surface 1119 of nail bin 1100, and the first layer 1111 and the second layer of nail bin support member 1110
1112.As layer 1111 and layer 1112 are compressed, referring again to Fig. 7 B, the second layer 1112 can be crushed, and follow closely 1120 leg
1121 pierceable first layers 1111 simultaneously enter in tissue T.For example, nail 1120 can be positioned at least partially in the second layer 1112
Nail cavity or gap 1115 in, and when the second layer 1112 is compressed, nail cavity 1115 is collapsible and therefore allows the second layer
1112 collapse around nail 1120.The second layer 1112 may include cover 1116, which may extend away on nail cavity 1115 simultaneously
Encapsulate or be at least partially enveloping nail cavity 1115.Fig. 7 B show the cover 1116 for being pressed downward and bursting in nail cavity 1115.The
It may include one or more weakening parts for two layer 1112, collapsing for the second layer 1112 can be conducive to.Optionally, such weakenings
Divide the cut controllably collapsed, perforation and/or the thin cross section that may include for example being conducive to warehouse 1110.First layer 1111
May include that one or more weakening parts that nail leg 1121 penetrates first layer 1111 can be conducive to.Optionally, such weakenings
Divide cut, perforation and/or the thin cross section that may include for example being aligned with nail leg 1121 or being at least substantially aligned.
Referring again to Fig. 7 A, when anvil block 1140 is in the non-firing position that part is closed, anvil block 1140 can be positioned so that
With 1131 distance 1101a of storehouse stayed surface so that define gap therebetween.This gap can be by with nail bin height 1102a
Nail bin 1100 and tissue T filling.As anvil block 1140 is moved downward to compress nail bin 1100, referring again to Fig. 7 B, tissue connects
Touching the distance between surface 1141 and storehouse stayed surface 1131 can be limited by the distance 1101b of shorter than distance 1101a.In various feelings
In shape, the gap limited by distance 1101b between the tissue contacting surface 1141 and storehouse stayed surface 1131 of anvil block 1140 can
More than original undeformed nail bin height 1102a.Referring now to Fig. 7 C, when anvil block 1140 is moved to closer to storehouse stayed surface
When 1131, the second layer 1112 can continue to collapse and the distance between nail leg 1121 and forming pit 1142 can reduce.Similarly,
The distance between tissue contacting surface 1141 and storehouse stayed surface 1131 can be reduced to distance 1101c, which can be greater than, equal to
Or less than original not deformed storehouse height 1102a.Referring now to Fig. 7 D, anvil block 1140 is moveable to final firing position,
Middle nail 1120 has been fully formed or has at least been shaped to Desired Height.In this position, the tissue contacting surface of anvil block 1140
1141 can be with 1131 distance 1101d of storehouse stayed surface, wherein distance 1101d can be shorter than original not deformed storehouse height
1102a.Equally as illustrated in fig. 7d, nail cavity 1115 can completely or at least substantially collapse, and following closely 1120 can completely or at least base
The second layer 1112 collapsed in sheet surrounds.In various scenarios, anvil block 1140 then can be moved far from nail bin 1100.Once anvil
Seat 1140 is detached from from nail bin 1100, then warehouse 1110 can for example, at least partly spread over various positions (that is, adjacent nail again
Position between 1120) in.The warehouse 1110 of conquassation resiliently may not again extend.The nail 1120 of forming is determined with other
Warehouse 1110 of the position between adjacent nail 1120 can apply pressure or compressing force to tissue T, this can provide various treatment benefits.
As described above, referring again to Fig. 7 A, each nail 1120 may include the nail leg extended from 1121.Although following closely 1120 quilts
It is schematically shown as including two nail legs 1121, however can also be used and may include a nail leg or alternately including being followed closely more than two
The various nails of leg (such as three nail legs or four nail legs).As shown in Figure 7 A, each nail leg 1121 can be embedded into warehouse 1110
The second layer 1112 in so that nail 1120 is fixed in the second layer 1112.Nail 1120 can be inserted into the nail cavity in warehouse 1110
In 1115 so that the top 1123 of nail leg 1121 is advanced into base portion 1122 in cavity 1115.It is inserted into chamber on top 1123
After body 1115, top 1123 can be pressed against in cover 1116 and cut the second layer 1112.Nail 1120 can be rested upon to the
Enough depths in two layer 1112 so that nail 1120 is not moved relative to the second layer 1112 or do not moved at least substantially.Nail
1120 can be rested upon enough depths into the second layer 1112 so that base portion 1122 is positioned or is embedded in nail cavity 1115.Make
It is selected for another kind, base portion 1122 can not be positioned or is embedded in the second layer 1112.Referring again to Fig. 7 A, base portion 1122 can be in storehouse
1118 lower section of bottom surface of body 1110 extends.Base portion 1122 can bear against in storehouse stayed surface 1130 or directly abut storehouse support
Surface 1130 positions.Storehouse stayed surface 1130 may include from its extension and/or be limited to support construction therein, for example, nail
1120 base portion 1122 can be positioned in such as one or more of nail bin supporting member 1130 support trenches, slit or slot 1132
In or supported by the one or more support trenches, slit or slot 1132, as described in more detail below.
Referring now to Fig. 8 and Fig. 9, nail bin (such as nail bin 1200) for example can include compressible implanted warehouse
1210, which includes outer layer 1211 and internal layer 1212.Similar to the above, nail bin 1200 may include being located at more in warehouse 1210
A nail 1220.Optionally, one or more nail legs 1221 that each nail 1220 may each comprise base portion 1222 and extend from it.Example
Such as, nail leg 1221 can be inserted into internal layer 1212 and be rested upon to the adjoining of base portion 1222 and/or neighbouring internal layer for for example making nail 1220
The depth that 1212 bottom surface 1218 positions.In figs. 8 and 9, internal layer 1212 does not include can receive nail 1220 one
The nail cavity divided, and alternatively, internal layer 1212 may include such nail cavity.Further described above, internal layer
1212 can be by can allow for the compressible material that warehouse 1210 is collapsed when applying compressive load to it (such as bioabsorbable
Foam and/or oxidized regenerated cellulose (ORC)) it constitutes.Internal layer 1212 can be by for example comprising polylactic acid (PLA) and/or polyethanol
The freeze dried foam of sour (PGA) is constituted.ORC can be commercially available with trade name Surgicel and may include loose Woven fabric
(as surgical sponge), loose fiber (as cotton balls) and/or foam.Internal layer 1212 can by including and/or on
The material that face is coated with drug (fibrin ferment and/or fibrin that are such as freeze-dried) is constituted, which can for example be suffered from
Fluid water activation in person's body and/or activation.For example, the fibrin ferment and/or fibrin of freeze-drying are positively retained at for example
On Vicryl (PGA) matrix.However, in some cases, such as when nail bin 1200 is inserted into the operative site of patient's body
When, activable drug can be activated unintentionally.Referring again to Fig. 8 and Fig. 9, outer layer 1211 can be by water impervious or at least
Substantially water impervious material is constituted so that liquid does not contact or do not contact internal layer 1212 at least substantially, until warehouse
1210 are compressed and nail leg has penetrated after outer layer 1211 and/or after outer layer 1211 cut in some manner.Example
Such as, outer layer 1211 can be by buttress material and/or plastic material (such as polydioxanone (PDS) and/or polyglycolic acid
(PGA)) it constitutes.Outer layer 1211 may include the wrappage of wrappage around internal layer 1212 and nail 1220.More particularly, nail 1220 can be inserted
Enter in internal layer 1212 and outer layer 1211 and is wrapped and is subsequently sealed around the sub-component for including internal layer 1212 and nail 1220.
As described herein, when anvil block moves to closed position, the nail of nail bin can be fully formed by anvil block.As other one
Kind selection, referring now to Figure 10-Figure 13, the nail of nail bin (such as nail bin 4100) for example can move to closed position by working as anvil block
When anvil block, and additionally by make nail towards closure anvil block move Staple drivers system and deform.Nail bin 4100 may include
Compressible warehouse 4110, compressible warehouse 4110 for example by foamed material and can be at least partially situated at compressible warehouse
Multiple nails 4120 in 4110 are constituted.Staple drivers system may include driver clamper 4160, be located in driver clamper
Staple drivers 4162 can be maintained at driving by multiple staple drivers 4162 in 4160 and cartridge tray 4180, the cartridge tray
In device clamper 4160.For example, staple drivers 4162 can be positioned on one or more of driver clamper 4160 slit
In 4163, wherein the side wall of slit 4163 can help to boot up staple drivers 4162 towards anvil block.Nail 4120 can be by staple drivers
4162 are supported in slit 4163, wherein when following closely 4120 and staple drivers 4162 are in its non-firing position, nail 4120 can be complete
It is located in slit 4163 entirely.Alternatively, when following closely 4120 and staple drivers 4162 are in its non-firing position, nail
The open end 4161 that 4120 at least part may pass through slit 4163 upwardly extends.For example, referring now primarily to Figure 11, nail
4120 base portion can be positioned in driver clamper 4160, and the top of nail 4120 can be embedded in compressible warehouse 4110
It is interior.The height of the about one third of nail 4120 can be positioned in driver clamper 4160, and follow closely about three points of 4120
Two height can be positioned in warehouse 4110.It may also include around warehouse 4110 and driving referring to Figure 10 A, such as nail bin 4100
The water impervious wrappage or film 4111 of device clamper 4160.
In use, for example, nail bin 4100 can be located in staple cartridge channel, and anvil block can move to closure towards nail bin 4100
Position.When anvil block moves to its closed position, anvil block can contact and compress compressible warehouse 4110.When anvil block is closed in it
When closing position, anvil block can not contact stud 4120.When anvil block moves to its closed position, the leg of the accessible nail of anvil block 4120 and
At least partly deform nail 4120.In any case in both cases, nail bin 4100 may also include one or more sledges
4170, one or more of sledges can along longitudinal direction promote in nail bin 4100 so that sledge 4170 then can engage staple drivers
4162 and make staple drivers 4162 and nail 4120 towards anvil block move.Sliding part 4170 can be in cartridge tray 4180 and staple drivers 4162
Between slide.In the case where the closure of anvil block has made the forming process of nail 4120 start, nail 4120 is moved upwards towards anvil block can
It completes forming process and nail 4120 is made to be deformed into the height or at least desired height that it is fully formed.Do not make in the closure of anvil block
In the case of 4120 deformation of nail, nail 4120 is moved upwards towards anvil block can start and complete forming process and nail 4120 is made to be deformed into
Its height being fully formed or at least desired height.Sliding part 4170 can be advanced to nail bin from the proximal extremity of nail bin 4100
4100 distal end so that before the nail 4120 in the distal end for being positioned at nail bin 4100 is fully formed, be positioned at nail
Nail 4120 in the proximal extremity in storehouse 4100 is fully formed.Referring to Figure 12, sliding part 4170 can include respectively at least one angulation
Degree or inclined surface 4711, can slide below staple drivers 4162 and lift staple drivers as shown in figure 13
4162。
Further described above, nail 4120 can be shaped, so as to by least part of tissue T and nail bin 4100
Compressible warehouse 4110 at least part capture wherein.After 4120 forming of nail, the anvil block and nail of surgical stapling device
Warehouse channel 4130 can be moved far from the nail bin 4100 being implanted into.In various scenarios, storehouse dish 4180 can jointing nail in a position-stable manner
Warehouse channel 4130, wherein as a result, when staple cartridge channel 4130 is pulled away from the warehouse 4110 being implanted into, storehouse dish 4180 can be from can
The warehouse 4110 of compression is dismantled.Referring again to Figure 10, storehouse dish 4180 may include that opposite side wall 4181, warehouse 4110 can be removable
Except ground is located between the opposite side wall 4181.For example, compressible warehouse 4110 can be compressed between side wall 4181 so that
Warehouse 4110 can be removably retained in therebetween during use, and when storehouse dish 4180 are pulled away from, and warehouse 4110 is from storehouse
Disk 4180 is releasedly detached from.For example, driver clamper 4160 may be connected to storehouse dish 4180 so that when storehouse dish 4180 are from operation
When position removes, driver holder 4160, driver 4162 and/or sliding part 4170 are positively retained in storehouse dish 4180.Driving
Device 4162 can be projected from driver clamper 4160 and be stayed in operative site.For example, driver 4162 can be by biological can inhale
Material (polyglycolic acid (PGA), polylactic acid (PLA or PLLA), the poly- dioxa hexamethylene such as sold with trade name Vicryl of receipts
Ketone (PDS), polyhydroxyalkanoatefrom (PHA), Poliglecaprone 25 (PGCL), the polycaprolactone sold with trade name Monocryl
(PCL), and/or the compound of PGA, PLA, PDS, PHA, PGCL and/or PCL) constitute.Driver 4162 could attach to nail
4120 so that driver 4162 is deployed with nail 4120.For example, each driver 4162 may include for example receiving nail 4120
The slot of base portion, wherein the slot can in a manner of pressure cooperation and/or snap fit receive base portion.
Further described above, driver clamper 4160 and/or sliding part 4170 can be projected from storehouse dish 4180.
For example, sliding part 4170 can slide between storehouse dish 4180 and driver clamper 4160 so that when sliding part 4170 promote with
When driving up staple drivers 4162 and nail 4120, sliding part 4170 also can make driver clamper 4160 move upward to storehouse dish
Except 4180.For example, driver clamper 4160 and/or sliding part 4170 can be by bioabsorbable materials (such as with commodity
Polyglycolic acid (PGA), polylactic acid (PLA or PLLA), polydioxanone (PDS), the poly- hydroxyalkanoate that name Vicryl is sold
Acid esters (PHA), the Poliglecaprone 25 (PGCL), polycaprolactone (PCL), and/or the PGA, PLA that are sold with trade name Monocryl,
The compound of PDS, PHA, PGCL and/or PCL) it constitutes.Sliding part 4170 can be integrally formed and/or be attached to driving rod or cut
Component is cut, the driving rod or cutting element push sliding part 4170 across nail bin 4100.In this case, sliding part
4170 can not project and can keep together with surgical stapling device from storehouse dish 4180, and sliding part 4170 is not attached to wherein
In the case of other of driving rod, sliding part 4170 can stay in operative site.In any case, to further being retouched above
It states, the compressibility of warehouse 4110 may be allowed to use thicker nail bin in the end effector of surgical stapling device, this is because
When the anvil block of stitching unstrument is closed, warehouse 4110 is compressible or shrinks.It is deformed at least partly as being followed closely when anvil block is closed
As a result, higher nail (such as with about 0.18 " nail of staple height) can be used, such as wherein about 0.12 " staple height
Can be positioned in compressible stratum 4110, and wherein compressible stratum 4110 may have about 0.14 " uncompressed height.
As described herein, nail bin can include multiple nails wherein.Optionally, such nail can be substantially U-shaped by being deformed into
The metal wire rod for nail leg that there are two configurations and tool is constituted.It is contemplated that wherein nail may include that various configuration (is such as engaged with one
Play and have two or more wire rods of three or more nail legs) alternate forms.It is used to form the one or more of nail
Wire rod may include circle or at least substantially round cross section.Staple line material may include any other suitable cross section, such as just
Rectangular and/or rectangle cross section.Nail can be made of plastic wire.Nail can be made of the metal wire rod coated with plastics.According to
The present invention, the replacement in addition to nail or as nail, storehouse may include the fastener of any suitable type.For example, this fastener can
Including pivotable arm, the arm can be folded when being engaged by anvil block.Two-part fastener can be used.For example, nail bin can
Including multiple first fastener portions, and anvil block may include multiple second fastener portions;When anvil block is compressed against nail bin,
Second fastener portion is connected to the first fastener portion.As described above, can sliding part or driver be promoted in nail bin to complete
The forming process of nail.Sliding part or driver can be promoted in anvil block, to make one or more formed parts move downwardly to
It is engaged with opposite nail bin and nail or the fastener being located in nail bin.
As described herein, nail bin may include being stored in four nails row therein.Four nails row can be configured to two
Inner side nail row and two outside nail rows.For example, inner side nail row and outside nail row can be positioned in cutting element or knife in nail bin
On first side of slit;Similarly, inner side nail row and outside nail row can be positioned in the second side of cutting element or cutter slit.
Nail bin may not include cutting element slit wherein;However, the replacement as nail bin slit, this nail bin may include can be by cutting element
The specified portions of cutting.Similarly, inner side nail row can be arranged in nail bin so that its with cutting element slit wherein equidistantly or extremely
It is few to be spaced apart substantially isometricly.Similarly, each outside staple can be arranged in nail bin so that itself and cutting element slit wherein etc.
It is equally spaced away from ground or at least substantially.According to the present invention, nail bin, which may include being stored in nail bin, is more or less than four
A nail row.Nail bin may include six nail rows.It goes for example, nail bin can include three nails on the first side of cutting element slit wherein, and
And includes three in the second side of cutting element slit wherein and follow closely row.Nail bin may include odd number nail row.For example, nail bin can cut
Include two staples on first side of component slit, and includes three staples in the second side of cutting element slit wherein.Staple
It may include the nail with identical or at least substantially identical unshaped staple height.Alternatively, one or more nails
Row may include with the nail for following closely different unshaped staple heights from other.For example, the nail on the first side of cutting element slit wherein can
With the first unshaped height, and the nail in the second side of cutting element slit wherein can have the second unshaped height, this second
Unshaped height is different from the first height.
Optionally, as described above, nail bin may include warehouse, which includes multiple being limited to nail cavity therein.Warehouse can
Including platform and top platform surface, wherein each nail cavity can limit the opening in platform surface.As also described above, nail can be determined
Position is in each nail cavity so that nail is stored in warehouse until it is emitted from warehouse.Before being emitted from warehouse, nail can
It is accommodated in warehouse so that nail is not projecting to platform surface top.In such cases, when nail is positioned under platform surface
Fang Shi can reduce nail and be damaged and/or the possibility of premature contact destination organization.In all cases, nail can not fire position
It sets and is moved between firing position, in non-firing position, not from warehouse protrusion, in firing position, revealed from warehouse
Go out and can contact the anvil block for being positioned in nail bin opposite.Anvil block and/or the forming pit being defined in anvil block can be in platform surfaces
Top positions preset distance so that when nail is disposed from warehouse, nail is deformed into scheduled forming height.In some cases,
Be trapped in the thickness variable of the tissue between anvil block and nail bin, therefore, thicker tissue can be trapped in certain nails and
Relatively thin tissue can be trapped in other certain nails.In either case, the clamping pressure or power of tissue are applied to by nail
Such as can be different because of nail, or nail row one end on nail and nail row the other end on nail between change.In some cases,
Controllable gap between anvil block and nail bin platform so that nail applies the clamping pressure of a certain minimum in each nail.However
In the case of some are such, the significant changes of the clamping pressure in different nails may possibly still be present.Surgery suturing appliance exists
Disclosed in having in the U.S. Patents Serial numbers 7,380,696 that on June 3rd, 2008 announces, the complete disclosure of the patent is to draw
It is incorporated herein with mode.It in co-pending and is co-owned for the illustrative multi-stroke handle of surgical stapling and cutting off apparatus
Entitled " SURGICAL STAPLING INSTRUMENT INCORPORATING A MULTISTROKE FIRING
It is carried out in the U.S. Patent application No.10/374,026 of POSITION INDICATOR AND RETRACTION MECHANISM "
More detailed description, the disclosure of the patent application is incorporated by reference accordingly is incorporated to.Meet the present invention other answer
With in combination with single firing schedule, such as in co-pending and jointly owned entitled " SURGICAL STAPLING
INSTRUMENT HAVING SEPARATE DISTINCT CLOSING AND FIRING SYSTEMS " U.S. Patent applications
No.10/441, described in 632, the disclosure of the patent application is incorporated by reference accordingly to be incorporated to.
As described herein, nail bin may include following device:The device is used for capturing the group in the nail from cartridge deployment
The thickness knitted compensates.Referring to Figure 14, nail bin (such as nail bin 10000) for example may include that rigid first part (such as props up
Point 10010) and compressible second part (such as tissue thickness compensation part 10020) support part.Referring first to Figure 16, support portion
10010 are divided to may include warehouse, top platform surface 10011 and multiple nail cavities 10012, wherein it is similarly as described above, it is each to follow closely
Chamber 10012 can limit the opening in platform surface 10011.Nail 10030 can be for example removably positioned in each nail cavity 10012
In.For example, one or more legs 10032 that each nail 10030 may include base portion 10031 and extend from base portion 10031.It is following closely
10030 by before disposing, and also as described in more detail below, the base portion 10031 for following closely 10030 can be by being located in support section 10010
Interior staple drivers support, and at the same time, following closely 10030 leg 10032 can at least be partly accommodated in nail cavity 10012.Nail
10030 can be disposed between non-firing position and firing position so that leg 10032 moves across tissue thickness compensation part
10020, the top surface of tissue thickness compensation part 10020 is penetrated, penetrates tissue T, and contacts that be positioned in nail bin 10000 right
The anvil block in face.When leg 10032 is against deflection, the leg 10032 of each nail 10030 can capture tissue thickness compensation part
A part for 10020 part and the tissue T in each nail 10030, and apply compressive force to tissue.To above into
Row further describes, and the leg 10032 of each nail 10030 can be made to be deformed downwardly toward the base portion 10031 of nail, to form nail retention region
10039, in the nail retention region, tissue T and tissue thickness compensation part 10020 can be captured.In all cases, nail retention area
Domain 10039 can be limited between the inner surface of strained leg 10032 and the inner surface of base portion 10031.Nail retention region
Size may depend on a number of factors, such as the width of the diameter of the length of leg, leg, base portion, and/or the degree of such as leg deformation.
In the past, surgeon usually needed the suitable nail for having appropriate staple height for the organizational choice to be sutured.Example
Such as, surgeon may be selected high nail and be used together and select low nail to be used together with thin tissue with thick tissue.However
Under some cases, the tissue being just sewn does not have consistent thickness, and therefore, some nails cannot achieve desired percussion configuration.
For example, Figure 48 is shown for the high nail in thin tissue.Referring now to Figure 49, when (such as tissue is thick for tissue thickness compensation part
Spend compensating part 10020) for example when thin tissue is used together, such as larger nail can shape as desired percussion configuration.
Due to the compression ratio of tissue thickness compensation part, the thickness for the tissue that tissue thickness compensation part can be to capture in each nail
Degree compensates.More particularly, referring now to Figure 43 and Figure 44, tissue thickness compensation part (such as tissue thickness compensation part
10020) each nail 10030 can be for example occupied according to the thickness of the tissue accommodated in nail retention region 10039 and/or type
The larger and/or smaller part of nail retention region 10039.For example, being trapped in the feelings in nail 10030 in thicker tissue T
Under condition, if relatively thin tissue T is trapped in nail 10030, tissue thickness compensation part 10020 can occupy nail retention region
10039 major part.Correspondingly, it is trapped in the situation in nail 10030 compared to relatively thin tissue T, if thicker group
It knits T to be trapped in nail 10030, then tissue thickness compensation part 10020 can occupy the smaller portions of nail retention region 10039.This
Sample, tissue thickness compensation part can compensate for compared with thin tissue and/or compared with thick tissue, and ensure that compression pressure is applied to tissue, without
Though by or at least substantially be trapped in nail in tissue thickness.In addition to the above, tissue thickness compensation part
10020 can compensate the tissue of the different type or different compression ratios that are trapped in different nails 10030.Referring now to figure
44, tissue thickness compensation part 10020 can apply compressive force to the vascular tissue T that may include blood vessel V, and therefore limit blood stream
Less compressible blood vessel V is crossed, but desired compressing force is still applied to the tissue T of surrounding.In all cases, to upper
Text is described further, and tissue thickness compensation part 10020 can also compensate for strained nail.Referring to Figure 45, various nails 10030
Deformation can lead to be limited to the larger nail retention region 10039 in such nail.Due to the rebound of tissue thickness compensation part 10020
Power, referring now to Figure 46, even if being limited at this nail retention region 10039 become in staple 10030 can be extended, positioning
Still enough compression pressures can be applied to tissue T having become the tissue thickness compensation part 10020 in staple 10030.Each
In the case of kind, the tissue thickness compensation part 10020 among adjacent nail 10030 can have been become appropriate around staple 10030
The nail 10030 of forming is biased against tissue T, and therefore is applied to for example to surround and/or be trapped in by compression pressure and deformed
Tissue in nail 10030.In all cases, tissue thickness compensation part can compensate for different tissue densities, the different group
Knitting density can for example be generated due to calcification, zone of fiber, and/or the previous tissue for having sutured or having handled.
According to the present invention, fixed or unmodifiable tissue space can be limited between support section and anvil block, because
No matter why the thickness of this tissue being trapped in nail can make nail be deformed into scheduled height.When tissue thickness compensation part is used
When such situation, tissue thickness compensation part is suitable for the tissue being trapped between anvil block and support section nail bin, and by
In the screen resilience of tissue thickness compensation part, additional compression pressure can be applied to tissue by tissue thickness compensation part.Referring now to
Figure 50-Figure 55, formed nail 10030 is predefined height H.With reference to Figure 50, tissue thickness compensation part is not used by, and group
It knits T and occupies entire nail retention region 10039.With reference to Figure 57, a part for tissue thickness compensation part 10020 has been trapped in nail
In 10030, tissue T is compressed, and has occupied at least part of nail retention region 10039.Referring now to Figure 52, thin group
T is knitted to be trapped in nail 10030.In this embodiment, compressed tissue T has the height of about 2/9H, and is pressed
The tissue thickness compensation part 10020 of contracting has the height of such as about 7/9H.Referring now to Figure 53, the tissue with interior thickness
T has been trapped in nail 10030.In this embodiment, compressed tissue T has the height of about 4/9H, and is compressed
Tissue thickness compensation part 10020 have such as about 5/9H height.Referring now to Figure 54, the tissue T with interior thickness
It has been trapped in nail 10030.In this embodiment, compressed tissue T has the height of about 2/3H, and compressed
Tissue thickness compensation part 10020 has the height of such as about 1/3H.Referring now to Figure 53, thick tissue T has been trapped in nail
In 10030.In this embodiment, compressed tissue T has the height of about 8/9H, and compressed tissue thickness compensates
Part 10020 has the height of such as about 1/9H.In all cases, tissue thickness compensation part may include compression height, the pressure
It contracts and highly includes:Such as about 10% nail retention height, about 20% nail retention height, about 30% nail retention it is high
Degree, about 40% nail retention height, about 50% nail retention height, about 60% nail retention height, about 70%
Nail retention height, about 80% nail retention height, and/or about 90% nail retention height.
Nail 10030 may include any suitable unshaped height.Nail 10030 may include for example between about 2mm and about
Unshaped height between 4.8mm.Nail 10030 may include such as about 2.0mm, about 2.5mm, about 3.0mm, about
The unshaped height of 3.4mm, about 3.5mm, about 3.8mm, about 4.0mm, about 4.1mm, and/or about 4.8mm.Nail can
The height H being deformed into can be determined by the distance between the platform surface 10011 of support section 10010 and opposite anvil block.It is flat
The distance between the tissue contacting surface of platform surface 10011 and anvil block may be, for example, about 0.097 ".Height H can also be by being limited to
The depth of forming pit in anvil block determines.Forming pit can for example have the depth measured from tissue contacting surface.Optionally,
As described in more detail below, nail bin 10000 may also include staple drivers, which can lift nail 10030 towards anvil block, and
And nail is lifted or " excessively driving " is to 10011 top of platform surface.In this case, 10030 forming height H is followed closely may be used also
It is determined by following closely the distance that 10030 are overdriven.For example, nail 10030 can be overdriven such as about .028 ", and can
Cause nail 10030 to be shaped as such as about 0.189 " height.Nail 10030 can be shaped as such as about 0.8mm, about
The height of 1.0mm, about 1.5mm, about 1.8mm, about 2.0mm, and/or about 2.25mm.Nail, which can be shaped as, to be for example situated between
Height between about 2.25mm and about 3.0mm.Further described above, the height of the nail retention region of nail can
It is determined by the width and diameter of the forming height followed closely and the wire rod including nail.The height of the nail retention region 10039 of nail 10030
Degree may include that the forming height H of nail subtracts two diameter widths of wire rod.Staple line may include such as about 0.0089 " diameter.
Staple line may include the diameter for example between about 0.0069 " and about 0.0119 ".For example, the forming height H of nail 10030
0.189 is may be about ", and staple line diameter may be about 0.0089 ", to for example generate about 0.171 " nail retention it is high
Degree.
Further described above, tissue thickness compensation part may include height that is unpressed or disposing in advance, and
Can be deformed into multiple compression heights one.Tissue thickness compensation part may include such as about 0.125 " uncompressed height
Degree.The compensating part of tissue thickness, which may include being greater than, is equal to about 0.080 " uncompressed height.Tissue thickness compensation part can
Including height that is unpressed or disposing in advance, this is highly more than the non-firing height of nail.Tissue thickness compensation part it is unpressed
Or the height disposed in advance is for example high than the non-firing height of nail about 10%, height about 20%, height about 30%, high about
40%, height about 50%, height about 60%, height about 70%, height about 80%, height about 90%, and/or height about 100%.
The non-firing height height such as up to about 100% of the comparable nail of height that is unpressed or disposing in advance of tissue thickness compensation part.
The non-firing height height of the comparable nail of height that is unpressed or disposing in advance of tissue thickness compensation part is for example more than 100%.Tissue
Thickness compensation part may include the uncompressed height of the non-firing height equal to nail.Tissue thickness compensation part may include being less than nail not
The uncompressed height of firing height.The non-firing height of the comparable nail of height that is unpressed or disposing in advance of tissue thickness compensation part
Such as low about 10%, it is low about 20%, low about 30%, low about 40%, low about 50%, low about 60%, low about
70%, low about 80%, and/or low about 90%.Compressible second part may include uncompressed height, the uncompressed height
Higher than the uncompressed height for the tissue T being just sewn.Tissue thickness compensation part may include uncompressed height, the uncompressed height etc.
In the uncompressed height for the tissue T being just sewn.Tissue thickness compensation part may include uncompressed height, which is less than
The uncompressed height for the tissue T being just sewn.
As described above, whether thick tissue or thin tissue are trapped in nail, tissue thickness compensation part can be multiple
It is compressed in forming nail.For example, the nail deformation in staple line or nail row can be made so that the nail retention region each followed closely includes for example big
The height of about 2.0mm, wherein tissue T and tissue thickness compensation part can be compressed in the height.In some cases, tissue T
It may include the compression height of the about 1.75mm in nail retention region, and tissue thickness compensation part may include in nail retention region
The compression height of interior about 0.25mm, to obtain adding up to the nail retention region height of such as about 2.0mm.In certain feelings
Under condition, tissue T may include the compression height of the about 1.50mm in nail retention region, and tissue thickness compensation part may include
The compression height of about 0.50mm in nail retention region, to which the nail retention region for obtaining adding up to such as about 2.0mm is high
Degree.In some cases, tissue T may include the compression height of the about 1.25mm in nail retention region, and tissue thickness is mended
The compression height for repaying the about 0.75mm that part may include in nail retention region, to obtain adding up to such as about 2.0mm's
Nail retention region height.In some cases, tissue T may include the compression height of the about 1.0mm in nail retention region, and
Tissue thickness compensation part may include the compression height of the about 1.0mm in nail retention region, for example big to obtain adding up to
The nail retention region height of about 2.0mm.In some cases, tissue T may include the about 0.75mm's in nail retention region
Compression height, and tissue thickness compensation part may include the compression height of the about 1.25mm in nail retention region, to obtain
Add up to the nail retention region height of such as about 2.0mm.In some cases, tissue T may include in nail retention region
The compression height of about 1.50mm, and tissue thickness compensation part may include that the compression of the about 0.50mm in nail retention region is high
Degree, to obtain adding up to the nail retention region height of such as about 2.0mm.In some cases, tissue T may include cutting in nail
The compression height of the about 0.25mm in region is stayed, and tissue thickness compensation part may include in nail retention region about
The compression height of 1.75mm, to obtain adding up to the nail retention region height of such as about 2.0mm.
Further described above, tissue thickness compensation part may include the uncompressed height of the firing height less than nail
Degree.Tissue thickness compensation part may include the uncompressed height of the firing height equal to nail.Tissue thickness compensation part may include being higher than
The uncompressed height of the firing height of nail.For example, the uncompressed height of tissue thickness compensation part may include for example following thickness:It should
Thickness be forming nail height about 110%, about the 120% of forming nail height, forming nail height about 130%, forming
About the 140% of staple height, about the 150% of forming nail height, about the 160% of forming nail height, forming nail height it is big
About 170%, about the 180% of forming nail height, about the 190% of forming nail height, and/or forming nail height be about
200%.Tissue thickness compensation part may include uncompressed height, this is highly twice or more of the firing height of nail.Tissue thickness
Compensating part may include compression height, this is highly about the 85% to about 150% of such as forming nail height.Optionally, as above
Described, tissue thickness compensation part can be compressed between uncompressed thickness and compressed thickness.The pressure of tissue thickness compensation part
Contracting thickness may be, for example, about the 10% of its uncompressed thickness, about the 20% of its uncompressed thickness, its uncompressed thickness it is big
About 30%, its uncompressed thickness about 40%, about the 50% of its uncompressed thickness, its uncompressed thickness about 60%,
About the 70% of its uncompressed thickness, about the 90% of about the 80% of its uncompressed thickness, and/or its uncompressed thickness.Group
Knit thickness compensation part uncompressed thickness can it is for example thicker than its compressed thickness approximately twice as, about ten times, about 50 times and/
Or about 100 times.The compressed thickness of tissue thickness compensation part can be between about the 60% to about 99% of its uncompressed thickness.
The uncompressed thickness of tissue thickness compensation part is than its compressed thickness thickness at least 50%.The uncompressed thickness of tissue thickness compensation part
Than at most 100 times of its compressed thickness thickness.Compressible second part can be elastic or at least partly elastic, and can
The deformation leg of tissue T against nail is biased.For example, compressible second part elasticity can expand between tissue T and the base portion of nail
Exhibition, to push tissue T against the leg of nail.It is discussed in detail as discussed further below, tissue thickness compensation part can be positioned in group
Among the nail leg for knitting T and deformation.In all cases, due to described above, tissue thickness compensation part can occupy nail retention area
Any gap in domain.
Tissue thickness compensation part may include the material for being characterized in that one or more of following characteristic:For example, biofacies
Capacitive, bioresorbable, bioresorbability, biodurable, biological degradability, compressibility, fluid absorbability, swelling
Property, from autgmentability, bioactivity, Drug, pharmaceutical activity, resistance to blocking, hemostatic, antibiosis disposition, antibiotic property, antiviral
Property, trophism, adhesiveness, permeability, hydrophily and/or hydrophobicity.According to the present invention, include the surgical instruments of anvil block and nail bin
It may include tissue thickness compensation part associated with anvil block and/or nail bin, it includes hemostat (such as fibrin and blood coagulation
Enzyme), at least one of antibiotic (such as doxycpl) and drug (such as matrix metalloprotease (MMPs)).
Tissue thickness compensation part may include synthesis and/or non-synthetic materials.Tissue thickness compensation part may include polymer group
Object is closed, the polymer composition includes one or more synthetic polymers and/or one or more non-synthetic polymers.Synthesis
Polymer may include the absorbable polymer of synthesis and/or the non-absorbable polymer of synthesis.Polymer composition may include example
Such as biocompatible foam.Biocompatible foam may include for example porous open celled foam and/or porous closed-cell foam.It is raw
Object biocompatible foam can be with uniform pore morphology or can be with gradient pore form (that is, entire depth of foam in one direction
On, orifice size, which gradually increases, becomes macropore).Polymer composition may include porous support, porous matrix, gel-in-matrix, water
Gel-in-matrix, solution matrix, Filamentous matrix, tubular matrix, complex matrix, film matrix, Biostatic polymer and can biology drop
One or more and combination thereof in the polymer of solution.For example, tissue thickness compensation part may include through Filamentous matrix
The foam of enhancing, or may include the foam with additional hydrogel layer, which extends in the presence of body fluid,
Organizationally to further provide for compressing.According to the present invention, tissue thickness compensation part can also be by material and/or the second layer or third
Coating on layer is constituted, which extends in the presence of body fluid, organizationally to further provide for compressing.Such layer can be water
Gel, which can be synthesize and/or natural source material, and it is durable and/or biodegradable to may be, for example, biology
's.Tissue thickness compensation part may include microgel or nanogel.Hydrogel may include coming self-carbon water compound microgel and/
Or nanogel.The usable fibrous nonwoven material that additional flexibility, rigidity, and/or intensity can be provided or fiber mesh class
Type element enhances tissue thickness compensation part.According to the present invention, tissue thickness compensation part has porous form, the porous form table
Reveal gradient-structure, such as aperture on a surface and larger hole on the other surface.Such form for
It is even more ideal for tissue growth or hemostasis behavior.In addition, gradient can also be combined with the bio-absorbable section of variation.It is short-term to inhale
It can be preferred to receive section, and to solve the problems, such as hemostasis, and Long-term absorption section can solve to make tissue more preferably be cured in the case of ne-leakage
The problem of conjunction.
The example of non-synthetic materials includes but not limited to lyophilized polysaccharide, glycoprotein, bovine pericardium, collagen, gelatin, fibrin
Albumen, fibrinogen, elastin laminin, proteoglycans, keratin, albumin, hydroxyethyl cellulose, cellulose, oxidized fibre
Element, oxidized regenerated cellulose (ORC), hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose, chitin, deacetylated shell
Polysaccharide, casein, alginates and combination thereof.
It synthesizes the example including but not limited to poly- (lactic acid) (PLA) of absorbable material, poly (L-lactic acid) (PLLA), gather in
Ester (PCL), polyglycolic acid (PGA), poly(trimethylene carbonate) (TMC), polyethylene terephthalate (PET), poly- hydroxyl
The copolymerization of the copolymer, glycolide and trimethylene carbonate of phenylalkanoic acid ester (PHA), glycolide and 6-caprolactone (PGCL)
Object, poly- (dioxanone) (PDS), polyester, poly- (ortho esters), polyoxy acid ester, gathers poly- (decanedioic acid glyceride) (PGS)
Ether-ether, makrolon, polyesteramide, polyanhydride, polysaccharide, poly- (ester-acid amide), tyrosine-based polyarylate, polyamine, tyrosine-based are poly-
Imido-carbonic ester, tyrosine-based polycarbonate, poly- (D, L- lactide-carbamate), poly- (butyric ester), poly- (B- hydroxyls
Base butyrate), poly- (E- caprolactones), polyethylene glycol (PEG), poly- [two (carboxyphenoxy) phosphonitriles], poly- (amino acid), quasi- poly-
(amino acid), absorbable polyurethane, poly- (phosphine piperazine), polyphosphazene, polyoxyalkylene, polyacrylamide, poly hydroxy ethyl acrylate,
Polyvinylpyrrolidone, poly- (caprolactone), polyacrylic acid, poly- acetic acid esters, polypropylene, aliphatic polyester, glycerine, is total to polyvinyl alcohol
Poly- (ether-ester), poly- oxalic acid alkylidene diol ester, polyamide, poly- (iminocarbonic ester), poly- oxalic acid alkylidene diol ester and it
Combination.Polyester can be selected from polylactide, polyglycolide, trimethylene carbonate, polydioxanone, polycaprolactone,
Polybutester and combination thereof.
The absorbable polymer of synthesis may include for example can with brand name VICRYL (polyglactic 910) from
Ethicon, Inc. commercially available 90/10 poly- (glycolide-L- lactides) copolymer, can with brand name DEXON from
Commercially available American Cyanamid Co. polyglycolide, can be with brand name PDS from Ethicon, Inc. is commercially available
Polydioxanone, can be with brand name MAXON from poly- (glycolide-commercially available American Cyanamid Co.
Trimethylene carbonate) statistic copolymer, can with brand name MONOCRYL from Ethicon companies it is commercially available 75/
It is one or more in 25 poly- (glycolide-s-caprolactone-poliglecaprolactone 25) copolymers.
Synthesis non-absorbable material include but not limited to polyurethane, polypropylene (PP), polyethylene (PE), makrolon,
Polyamide, z such as nylon, polyvinyl chloride (PVC), polymethyl methacrylate (PMMA), polystyrene (PS), polyester, polyethers
Ether ketone (PEEK), polytetrafluoroethylene (PTFE) (PTFE), polytrifluorochloroethylene (PTFCE), polyvinyl fluoride (PVF), fluorinated ethylene propylene
(FEP), polyacetals, polysulfones, silicon and combination thereof.The non-absorbable polymer of synthesis may include but be not limited to foam elastic
Property body and porous elastomers, such as siloxanes, polyisoprene and rubber.Synthetic polymer may include the polytetrafluoroethylene (PTFE) of extension
(ePTFE), can be with brand name GORE-TEX soft tissue slices from W.L.Gore&Associates, Inc. is commercially available;And altogether
Polyesteretherurethane foam, it is commercially available from Polyganics with brand name NASOPORE.
Polymer composition may include the polymer composition of such as by weight about 50% to about 90% PLLA,
And by weight about 50% to about 10% PCL polymer composition.Polymer composition may include for example by weight
The PLLA of gauge about 70%, and by weight about 30% PCL.Polymer composition may include for example big by weight
The polymer composition of about 55% to about 85% PGA, and by weight 15% to 45% PCL combination of polymers
Object.Polymer composition may include such as by weight about 65% PGA, and by weight about 35% PCL.Polymerization
Compositions may include the polymer composition of such as by weight about 90% to about 95% PGA, and by weight
The polymer composition of about 5% to about 10% PLA.
The absorbable polymer of synthesis may include bioabsorbable, biocompatible elastomers copolymer.It is suitable raw
Object is absorbable, bio-compatible elastomer copolymer includes but not limited to that (ε-is in oneself for the copolymer of 6-caprolactone and glycolide
The molar ratio of ester and glycolide is preferably about 30:70 to about 70:30, it is therefore preferable to 35:65 to about 65:35, and more preferably
Ground is 45:55 to 35:65);6-caprolactone and lactide (including L- lactides, D- lactides, their blend or lactic acid are total
Polymers) elastomer copolymer (molar ratio of 6-caprolactone and lactide is preferably about 35:65 to about 65:35, and it is more excellent
Selection of land is 45:55 to 30:70);To dioxanone (1,4- dioxane -2- ketone) and lactide, (including L- third is handed over
Ester, D- lactides and lactic acid) elastomer copolymer (40 are preferably about to the molar ratio of dioxanone and lactide:
60 to about 60:40);6-caprolactone and to the elastomer copolymer of dioxanone (6-caprolactone with to dioxanone
Molar ratio be preferably about 30:70 to about 70:30);Elastomer copolymerization to dioxanone and trimethylene carbonate
Object (is preferably from about 30 to the molar ratio of dioxanone and trimethylene carbonate:70 to about 70:30);Trimethylene carbonic acid
(molar ratio of trimethylene carbonate and glycolide is preferably from about 30 to the elastomer copolymer of ester and glycolide:70 to about 70:
30);Trimethylene carbonate and lactide (including L- lactides, D- lactides, their blend or lactic acid copolymer)
(molar ratio of trimethylene carbonate and lactide is preferably from about 30 to elastomer copolymer:70 to about 70:30);And they
Blend.Elastomer copolymer can be the copolymer of glycolide and 6-caprolactone.Alternatively, elastomer copolymer
For the copolymer of lactide and 6-caprolactone.
It is published in the United States Patent (USP) of entitled " the ELASTOMERIC MEDICAL DEVICE " on November nineteen ninety-five 21
No.5,468,253 and entitled " the FOAM BUTTRESS FOR STAPLING for being published on December 4th, 2001
The disclosure of the United States Patent (USP) No.6,325,810 of APPARATUS " is respectively incorporated by reference accordingly to be incorporated herein.
Tissue thickness compensation part may include emulsifier.The example of emulsifier may include but be not limited to water-soluble polymer, all
Such as polyvinyl alcohol (PVA), vinylpyrrolidone (PVP), polyethylene glycol (PEG), polypropylene glycol (PPG), pluronic
(PLURONICS), tween (TWEENS), polysaccharide and combination thereof.
Tissue thickness compensation part may include surfactant.
The example of surfactant may include but be not limited to polyacrylic acid, methylase, methylcellulose, ethyl cellulose
Element, propyl cellulose, hydroxy ethyl cellulose, carboxy methyl cellulose, polyoxyethylene cetyl ether, polyoxyethylene laural base
Ether, polyoxyethylene octyl ether, NONIN HS 240, polyoxyethylene oleyl ether, polyoxyethylene sorbitan Dan Yue
Cinnamic acid ester, polyoxyethylene stearyl base ether, ethylene nonyl phenyl ether, dialkylphenoxypoly (ethyleneoxy) ethyl alcohol, He Bo
Luo Shamu.
Polymer composition may include pharmaceutically active agents.The pharmaceutical activity of the releasable therapeutically effective amount of polymer composition
Agent.When polymer composition is desorbed/absorbs, pharmaceutically active agents can be released.Pharmaceutically active agents can be released to fluid such as
It flows through in the blood on polymer composition or across polymer composition.The example of pharmaceutically active agents may include but be not limited to
Hemostat and drug, such as fibrin, fibrin ferment and oxidized regenerated cellulose (ORC);Anti-inflammatory drug, such as double chlorine are fragrant
Acid, aspirin, naproxen, sulindac and hydrocortisone;Antibiotic and antimicrobial agents or preparation, such as triclosan,
Ionic silver, ampicillin, gentamicin, polymyxin B, chloramphenicol;And anticancer agent, such as cis-platinum, mitomycin, Ah mould
Element.
Polymer composition may include hemostatic material.Tissue thickness compensation part may include hemostatic material comprising poly- (breast
Acid), poly- (glycolic), poly- (butyric ester), poly- (caprolactone), poly- (dioxanone), polyoxyalkylene, copolymerization (ether-
Ester), collagen, gelatin, fibrin ferment, fibrin, fibrinogen, fibronectin, elastin laminin, albumin, hemoglobin,
Ovalbumin, polysaccharide, hyaluronic acid, chondroitin sulfate, hydroxyethyl starch, hydroxyethyl cellulose, cellulose, oxycellulose,
Hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose, chitin, chitosan, agarose, maltose, malt
Magma essence, alginate, coagulation factor, methacrylate, polyurethane, acrylate, platelet agonist, vessel retraction
Agent, alum, calcium, RGD peptide, protein, protamine sulfate, ε-aminocaproic acid, ferric sulfate, ferric subsulfate, iron chloride, zinc,
Zinc chloride, aluminium chloride, aluminum sulfate, aluminum acetate, permanganate, tannic acid, bone wax, polyethylene glycol, fucosan and they
Combination.The feature of tissue thickness compensation part can be haemostatic properties.
The polymer composition of tissue thickness compensation part is characterized in that such as percent porosity, pore size, and/or hard
Degree.Polymer composition can have such as about 30% to about 99% percent porosity by volume.Polymer composition
There can be such as about 60% to about 98% percent porosity by volume.Polymer composition can have for example by volume
The percent porosity of meter about 85% to about 97%.Polymer composition may include such as by weight about 70% PLLA
By weight about 30% PCL, and may include such as about 90% porosity by volume.For example, therefore polymerizeing
Compositions by include by volume about 10% copolymer.Polymer composition may include such as by weight about 65%
PGA and by weight about 35% PCL, and can have such as by volume about 93% to by volume about 95%
Percent porosity.Polymer composition may include being more than by volume 85% porosity.Polymer composition can have example
Such as about 5 microns to about 2000 microns of pore size.Polymer composition can have for example between about 10 microns to about
Pore size between 100 microns.For example, polymer composition can for example include the copolymer of PGA and PCL.Polymer composition
There can be the pore size for example between about 100 microns to about 1000 microns.For example, polymer composition can be wrapped for example
Include the copolymer of PLLA and PCL.
According in some terms, the hardness of polymer composition can indicate that the Shore hardness can be defined as with Shore hardness
The tolerance of the permanent dent to material such as measured by sclerometer.In order to assess the durometer value of given material,
According to the ASTM of entitled " Standard Test Method for Rubber Property-Durometer Hardness "
Program D2240-00 applies pressure to material with hardness head pressure feet, and the full text is incorporated as a reference herein.It can will be hard
Degree meter pressure head foot is administered to material and continues enough a period of times, such as 15 seconds, is read for example, wherein reading from suitable scale
It takes.According to scale type used, when pressure head foot completely penetrates through material, reading 0 is can get, and when material is not pierced
When, it can get reading 100.The reading dimensionless.It can be for example according to ASTMD2240-00 according to any suitable scale such as A classes
And/or OO classes scales determines hardometer.The polymer composition of tissue thickness compensation part may have about 4A to about 16A's
Shore A Hardness value, the Shore A Hardness value is for example in the Shore OO ranges of about 45OO to about 65OO.For example, combination of polymers
Object may include such as PLLA/PCL copolymers or PGA/PCL copolymers.The polymer composition of tissue thickness compensation part can have
Shore A Hardness value less than 15A.The polymer composition of tissue thickness compensation part can have the Shore A Hardness value less than 10A.
The polymer composition of tissue thickness compensation part can have the Shore A Hardness value less than 5A.Polymer material can have for example big
The Shore OO composition values of about 35OO to about 75OO.
Polymer composition can be at least two in the above-mentioned characteristic identified.Polymer composition can have above-mentioned
At least three kinds in the characteristic identified.Polymer composition can have such as 85% to 97% porosity, 5 micro- by volume
Rice is to 2000 microns of pore size and the Shore A Hardness value of 4A to 16A and the shore OO hardness value of 45OO to 65OO.Polymerization
Compositions may include the polymer composition of the polymer composition of the PLLA of 70 weight % and the PCL of 30 weight %;Institute
Stating polymer composition has such as 90% porosity, 100 microns to 1000 microns of pore size and 4A to 16A by volume
Shore A Hardness value and 45OO to 65OO shore OO hardness value.Polymer composition may include that the PGA's of 65 weight % is poly-
The polymer composition of the PCL of polymer composition and 35 weight %;The polymer composition have for example by volume from
93% to 95% porosity, the Shore A Hardness value of 10 microns to 100 microns of pore size and 4A to 16A and 45OO are arrived
The shore OO hardness value of 65OO.
Tissue thickness compensation part may include the material of extension.As described above, tissue thickness compensation part may include uncompressed
Or the compression material extended when deployment.Tissue thickness compensation part may include being formed in situ from expansion material.Tissue thickness compensates
Part may include at least one precursor, the precursor can be chosen so as to in other one or more precursors, water and/or body fluid extremely
It is spontaneously crosslinked when few one contact.Referring to Figure 20 5, other accessible one or more precursors of the first precursor are expansible to be formed
And/or swellable tissue thickness compensation part.Tissue thickness compensation part may include the swollen composition of such as fluid-soluble, such as
The composition of water-swellable.Tissue thickness compensation part may include the gel for including water.
Referring to Figure 189 A and Figure 189 B, for example, tissue thickness compensation part 70000 may include at least one hydrogel precursor
70010, which is chosen so as to form hydrogel in situ and/or in vivo, to make tissue thickness compensation part
70000 extensions.Figure 189 A show that the tissue thickness compensation part 70000 including packaging part, the packaging part include before extension
First hydrogel precursor 70010A and the second hydrogel precursor 70010B.As shown in Figure 189 A, the first hydrogel precursor 70010A
It can be physically separated from one another in identical packaging part with the second hydrogel precursor 70010B.First packaging part may include first
Hydrogel precursor 70010A, and the second packaging part may include the second hydrogel precursor 70010B.Figure 189 B, which are shown, works as water-setting
The extension of thickness Tissue compensating part 70000 when glue is formed in situ and/or in vivo.As shown in Figure 189 B, packaging part is rupturable, and
And first hydrogel precursor 70010A can contact the second hydrogel precursor 70010B to form hydrogel 70020.Hydrogel can wrap
Include expansible material.It is up to 72 hours for example, hydrogel is expansible.
Tissue thickness compensation part may include biodegradable foam, the biodegradable foam have comprising it is embedded its
In dried hydrogel particle or granule packaging part.It is not intended to be limited to any specific theory, the packaging part in foam can
By contact hydrogel precursor aqueous solution and biocompatible materials organic solution by formed, to form foam.Such as
Shown in Figure 20 6, aqueous solution and organic solution can form micella.Aqueous solution and organic solution can be dried to encapsulate in foam
Dried hydrogel particle or granule.For example, hydrogel precursor (such as hydrophilic polymer) is dissolvable in water water to form glue
The dispersion of beam.The organic solution of the accessible dioxane comprising poly- (glycolic) and polycaprolactone of aqueous solution.Water
Property solution and organic solution can be lyophilized to be formed and have the biology for disperseing dried hydrogel particle therein or granule can
The foam of degradation.It is not intended to be limited to any specific theory, it is believed that micelle forma-tion has the drying water being dispersed in foaming structure
The packaging part of gel particle or granule.The packaging part is rupturable, and dried hydrogel particle or granule can contact fluid
(such as body fluid) simultaneously extends.
For example, tissue thickness compensation part is expansible when contacting activator (such as fluid).Referring to Figure 190, for example, tissue
Thickness compensation part 70050 may include swellable material, such as hydrogel, and the swellable material is for example in contact fluid 70055
It is extended when (such as body fluid, saline solution, water and/or activator).The example of body fluid may include but be not limited to blood, blood plasma, abdomen
Film liquid, celiolymph, urine, lymph, synovia, vitreous humor, saliva, gastrointestinal cavity content, bile, and/or gas (such as
CO2).Tissue thickness compensation part 70050 is expansible when tissue thickness compensation part 70050 absorbs fluid.For another example, tissue thickness is mended
It repays part 70050 and may include non-cross-linked hydrogels, which extends when contact includes the activator 70 055 of crosslinking agent
To form cross-linked hydrogel.Tissue thickness compensation part is expansible when contacting activator.Tissue thickness compensation part can be opened from contact
Begin extension or swelling is up to 72 hours, such as from 24 hours to 72 hour, up to 24 hours, small up to 48 hours and up to 72
When, to which for example, tissue provides the pressure continuously enlarged and/or compression.As shown in Figure 190, tissue is contacted in fluid 70055
After thickness compensation part 70050, the original depth of tissue thickness compensation part 70050 is smaller than extension thickness.
Referring to Figure 187 and Figure 188, nail bin 70100 may include tissue thickness compensation part 70105 and include respectively nail leg
70112 multiple nails 70110.As shown in Figure 187, tissue thickness compensation part 70105 can have the firing height for being less than nail 70110
Original depth or compression height.Tissue thickness compensation part 70100 can with fluid 70102 (such as body fluid, saline solution
And/or activator) contact when it is in situ and/or extend in vivo, to which the leg 70112 for example against nail 70110 pushes tissue T.
As shown in Figure 188, tissue thickness compensation part 70100 can be extended and/or be swollen when contacting fluid 70102.Tissue thickness compensates
Part 70105 can compensate for the thickness of the tissue T captured in each nail 70110.As shown in Figure 188, tissue thickness compensation part 70105
Can have the extension thickness or uncompressed height of the firing height for being less than nail 70110.
Optionally, as described above, tissue thickness compensation part may include original depth and extension thickness.Tissue thickness compensation part
Original depth can be for example, its extend thickness about 0.001%, its extend thickness about 0.01%, its extend thickness
About 0.1%, its extend thickness about 1%, its extend thickness about 10%, its extend thickness about 20%, its
Extend thickness about 30%, its extend thickness about 40%, its extend thickness about 50%, its extend thickness about
60%, it extends about the 90% of about the 70% of thickness, about the 80% of its extension thickness, and/or its extension thickness.Tissue
The extension thickness of thickness compensation part than for example, about 2 times of its original depth thickness, about 5 times, about 10 times, about 50 times, about 100 times, about
200 times, about 300 times, about 400 times, about 500 times, about 600 times, about 700 times, about 800 times, about 900 times and/or about 1000 times.Group
Knit thickness compensation part original depth may be up to its extend thickness 1%, up to its to extend the 5% of thickness, up to its extension thick
The 10% of degree and the 50% of up to its extension thickness.The extension thickness of tissue thickness compensation part is at least than its original depth thickness
50%, thicker than its original depth at least 100%, thicker than its original depth at least 300% and thicker than its original depth at least
500%.As described above, in all cases, as above-described as a result, tissue thickness compensation part can occupy nail retention area
Any gap in domain.
As described above, tissue thickness compensation part may include hydrogel.Hydrogel may include homopolymer hydrogel, copolymer water
Gel, multipolymer hydrogel, interpenetrating polymer hydrogel and combination thereof.Hydrogel may include microgel, nanometer
Gel and combination thereof.Hydrogel can generally include the hydrophilic polymer network that can absorb and/or retain fluid.Water
Gel may include noncrosslinking hydrogel, crosslinked hydrogel and combination thereof.Hydrogel may include chemical cross-linking agent, object
Manage crosslinking agent, hydrophobic patch and/or the undissolved segment of water.Hydrogel can be crosslinked by polymerisation, small molecule and/or polymerization
Object-crosslinked polymer is chemically crosslinked.Hydrogel can be mutual by ionic interaction, hydrophobic interaction, Hydrogenbond
Effect, stereocomplex and/or supramolecular chemistry are physically crosslinked.Due to crosslinking agent, hydrophobic patch and/or undissolved of water
Section, hydrogel can be substantially undissolved, but due to absorbing and/or keeping fluid, hydrogel is expansible and/or is swollen.Before
Body can be crosslinked with endogenous material and/or tissue.
Hydrogel may include enviromental sensitive hydrogel (ESH).ESH may include having molten with the relevant fluid of environmental condition
The material of swollen property characteristic.Environmental condition may include but be not limited to the physical condition in operative site, biotic factor and/or chemical item
Part.For example, in response to temperature, pH, electric field, ionic strength, enzyme and/or chemical reaction, electricity and/or Neural stem cell and other lifes
Reason and environment variable, hydrogel is swellable or shrinks.ESH may include polyfunctional acrylate, hydroxyethyl methacrylate second
Ester (HEMA), elastomeric acrylate and relevant monomer.
Tissue thickness compensation part including hydrogel may include at least one of above-mentioned non-synthetic materials and synthetic material.
Hydrogel may include synthetic hydrogel and/or non-synthetic hydrogel.Tissue thickness compensation part may include multiple layers.Multiple layers can wrap
Include porous layer and/or non-porous layer.For example, tissue thickness compensation part may include non-porous layer and porous layer.For another example, tissue thickness compensates
Part may include the porous layer among the first non-porous layer and the second non-porous layer.For another example, tissue thickness compensation part may include that first is porous
Non-porous layer among layer and the second porous layer.Non-porous layer and porous layer can be relative to the surfaces of nail bin and/or anvil block by any
Positioned in sequence.
The example of non-synthetic materials may include but be not limited to albumin, alginates, carbohydrate, casein, cellulose,
Chitin, chitosan, collagen, blood, glucan, elastin laminin, fibrin, fibrinogen, gelatin, liver
Element, hyaluronic acid, keratin, protein, serum and starch.Cellulose may include hydroxyethyl cellulose, oxycellulose, oxidation
Regenerated cellulose (ORC), hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose and combination thereof.Collagen can wrap
Include bovine pericardium.Carbohydrate may include polysaccharide, such as lyophilized polysaccharide.Protein may include glycoprotein, proteoglycans and
Combination thereof.
The example of synthetic material may include but be not limited to poly- (lactic acid), poly- (glycolic), poly- (butyric ester), poly- (phosphine
Piperazine), polyester, polyethylene glycol, polyethylene oxide, polyethylene oxide-polypropylene oxide copolymers, copolymerization ethylene oxide, polyoxygenated
Alkene, polyacrylamide, poly hydroxy ethyl acrylate, polyvinylpyrrolidone), polyvinyl alcohol, poly- (caprolactone), poly- (dioxy
Heterocycle hexanone), polyacrylic acid, poly- acetic acid esters, polypropylene, aliphatic polyester, glycerine, poly- (amino acid), copolymerization (ether-ester), poly- grass
Sour alkylidene diol ester, polyamide, poly- (iminocarbonic ester), polyoxy acid ester, polyorthoester, polyphosphazene and their group
It closes.It conventional method can be used synthetically to prepare above-mentioned non-synthetic materials, such as synthesize hyaluronic acid.
Hydrogel can be made of one or more hydrogel precursors.Precursor may include monomer and/or macromonomer.Water-setting
Glue precursor may include electrophilic body functional group and/or nucleophile electrophilic body functional group.In general, electrophilic body can be with nucleophilic precursor reactant
To form chemical bond.Term " functional group " used herein refer to be capable of reacting with each other to form chemical bond electrophilic group or
Nucleophilic group.It is sub- that the example of electrophilic functional group may include but be not limited to n-hydroxysuccinimide (" NHS "), sulfosuccinic acyl
Amine, carbonyl dimidazoles, sulfonic acid chloride, aryl halide, sulfosuccinic ester, N-hydroxy-succinamide ester, succinimide ester, it is all
Such as succinimidyl succinate and/or succinimidyl propionate, isocyanide ester, thiocyanates, carbodiimides, benzo three
Azoles carbonic ester, epoxide, aldehyde, maleimide, imidoate, combination thereof etc..Electrophilic functional group may include amber
Amber imide ester.The example of nucleophilic functional group may include but be not limited to-NH2、-SH、-OH、-PH2With-CO-NH-NH2。
Hydrogel can be formed by single precursor or multiple precursors.Hydrogel can be formed by the first precursor and the second precursor.The
One hydrogel precursor and the second hydrogel precursor can form hydrogel in situ or in vivo at the time of contact.Hydrogel precursor generally may be used
Refer to polymer, functional group, macromolecular, small molecule and/or can participate in reacting to form the crosslinking agent of hydrogel.Precursor may include
Such as homogeneous solution, the non-uniform or solution that is separated in appropriate solvent, such as water or buffer solution.The pH of buffer solution can be
For example, about 8 to about 12, such as about 8.2 to about 9.The example of buffer solution may include but be not limited to borate buffer solution.Precursor can be
In lotion.According to the present invention, the first precursor can be with the second precursors reaction to form hydrogel.First precursor can with the second precursor
It is spontaneously crosslinked when contact.According to the present invention, first group of electrophilic functional group on the first precursor can be with second on the second precursor
Group nucleophilic functional group reaction.When precursor is blended in the environment for allowing reaction (for example, when related to pH, temperature and/or solvent
When), functional group can react with each other to form covalent bond.In at least some of precursor and more than one others precursors reaction
When, precursor can become crosslinked.
Tissue thickness compensation part may include that at least one monomer, the monomer are selected from 3- sulfopropyl acrylic acid sylvite
(" KSPA "), sodium acrylate (" NaA "), N- (three (hydroxymethyl) methyl) acrylamides (" triacryl ") and 2- acryloyls
Amine -2- methyl-1s-propane sulfonic acid (AMPS).Tissue thickness compensation part may include copolymer, which includes two or more
Monomer selected from KSPA, NaA, triacryl, AMPS.Tissue thickness compensation part may include from KSPA, NaA, three propylene
The homopolymer of acyl group, AMPS.Tissue thickness compensation part may include the hydrophilically modified monomer that can be copolymerized with it.Hydrophilically modified list
Body may include methyl methacrylate, butyl acrylate, cyclohexyl acrylate, styrene, styrene sulfonic acid.
Tissue thickness compensation part may include crosslinking agent.Crosslinking agent may include low molecular weight two or polyvinyl crosslinking agents, such as
Glycol diacrylate or dimethylacrylate, two, three or tetravinyl-glycol diacrylate or dimethyl allene
Acid esters, allyl (methyl) acrylate, C2-C8Alkylidene diacrylate or dimethylacrylate, divinyl ether, diethyl
Alkene sulfone, two and trivinylbenzene, trimethylolpropane trimethacrylate or trimethyl acrylic ester, pentaerythritol tetraacrylate
Or tetramethyl acrylate, bisphenol a diacrylate or dimethylacrylate, methylene-bisacrylamide or dimethyl allene
Amide, ethylene bisacrylamide or ethylene dimethacrylamide, triallyl phthalate or diallyl phthalate third
Ester.Crosslinking agent may include N, N'- methylene-bisacrylamides (" MBAA ").
Tissue thickness compensation part may include acrylate and/or methacrylate function hydrogel, biocompatibility light
At least one of initiator, alkyl-cyanoacrylate, isocyanate-functional macromonomer optionally include amine function
Macromonomer, optionally includes amine and/or Mercaptofunctional macromonomer, ring at succinimide ester function macromonomer
Oxygroup function macromonomer, the mixing for optionally including amine function macromonomer, protein and/or polypeptide and aldehyde cross-linking agent
Carbodiimides, anion polysaccharide and the polyvalent cation of object, Geniposide (Genipin) and water dissolvable.
Tissue thickness compensation part may include undersaturated organic acid monomer, acrylic acid substituted alcohols and/or acrylamide.Tissue
Thickness compensation part may include methacrylic acid, acrylic acid, glyceryl acrylate, glycerol methacrylate, 2- hydroxyethyl first
Base acrylate, 2- hydroxy-ethyl acrylates, 2- (dimethyl aminoethyl) methacrylate, n-vinyl pyrrolidone, first
Base acrylamide and/or N, N- dimethacrylamide are poly- (methacrylic acid).
Tissue thickness compensation part may include reinforcing material.Reinforcing material may include above-described non-synthetic materials and synthesis
At least one of material.Reinforcing material may include collagen, gelatin, fibrin, fibrinogen, elastin laminin, angle egg
In vain, albumin, hydroxyethyl cellulose, cellulose, oxycellulose, hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose
Element, chitosan, alginates, poly- (lactic acid), poly- (glycolic), poly- (butyric ester), poly- (phosphine piperazine), gathers chitin
Ester, polyoxyalkylene, polyacrylamide, poly hydroxy ethyl acrylate, polyvinylpyrrolidone, polyvinyl alcohol, gathers polyethylene glycol
(caprolactone), poly- (dioxanone), poly- acetic acid esters, pla-pcl, polypropylene, aliphatic polyester, glycerine, gather polyacrylic acid
(amino acid), copolymerization (ether-ester), poly- oxalic acid alkylidene diol ester, polyamide, poly- (iminocarbonic ester), poly- oxalic acid alkylidene
Diol ester, polyoxy acid ester, polyorthoester, polyphosphazene and combination thereof.
Tissue thickness compensation part may include the layer for including reinforcing material.The porous layer of tissue thickness compensation part and/or non-porous
Layer may include reinforcing material.For example, porous layer may include reinforcing material and non-porous layer may not include reinforcing material.Enhancement layer can
Including the internal layer among the first non-porous layer and the second non-porous layer.Enhancement layer may include the outer layer of tissue thickness compensation part.Enhancement layer
It may include the outer surface of tissue thickness compensation part.
Reinforcing material may include mesh sheet, monofilament, multifilament weave fabric, fiber, pad, felt, particle and/or pulvis.Reinforcing material
It can be coupled in the layer of tissue thickness compensation part.Reinforcing material can be coupled at least one of non-porous layer and porous layer.It can
Using routine techniques (such as be knitted, weave, tatting and/be knitted or to form the mesh sheet including reinforcing material.
According to the present invention, multiple reinforcing materials can be orientated with random direction and/or common direction.Common direction can be for example
It is parallel to staple line and one kind in staple line.For example, monofilament and/or multifilament weave fabric can be with random directions and/or common
Direction is orientated.Monofilament and multifilament weave fabric can be associated with non-porous layer and/or porous layer.Tissue thickness compensation part may include multiple
The multiple reinforcing fibers being orientated with random direction in non-porous layer.Tissue thickness compensation part may include it is multiple in non-porous layer with altogether
Multiple reinforcing fibers of equidirectional orientation.
Referring to Figure 199, anvil block 70300 may include tissue thickness compensation part 70305, the tissue thickness compensation part 70305 packet
Include the first non-porous layer 70307 and the second non-porous layer 70309 for hermetically encapsulating enhancement layer 70310.Enhancement layer 70310 may include water
Gel, which includes the ORC particles or fiber being embedded, and non-porous layer may include ORC.As shown in Figure 199, tissue
Thickness compensation part 70305 can conform to the profile of anvil block 70300.The internal layer of tissue thickness compensation part 70305 can conform to anvil
The inner surface of seat 70300 comprising forming pit 70301.
Fiber can form such as non-woven material, such as pad and felt.Fiber can have any length appropriate, such as from
0.1mm to 100mm and 0.4mm to 50mm.Reinforcing material can be ground into powder.Powder can have for example from 10 microns to 1 li
The granularity of rice.Powder can be coupled in tissue thickness compensation part.
Tissue thickness compensation part can be formed in situ.Hydrogel can be formed in situ.Tissue thickness compensation part can by covalently from
Son and/or hydrophobic bond are formed in situ.(non-covalent) crosslinking of physics can be mutual by complexing, hydrogen bonding, desolvation, Van der Waals
Effect, ionic bonding and combination thereof cause.Chemistry it is (covalent) be crosslinked can be realized by any of multiple mechanism,
The mechanism includes:Raolical polymerizable, polycondensation reaction, anion or cationic polymerization, step-growth polymerization reaction,
Electrophile-nucleophile reacts and combination thereof.
Optionally, being formed in situ for tissue thickness compensation part may include making two or more precursors reactions, the precursor
It is physically separated from until situ contact and/or is reacted to environmental condition, to react with each other to form hydrogel.It is in situ
Polymerizable polymer can be prepared by precursor, and the precursor can be reacted to form polymer in operative site.Tissue thickness compensates
Part can be formed by the cross-linking reaction of precursor in situ.Precursor may include that the shape in situ tissue thickness compensation part can be caused
At polymerisation initiator.Tissue thickness compensation part may include before being activated when forming the application of cross-linked hydrogel
Body.Being formed in situ for tissue thickness compensation part may include exciting at least one precursor to form chemical bond, to form tissue thickness
Spend compensating part.Optionally, activation can be by the change in operative site physical condition, biotic factor and/or electrochemical conditions come real
Existing, it includes but not limited to temperature, pH, electric field, ionic strength, enzyme and/or chemical reaction, electricity and/or magnetic thorn that the condition, which changes,
Sharp and other physiological and environmental variances.Precursor can be contacted outside body and can be introduced in operative site.
Tissue thickness compensation part includes that can store the one or more packaging parts or unit of wherein at least one component.Envelope
Piece installing can store hydrogel precursor wherein.Packaging part can store two kinds of components for example therein.Packaging part can be at it
The first hydrogel precursor of middle storage and the second hydrogel precursor.First packaging part can store the first hydrogel precursor wherein,
And the second packaging part can store the second hydrogel precursor wherein.As described above, packaging part can be aligned or at least with nail leg
Substantial registration is to pierce through packaging part when nail leg contacts packaging part and/or in other words packaging part be made to rupture.When deployment is followed closely
When, which can be compressed, is crushed, collapses and/or in other words ruptures.After packaging part rupture, storage component wherein
Packaging part can be flowed out.Storage component can contact the layer and/or tissue of other components, tissue thickness compensation part wherein.It is other
Component may be from identical or different packaging part, provides in the layer of tissue thickness compensation part and/or is provided by clinician
To operative site.As above-described as a result, the component being stored in packaging part can provide the extension of tissue thickness compensation part
And/or swelling.
Tissue thickness compensation part may include include packaging part layer.Packaging part may include gap associated with layer, pit,
Dome, pipe and combination thereof.The packaging part may include the gap in layer.Layer may include that mutual two can be attached to
Layer, wherein packaging part can be defined between two layers.Packaging part may include the dome in layer surface.For example, packaging part is at least
A part can be positioned in the dome upwardly extended from layer.Packaging part may include the pit formed in layer.The of packaging part
A part may include dome, and the second part of packaging part may include pit.Packaging part may include the pipe being embedded in layer.Guan Ke
Including non-synthetic materials as described herein and/or synthetic material, such as PLA.Tissue thickness compensation part may include bioabsorbable
Foam, such as ORC, the bioabsorbable foam includes the PLA pipes being embedded, and the pipe can encapsulate such as water-setting
Glue.Packaging part may include mutual unconnected separate unit.One or more of packaging part can be via extending through the one of layer
A or multiple accesses, conduit, and/or channel and be in fluid communication with each other.
The release rate of component from packaging part can be controlled by as described below:Such as tissue thickness compensation part thickness,
The component part of tissue thickness compensation part, the size of component, the hydrophily of component, and/or the physics in component and/or change
Learn interaction, tissue thickness compensation part component part, and/or surgical instruments.Layer may include one or more light filling bars or weak
Change part (such as local perforations), such as one or more of light filling bars or weakening part can be conducive to incised layer and make packaging part
Rupture.Local perforations can not extend completely through layer, and in some cases, perforation may extend entirely through layer.
Referring to Figure 194 and Figure 195, tissue thickness compensation part 70150 may include the outer layer 70152A for including packaging part 70154
With internal layer 70152B.Packaging part may include the first encapsulating component and the second encapsulating component.Packaging part can include independently the first envelope
Fill one of component and the second encapsulating component.First encapsulating component can be separated with the second encapsulating component.Outer layer 70152A can be wrapped
Include tissue contacting surface.Internal layer 70152B may include Device contacts surface.Device contacts surface 70152B can be releasedly attached
It is connected to anvil block 70156.Outer layer 70152A could attach to internal layer 70152B to be limited between outer layer 70152A and internal layer 70152B
Gap.As shown in Figure 194, each packaging part 70154 may include the dome in the Device contacts surface of internal layer 70152B.The circle
Top may include local perforations to promote incised layer by the rupture of nail leg and packaging part.As shown in Figure 195, anvil block 70156 can wrap
Multiple forming pit rows 70158 are included, the wherein dome of packaging part 70154 can be aligned with forming pit 70158.Tissue contacting surface
It may include not having vaulted flat surfaces.Tissue contacting surface may include one or more packaging parts, such as from the envelope that it extends
Piece installing 70154.
Optionally, anvil block may include that tissue thickness compensation part, the tissue thickness compensation part include at least one micro-
The encapsulating component of ball particle.Tissue thickness compensation part may include the packaging part for including the first encapsulating component and the second encapsulating component.
Tissue thickness compensation part may include the packaging part for including the first microsphere particle and the second microsphere particle.
Referring to Figure 196, robotic suturing device may include anvil block 70180 and nail bin (being shown in other accompanying drawings).The nail 70190 of nail bin
It can be deformed by anvil block 70180 when anvil block 70180 is moved into closed position and/or by the way that 70190 will be followed closely to closed anvil
The Staple drivers system 70192 of 70180 movements deforms.The leg 70194 of nail can contact anvil block 70180 so that at least portion of nail 70190
Divide ground deformation.Anvil block 70180 may include tissue thickness compensation part 70182 comprising outer layer 70183A, internal layer 70183B.Tissue
Thickness compensation part 70182 may include the first encapsulating component and the second encapsulating component.Packaging part 210185 can be aligned or at least basic
Upper alignment so that when nail leg 70194 is pushed across tissue T and outer layer 70183A, nail leg 70194 can pierce packaging part
70185 and/or in other words make packaging part 70185 rupture.As shown in Figure 196, nail 70190C is in its complete firing position, follows closely
70190B is in just fired during, and follow closely 70190A and be in its non-firing position.Follow closely the leg of 70190C and 70190B
The internal layer 70183B of tissue T, outer layer 70183A and tissue thickness compensation part 70182 is had been moved across, and has contacted positioning
Anvil block 70180 on nail bin opposite.After packaging part 70185 ruptures, encapsulating component can flow out and such as body fluid that is in contact with each other
And/or tissue T.Encapsulating component can be reacted to form reaction product (such as hydrogel), with for example the base portion of tissue T and nail it
Between extend and against the leg of nail push tissue T.In all cases, due to described above, tissue thickness compensation part can account for
According to any gap in nail retention region.
Tissue thickness compensation part may be adapted to be used together with surgical instruments.As described above, tissue thickness compensation part can be with nail
Storehouse and/or anvil block are associated.Tissue thickness compensation part may be configured to any shape, the size that are adapted for engagement with nail bin and/or anvil block
And/or dimension.As described herein, tissue thickness compensation part can be releasably attached to nail bin and/or anvil block.In sewing process
Before and during sewing process, tissue thickness compensation part can keep tissue thickness compensation part and nail bin and/or anvil
Seated connection touch it is any machinery and/or chemical mode be attached to nail bin and/or anvil block.Sting wear tissue thickness compensation part with
Afterwards, tissue thickness compensation part can be removed or discharged from nail bin and/or anvil block.When nail bin and/or anvil block move away from tissue thickness
When spending compensating part, tissue thickness compensation part can be removed or discharged from nail bin and/or anvil block.
Referring to Figure 191-Figure 193, robotic suturing device 70118 may include anvil block 70120 and including firing member 70124, multiple
The nail bin 70122 of nail 70128, blade 70129 and tissue thickness compensation part 70130.Tissue thickness compensation part 70130 may include to
A kind of few encapsulating component.When tissue thickness compensation part is by compression, suture and/or cutting, encapsulating component can break scattered.Referring to figure
192, for example, nail 70128 can be deployed between non-firing position and firing position so that nail leg moves across tissue thickness's compensation
Part 70130 penetrates the bottom surface and top surface of tissue thickness compensation part 70130, penetrates tissue T, and contact and be located in
The anvil block 70120 on 70118 opposite of nail bin.Encapsulating component can interreaction, and it is embedded and be dispersed in tissue thickness compensation part
Lyophilic powder reacts and/or with humoral response so that the extension of tissue thickness compensation part 70130 or swelling.When leg becomes against anvil block
When shape, the leg each followed closely can capture a part and one of the tissue T in each nail 70128 for tissue thickness compensation part 70130
Partly and to tissue T apply compressing force.As shown in Figure 192 and Figure 193, tissue thickness compensation part 70130 can compensate for each
The thickness of the tissue T captured in nail 70128.
Referring to Figure 197, surgical instruments 70200 may include that anvil block 70205 and nail bin 70215, the anvil block 70205 include upper
Portion's tissue thickness compensation part 70210, the nail bin 70215 include the lower part tissue thickness for having outer layer 70220 and internal layer 70225
Compensating part.Top tissue thickness compensation part 70210 can be positioned on the first side of destination organization, and lower part tissue thickness compensates
Part can be positioned in the second side of tissue.Top tissue thickness compensation part 70210 may include ORC, the compensation of lower part tissue thickness
The outer layer of part may include the hydrogel with the ORC particles being embedded, and the internal layer of Lower tissue thickness compensation part can wrap
Include such as ORC.
Referring to Figure 200-Figure 20 2, surgical instruments 70400 may include nail bin 70405 and anvil block 70410.Nail bin 70405 can wrap
Include tissue thickness compensation part 70415 comprising bioabsorbable foam.Bioabsorbable foam may include packaging part,
Including encapsulating component 70420.Bioabsorbable foam may include ORC, and encapsulating component may include such as drug.Anvil block
70410 tissue thickness compensation part 70415 may include internal layer 70425 and outer layer 70430.Internal layer 70425 may include can biology suction
The foam of receipts, and outer layer 70430 may include the hydrogel for for example optionally including reinforcing material.In the exemplary percussion sequence phase
Between, referring first to Figure 20 1, sliding part 70435 contact stud 70440A first and can start follow closely and be lifted up.Work as sliding part
70435 towards farther side when being further promoted, sliding part 70435 can start will to follow closely 70440B-D and any other follow-up nail with
Sequential order is lifted.Sliding part 70435 can drive up nail 70440 so that the leg of nail contacts opposite anvil block 70410 and deforms
At required shape.With reference to the percussion sequence shown in Figure 20 1, nail 70440A- nails 70440C has been moved to hitting completely for they
Send out position, nail 70440D is in just fired during, and follow closely 70420E and be still within its non-firing position.It is hit exemplary
During sending out sequence, encapsulating component 70470 can be broken by nail leg to be dissipated.Encapsulating component 70420 may be from the packaging part around nail leg
To contact tissue T.In all cases, additional drug can be squeezed out packaging part by the additional compression of tissue thickness compensation part.It should
Drug can treat tissue and can reduce tissue bleeding immediately.
In all cases, surgeon or other clinician can by fluid delivery to tissue thickness compensation part with
Manufacture is included therein the tissue thickness compensation part of at least one drug of storage and/or absorption.According to the present invention, nail bin and/
Or anvil block may include being capable of providing the port for leading to tissue thickness compensation part entrance.Referring to Figure 20 3B, nail bin 70500 may include example
Such as in the port of its distal end 70505.Port 70505 can receive needle 70510, the perforated needle being such as shown in Figure 20 3A.
Needle 70510 can be inserted by port 70505 in tissue thickness compensation part 70515 by clinician, to deliver a fluid to
Tissue thickness compensation part 70515.Fluid may include such as drug and hydrogel precursor.As described above, working as tissue thickness compensation part
When rupture and/or compression, fluid can be discharged into tissue from tissue thickness compensation part.For example, when tissue thickness compensation part 70515 into
When row is biodegradable, drug can be discharged from tissue thickness compensation part 70515.
Referring now to Figure 14, nail bin (such as nail bin 10000) for example may include support section 10010 and compressible tissue
Thickness compensation part 10020.Referring now to Figure 16-Figure 18, support section 10010 may include platform surface 10011 and be limited to branch
Multiple nail cavities 10012 in support part point 10010.The size of each nail cavity 10012 can for example be set to and can be removable wherein
It is followed closely except ground stores, such as follows closely 10030.Nail bin 10000 may also include multiple staple drivers 10040, when nail 10030 and staple drivers
10040 when being in its non-firing position, and each staple drivers can support one or more nails 10030 in nail cavity 10012.Example
Such as, referring first to Figure 22 and Figure 23, each staple drivers 10040 may include for example one or more holders or slot 10041, the branch
Frame or slot support nail and can limit the relative motion between nail 10030 and staple drivers 10040.Referring again to Figure 16, nail bin
10000 may also include nail percussion sliding part 10050;The nail percussion sliding part can move to far from the proximal extremity 10001 of nail bin
Side end 10002, so as to successively that staple drivers 10040 and nail 10030 are right from its non-firing position to nail bin 10000 is located in
The anvil block in face lifts.Referring first to Figure 16 and Figure 18, each nail 10030 may include base portion 10031 and extend from base portion 10031
One or more legs 10032, wherein each nail can be at least one of for example substantially U-shaped and basic V-shaped.Nail 10030 can
So that when following closely 10030 and being in its non-firing position, the platform surface of the top of nail leg 10032 relative to support section 10010
10011 recess.Nail 10030 is enabled to when following closely 10030 in its non-firing position, and the top of nail leg 10032 is relative to branch
The platform surface 10011 of support part point 10010 flushes.Nail 10030 is enabled to when following closely 10030 in its non-firing position, nail
The top of leg 10032 or at least certain part of nail leg 10032 extend to 10011 top of platform surface of support section 10010.?
In this case, when following closely 10030 in its non-firing position, nail leg 10032, which may extend into, enters and is embedded in tissue thickness
It spends in compensating part 10020.For example, nail leg 10032 can for example extend to 10011 top about 0.075 of platform surface ".Nail leg
10032 can for example extend to the distance between 10011 top about 0.025 " and about 0.125 " of platform surface.To carrying out above
It further describes, tissue thickness compensation part 10020 may include the uncompressed thickness between such as about 0.08 " and about 0.125 "
Degree.
In use, as further described above and referring primarily to Figure 31, anvil block such as anvil block 10060 can for example be transported
Move the closed position opposite with nail bin 10000.As described in more detail below, anvil block 10060 can will be organized against tissue thickness
Compensating part 10020 positions and for example presses to tissue thickness compensation part 10020 platform surface 10011 of support section 10010.
Once anvil block 10060 is appropriately positioned, then nail 10030 can be disposed, it is same as shown in figure 31.Optionally, as described above, nail is hit
Hair sliding part 10050 can be moved from 10001 distal end 10002 of proximal extremity of nail bin 10000, as shown in figure 32.Work as cunning
When moving part 10050 is pushed into, sliding part 10050 can contact staple drivers 10040 and in nail cavity 10012 by staple drivers
10040 are lifted up.Sliding part 10050 and staple drivers 10040 can include respectively one or more slopes or inclined-plane, this
Or multiple slopes or inclined-plane can cooperate so that staple drivers 10040 are moved upwards from its non-firing position.For example, with reference to Figure 19-
Figure 23, each staple drivers 10040 may include at least one inclined surface 10042, and sliding part 10050 may include one or
Multiple inclined surfaces 10052 are enabled to when sliding part 10050 is pushed into nail bin towards distal side, inclined surface 10052
In 10042 lower slider of inclined surface.When staple drivers 10040 are lifted up in its respective nail cavity 10012, nail driving
Nail 10030 can be lifted up by device 10040 so that nail 10030 can be by the opening in nail platform 10011 from its nail cavity 10012
Middle exposing.During exemplary percussion sequence, referring first to Figure 25-Figure 27, sliding part 10050 can contact stud 10030a first simultaneously
And starts that 10030a will be followed closely and be lifted up.When sliding part 10050 is further promoted towards distal side, sliding part 10050 can start
10030b, 10030c, 10030d, 10030e and 10030f will be followed closely and any other follow-up nail is lifted in order.Such as Figure 27 institutes
Show, sliding part 10050 can drive up nail 10030 so that the leg 10032 of nail contacts opposite anvil block and is deformed into desired
Shape, and be emitted from support section 10010.In all cases, as a part for percussion sequence, sliding part 10030
Multiple nails can be moved upwards simultaneously.The percussion sequence with reference to shown in Figure 27, nail 10030a and 10030b have moved to it completely
Firing position and be emitted from support section 10010, nail 10030c and 10030d is in fired during and by extremely
It is partially contained in support section 10010, and follows closely 10030e and 10030f and be still within its non-firing position.
As described above and referring to Figure 33, when following closely 10030 in its non-firing position, following closely 10030 nail leg 10032 can prolong
Reach 10011 top of platform surface of support section 10010.With further reference to the percussion sequence shown in Figure 27,10030e is followed closely
It is illustrated at its non-firing position with 10030f, and its nail leg 10032 extends to 10011 top of platform surface and extends
Into tissue thickness compensation part 10020.When following closely 10030 in its non-firing position, the top of nail leg 10032 or nail leg
10032 any other part convex may not wear the top tissue contacting surface 10021 of tissue thickness compensation part 10020.Such as figure
Shown in 27, when nail 10030 moves to its firing position from its non-firing position, the top of nail leg convex can wear tissue contacting surface
10032.The top of nail leg 10032 may include the sharp top that can cut and penetrate tissue thickness compensation part 10020.Tissue
Thickness compensation part 10020 may include that multiple holes, the multiple hole can receive nail leg 10032 and allow nail leg 10032 opposite
It is slided in tissue thickness compensation part 10020.Support section 10010 may also include the multiple guiding extended from platform surface 10011
Part 10013.Guiding piece 10013 can be positioned so that the nail cavity opening of neighbouring platform surface 10011 so that nail leg 10032 can be at least
Partly supported by guiding piece 10013.Guiding piece 10013 can be positioned in the proximal extremity and/or distal end of nail cavity opening
Place.According to the present invention, the first guiding piece 10013 can be positioned in the first end of each nail cavity opening, and the second guiding piece
10013 can be positioned in the second end of each nail cavity opening so that each first guiding piece 10013 can support nail 10030
First nail leg 10032, and the second nail leg 10032 of the sustainable nail of each second guiding piece 10013.Referring to Figure 33, Mei Geyin
Guiding element 10013 may include that groove or slit, such as groove 10016, such as nail leg 10032 can be slidably received the groove
In.Optionally, each guiding piece 10013 may include from platform surface 10011 to extend and may extend into tissue thickness compensation part
Anti-skid stud, protrusion in 10020, and/or spike.As described in more detail below, anti-skid stud, protrusion, and/or spike can reduce group
Knit the relative motion between thickness compensation part 10020 and support section 10010.The top of nail leg 10032 can be positioned in guiding
It can not extended to above the top surface of guiding piece 10013 in part 10013 and when following closely 10030 and being in its non-firing position.
For example, guiding piece 10013 can limit steering level, and it can not extend to this when following closely 10030 and being in its non-firing position and draw
Lead elevation-over.
According to the present invention, tissue thickness compensation part (such as tissue thickness compensation part 10020) for example can be by single material piece
It constitutes.Tissue thickness compensation part may include continuous sheet, which can cover the entire top of support section 10010
Platform surface 10011, or alternatively, covering is less than entire platform surface 10011.Material piece can cover support section
Nail cavity opening in 10010, however alternatively, material piece may include being aligned with nail cavity opening or at least portion
Divide the opening of alignment.According to the present invention, tissue thickness compensation part can be made of multilayer material.Referring now to Figure 15, tissue thickness
Compensating part may include compressible core and the wrappage around compressible core.Wrappage 10022 can be by compressible core releasedly
Remain to support section 10010.For example, support section 10010 may include the one or more protruding portions for example extended from it, it is all
Such as protruding portion 10014 (Figure 18), which can receive in one or more holes and/or slit, such as be limited to wrappage
In hole 10024 in 10022.Protruding portion 10014 and hole 10024 enable to protruding portion 10014 that can keep wrappage 10022
To support section 10010.The end of protruding portion 10014 deforms by can for example being handled by heating, to expand protruding portion 10014
End, and therefore limit the relative motion between wrappage 10022 and support section 10010.Wrappage 10022 may include
One or more perforation 10025, can be conducive to discharge wrappage 10022 from support section 10010, as shown in figure 15.It is existing
Referring to Figure 24, tissue thickness compensation part may include wrappage 10222, which includes multiple holes 10223, mesoporous
10223 can be aligned with the nail cavity opening in support section 10010 or at least partly be aligned.The core of tissue thickness compensation part can also wrap
Include the hole for being aligned or being at least partly aligned with the hole 10223 in wrappage 10222.Alternatively, tissue thickness compensates
The core of part may include continuous main body and may extend into below hole 10223 so that in continuous main body covering platform surface 10011
Nail cavity opening.
Optionally, as described above, tissue thickness compensation part may include for compressible core to be releasably held support
The wrappage of part 10010.For example, with reference to Figure 16, nail bin may also include retainer fixture 10026, which can
Wrappage and compressible core is inhibited prematurely to be detached with support section 10010.Optionally, each retainer fixture 10026 can wrap
The hole 10028 of the protruding portion 10014 extended from support section 10010 can be received by including so that retainer fixture 10026 can be protected
Hold support section 10010.Retainer fixture 10026 can include respectively at least one flat of bottom 10027, which can
It extends to below support section 10010 and in 10010 inner support of support section and keeps staple drivers 10040.As described above,
Tissue thickness compensation part can be removably attachable to support section 10010 by nail 10030.More particularly, as also described above,
When following closely 10030 and being in its non-firing position, follows closely 10030 leg and may extend into tissue thickness compensation part 10020, and therefore will
Tissue thickness compensation part 10020 releasably holds support section 10010.The leg of nail 10030 can its corresponding nail cavity
10012 side wall contact, wherein due to the friction between nail leg 10032 and side wall, nail 10030 and tissue thickness compensation part
10020 can be maintained at appropriate location, until nail 10030 is disposed from nail bin 10000.After nail 10030 is disposed, tissue is thick
Degree compensating part 10020 can be trapped in nail 10030 and is kept against the tissue T of suture.It is beaten when anvil block is subsequently moved into
When open position is to discharge tissue T, support section 10010 is movable far from the tissue thickness compensation part 10020 for having been secured to tissue.
It can be used adhesive tissue thickness compensation part 10020 is removedly remained to support section 10010.It can be used two parts viscous
Mixture, wherein the first part of adhesive can be placed on platform surface 10011, and the second part of adhesive can quilt
It is placed into tissue thickness compensation part 10020 so that when tissue thickness compensation part 10020, which is close to platform surface 10011, places,
First part can contact second part to enable adhesive and tissue thickness compensation part 10020 is separably bound to support portion
Divide 10010.Optionally, any other suitable method can be used that tissue thickness compensation part is separably remained to the branch of nail bin
Support part point.
Further described above, sliding part 10050 proximally can be advanced to distal end in end 10001
10002 are accommodated in all nails 10030 in nail bin 10000 with complete deployment.Referring now to Figure 56-Figure 60, sliding part 10050
It can be pushed away towards distal side by the knife bar 10052 of firing member or surgical stapling device in the longitudinal cavity 10016 in support section 10010
Into.In use, nail bin 10000 can be inserted into the staple cartridge channel in the jaw of surgical stapling device, such as staple cartridge channel
10070, and firing member 10052 can be advanced to and be contacted with sliding part 10050, as shown in figure 56.When sliding part 10050 by
When firing member 10052 is promoted towards distal side, sliding part 10050 can contact the staple drivers or driver 10040 of recent side, and
Nail 10030 is fired or projected from warehouse 10010, as described above.As shown in figure 56, firing member 10052 may also include cutting
Sword 10053, when nail 10030 is fired, which can be pushed by the cutter slit in support section 10010 towards distal side.
According to the present invention, corresponding cutter slit can extend across the anvil block for being located in 10000 opposite of nail bin so that cutting edge 10053 can
Extend between anvil block and support section 10010 and cuts the tissue and the tissue thickness compensation part that position therebetween.In various feelings
Under condition, sliding part 10050 can be promoted by firing member 10052 towards distal side, until sliding part 10050 reaches the remote of nail bin 10000
Side end 10002, as shown in figure 58.At this point, firing member 10052 can proximally bounce back.Sliding part 10050 can be with firing member
10052 proximally bounce back, but referring now to Figure 59, when firing member 10052 bounces back, sliding part 10050 can be left on nail
In the distal end 10002 in storehouse 10000.Once firing member 10052 fully bounces back, anvil block can be opened again, and tissue is thick
Degree compensating part 10020 can be detached with support section 10010, and exhaust the remaining non-implanted portion of nail bin 10000, including
Support section 10010 can be removed from staple cartridge channel 10070.
When exhausted nail bin 10000 from staple cartridge channel be removed after, further described above, new nail bin
10000 or any other suitable nail bin can be inserted into staple cartridge channel 10070.Further described above, nail bin is logical
Road 10070, firing member 10052, and/or nail bin 10000 may include cooperative structures, which can be in new non-percussion nail
Storehouse 10000 prevents firing member 10052 to be pushed into again or then towards distal side when being not located in staple cartridge channel 10070.
More particularly, referring again to Figure 56, when firing member 10052, which is advanced to, to be contacted with sliding part 10050, and when sliding
When part 10050 is in its nearside non-firing position, the support nose 10055 of firing member 10052 can be positioned in sliding part
On support lugn 10056 on 10050 and/or on so that firing member 10052 is maintained at position upward enough, with
Prevent the lock extended from firing member 10052 or crossbeam 10054 from falling into the lock crossbeam being limited in staple cartridge channel.Due to lock
10054 when will not fall into lock crossbeam, and in such cases, when firing member 10052 is pushed into, lock 10054 can not abut lock
The distal side side wall 10057 of groove.When firing member 10052 pushes sliding part 10050 towards distal side, firing member 10052 can
It is supported on its upward firing position due to leaning against the support nose 10055 on support lugn 10056.Work as firing member
10052 relative to sliding part 10050 when bouncing back, and as described above and as shown in figure 59, is being slided when support nose 10055 does not rely on
When on the support lugn 10056 of part 10050, firing member 10052 can fall from its upward position.For example, surgical staples may include
Firing member 10052 can be biased to the spring 10058 and/or any other suitable biasing element of its down position.One
Denier firing member 10052 has been fully retracted, and as shown in figure 60, firing member 10052 cannot again pass through the nail bin 10000 used up
It is pushed into towards distal side.More particularly, when the sliding part 10050 for being now in operation order has been left on the remote of nail bin 10000
When at side end 10002, firing member 10052 cannot keep position at an upper portion thereof by sliding part 10050.Therefore, as described above,
If firing member 10052 is re-advanced in the case of no replacement nail bin, lock beams 10054 will contact lock crossbeam
Side wall 10057, this will prevent firing member 10052 to be advanced in nail bin 10000 towards distal side again.In other words, once with
Most nail bin 10000 is replaced by new nail bin, and for new nail bin by with proximally-oriented sliding part 10050, this is proximally-oriented
Sliding part firing member 10052 can be maintained to its upward position, and firing member 10052 is made to be pushed away again towards distal side
Into.
As described above, sliding part 10050 can be by staple drivers 10040 in the first non-firing position and the second firing position
Between move, projected from support section 10010 so that 10030 will be followed closely.It has been emitted from support section 10010 in nail 10030
After, staple drivers 10040 can be accommodated in nail cavity 10012.Support section 10010 may include that staple drivers can be prevented
The 10040 one or more holding feature structures for projecting or dropping out from nail cavity 10012.Alternatively, sliding part
10050 can project staple drivers 10040 from the support section 10010 with nail 10030.For example, staple drivers 10040
It can be made of for example bioabsorbable and/or biocompatible materials, such as polyetherimide (Ultem).Staple drivers can
It is attached to nail 10030.For example, staple drivers can be molded on the base portion of each nail 10030 and/or surrounding so that driving
Device is integrally formed with nail.Entitled " the SURGICAL STAPLES HAVING COMPRESSIBLE that September in 2006 is submitted on the 29th
OR CRUSHABLE MEMBERS FOR SECURING TISSUE THEREIN AND STAPLING INSTRUMENTS FOR
DEPLOYING THE SAME " U.S. Patent Application Serial Numbers 11/541,123, which are incorporated by reference, to be incorporated herein.
As described above, surgery suturing appliance may include that the staple cartridge channel of nail bin can be received, be rotationally coupled to nail bin
The anvil block in channel and firing member including blade, the firing member can be moved relative to anvil block and staple cartridge channel.It is using
In, nail bin can be positioned in staple cartridge channel, and after nail bin is consumed at least partly, and nail bin can be removed from staple cartridge channel
And it is replaced by new nail bin.For example, the staple cartridge channel of surgery suturing appliance, anvil block, and/or firing member can be with replacement nail bins one
It rises and is reused.Alternatively, nail bin may include a part for disposable loading unit component, this disposably adds
Carrier unit component for example may include staple cartridge channel, anvil block, and/or firing member, these can be used as replacement disposable loading unit
A part for component is replaced with nail bin.Certain disposable loading unit components are disclosed in be submitted on 2 15th, 2008
Entitled " END EFFECTOR COUPLING ARRANGEMENTS FOR A SURGICAL CUTTING AND STAPLING
In the U.S. Patent Application Serial Number 12/031,817 of INSTRUMENT ", the complete disclosure of the patent application is with the side of reference
Formula is incorporated herein.
Tissue thickness compensation part may include composition that is extrudable, can casting and/or can be molded comprising as described herein
At least one of synthetic material and/or non-synthetic materials.Tissue thickness compensation part may include the film with two or more layers
Or piece.Tissue thickness compensation part can be used conventional method obtain, such as mixing, blending, combination, spraying, wicking, evaporation of the solvent,
Dipping, brushing, gaseous phase deposition, extrusion, calendering, casting, molding etc..When extrusion, opening may include at least one opening
The form of mold is that the extrudate exposed assigns shape.When calendering, opening may include the roll gap between two rollers.Conventional molding
Method may include but be not limited to blowing, injection molding, foam injection, compression moulding, hot forming, extrusion, foaming extrusion, film blow blowing, calendering,
Spinning, solvent welding, coating method such as dip-coating and spin coating, solution curtain coating and film casting, plastisol processing (including scraper
Coating, roller coating and casting) and combination thereof.When injection molding, opening may include nozzle and/or channel/runner and/or mold
Cavity and feature structure.When compression moulding, composition can be positioned in cavity body of mould, be heated to suitable temperature, and by opposite
It is compressed and is shaped under high pressure.When casting, composition may include that liquid or slurries, injection or in other words offer arrive mold
Or the inside, the above and/or surrounding of object, with the feature structure of copy mold or object.After casting, composition can by drying,
Cool down and/or be cured to form solid.
According to the present invention, the method for manufacturing tissue thickness compensation part can generally include:Tissue thickness compensation part combination is provided
Object, liquefaction the composition is so that its is flowable, and the composition of melting, semi-molten or mecystasis is formed to have expectation
The layer and/or film of thickness.Referring to Figure 198 A, tissue thickness compensation part can be made up of following steps:It is dissolved in aqueous solution
Hydrogel precursor disperses biocompatible particles and/or fiber wherein, provides the wherein mould with biocompatible particles
Tool, solution is provided in mold, makes activator and solution contact and curing solution to form tissue thickness compensation part, should
Tissue thickness compensation part include comprising biocompatible particles outer layer and comprising in the biocompatible particles being embedded
Layer.As shown in Figure 198 A, biocompatible layer 70250 can be provided in the bottom of mold 70260, and can will be provided with
There is the aqueous solution of the hydrogel precursor 70255 of biocompatible particles 70257 to be provided to mold 70260, and can will be aqueous
Solution is cured to form tissue thickness compensation part, and it includes biocompatible materials (such as ORC) which, which has,
First layer, and include the second layer for the hydrogel for being provided with biocompatible fibres (such as ORC fibers).Tissue is thick
Degree compensating part may include foam, and the foam includes outer layer containing biocompatible particles and containing the biocompatibility being embedded
The internal layer of particle.Tissue thickness compensation part can be manufactured by following steps:Mosanom is dissolved in water, disperses ORC wherein
Grain provides the wherein mold with ORC particles, solution is poured into mold, spraying or injection calcium chloride are to contact solution, to draw
Send out mosanom crosslinking, freeze-drying hydrogel to form tissue thickness compensation part comprising comprising ORC outer layer and comprising embedding
Enter the internal layer of hydrogel and ORC particle therein.
Referring to Figure 198 B, the method for manufacture three-layer weave thickness compensation part can generally include:It is molten in the first aqueous solution
The first hydrogel precursor is solved, biocompatible particles and/or fiber are disperseed in the first aqueous solution, providing wherein has biology
The mold 70260 of the first layer 70250 of biocompatible particle, the first aqueous solution is provided in mold, activator and first are made
Aqueous solution contacts, and the first aqueous solution of solidification dissolves the second hydrogel to form the second layer 70255 in the second aqueous solution
Precursor provides the second aqueous solution in mold, and the second aqueous solution of solidification is to form third layer 70265.Three-layer weave is thick
Degree compensating part can manufacture by the following method:Dissolving mosanom is to form the first aqueous solution in water, in the first aqueous solution
Middle dispersion ORC particles provide the mold of the wherein first layer with ORC particles, the first aqueous solution are poured into mold, spray
Or injection calcium chloride, to contact the first aqueous solution, to cause the crosslinking of mosanom, the first aqueous solution of freeze-drying is with shape
At the second layer for including the hydrogel with the ORC particles being embedded, it is aqueous molten to form second that mosanom is dissolved in water
Liquid pours into the second aqueous solution in mold, and spraying or injection calcium chloride are to contact the second aqueous solution, to cause mosanom
Crosslinking, freeze-drying the second aqueous solution to form the third layer including hydrogel.
According to the present invention, manufacture includes at least one tissue thickness compensation part for storing and/or being absorbed in drug therein
Method offer tissue thickness compensation part can be provided, and make tissue thickness compensation part and medicament contact to keep drug
In tissue thickness compensation part.Manufacture includes that the method for antiseptic materials microstructure thickness compensation part may include providing hydrogel,
Dried hydrogel, the swollen hydrogel in silver nitrate aqueous solution make hydrogel and sodium chloride solution contact, and resist to be formed to have
The tissue thickness compensation part of bacterium characteristic.Tissue thickness compensation part may include the silver being dispersed therein.
Referring to Figure 20 4, the method for manufacturing tissue thickness compensation part may include coetrusion and/or Method for bonding.For example, tissue
Thickness compensation part 70550 may include that lamilate, the lamilate include first layer 70555 and surround in a sealing manner to include water
The second layer 70560 of the internal layer 70565 of gel.Hydrogel may include such as dry film, dry foam, powder and/or granule.Water-setting
Glue may include super-absorbent material, such as polyvinylpyrrolidone, carboxymethyl cellulose, polysulfide propyl acrylate.It can pass through
By the raw material of first layer and the second layer respectively from hopper feed in extruder, first layer and the second layer are then provided sequentially to make
Make first layer and/or the second layer.Extruder hopper can be added in the raw material of internal layer 70565.Raw material can squeeze at high temperature
Go out in machine dispersion mixing and compound.As raw material leave mold 70570 in opening, internal layer 70565 can be deposited into first layer
On 70555 surface.Tissue thickness compensation part may include foam, film, powder and/or particle.First layer 70555 and the second layer
70560 can position face-to-face.The second layer 70560 can be face-to-face aligned by roller 70575 with first layer 70555.First layer
70555 may be affixed to the second layer 70560, and wherein first layer 70555 and the second layer 70560 can Physical entrapment internal layer 70565.Layer can
With for example optical pressure, conventional hot calendering bonding technique and/or by using adhesive bond together, with formed tissue thickness compensation
Part 70550.As shown in Figure 78, first layer 70555 and the second layer 70560 can be by using the rollings of grooved roller 70580
Process is bonded together.Optionally, as above-described as a result, can be by the way that the first layer of outer layer or barrier can be collectively formed
70555 and the second layer 70560 accommodate and/or sealing internal layer 70565.Outer layer can prevent or reduce 70565 contact wetting of internal layer, directly
It is ruptured to outer layer.
Referring to Figure 61, the end effector 12 (Fig. 1) of surgical instruments 10 can receive fastener cartridge assembly, such as nail bin
20000.As shown in Figure 61, nail bin 20000 can coordinate in the staple cartridge channel 20072 of the jaw 20070 of end effector 12.
Alternatively, nail bin 20000 can be integral with end effector 12 so that nail bin 20000 and end effector
12 are formed as individual unit construction.Nail bin 20000 may include such as the first main part, such as rigid support portion 20010.Nail
Storehouse 20000 may also include such as the second main part, such as compressible part or tissue thickness compensation part 20020.As another
A kind of outer selection, tissue thickness compensation part 20020 may not include the integral part of nail bin 20000, but can be executed relative to end
Device 12 is positioned in other ways.For example, tissue thickness compensation part 20020 can be fixed the anvil block 20060 of end effector 12
Or it can otherwise be maintained in end effector 12.Referring to Figure 78, nail bin may also include retainer fixture 20126, energy
Enough tissue thickness compensation part 20020 is inhibited prematurely to be detached from support section 20010.Reader will be appreciated that, as described herein group
Knit thickness compensation part can be mounted on a variety of end effectors in or in other words engaged with a variety of end effectors, and these
In the scope of the present invention.
Similar to tissue thickness compensation part as described herein, referring now to Figure 78, tissue thickness compensation part 20020 can be from outer
Section's end effector 12 is discharged or is detached from it.For example, the rigid support portion 20010 of nail bin 20000 can keep holding with end
The fastener cartridge channel 20072 of row device jaw 20070 engages, and tissue thickness compensation part 20020 is from rigid support portion 20010
Middle disengaging.20030 (Figure 78-Figure 83) will followed closely after the nail cavity 20012 in rigid support portion 2010 is disposed, tissue thickness is mended
Repaying part 20020 can discharge from end effector 12.Nail 20030 can be fired from nail cavity 20012 so that 20030 engagement tissue of nail is thick
Spend compensating part 20020.In addition, referring generally to Figure 63, Figure 82 and Figure 83, nail 20030 can capture tissue thickness compensation part 20020
Tissue T of the part together with suture.Tissue thickness compensation part 20020 can be deformable, and capture in percussion nail 20030
The part of tissue thickness compensation part 20020 can be compressed.Similar to tissue thickness compensation part as described herein, tissue thickness
Compensating part 20020 can compensate for the tissue T of different-thickness, compressibility and/or density being trapped in each nail 20030.In addition,
As described herein, tissue thickness compensation part 20020 can compensate for becoming the gap that staple 20030 generates.
Tissue thickness compensation part 20020 can be compressed between uncompressed height and compression height.Referring to Figure 78, tissue thickness
Compensating part 20020 can have top surface 20021 and bottom surface 20022.The height of tissue thickness compensation part can be top
The distance between surface 20021 and bottom surface 20022.Minimum force or do not apply when applying to tissue thickness compensation part 20020
When power, i.e., when tissue thickness compensation part 20020 is not compressed, the uncompressed height of tissue thickness compensation part 20020 can be with
It is the distance between top surface 20021 and bottom surface 20022.It is all such as when to 20020 applied force of tissue thickness compensation part
Such as when percussion nail 20030 captures a part for tissue thickness compensation part 20020, the compression of tissue thickness compensation part 20020 is high
Degree can be the distance between top surface 20021 and bottom surface 20022.Tissue thickness compensation part 20020 can have distal side
End 20025 and proximal extremity 20026.As shown in Figure 78, the uncompressed height of tissue thickness compensation part 20020 can be thick in tissue
It is consistent between the distal end 20025 and proximal extremity 20026 of degree compensating part 20020.Alternatively, it does not press
Contracting height can change between distal end 20025 and proximal extremity 20026.For example, the top of tissue thickness compensation part 20020
Surface 20021 and/or bottom surface 20022 can angulation and/or stageds relative to other parts so that uncompressed height is close
Change between side end 20026 and distal end 20025.The uncompressed height of tissue thickness compensation part 20020 may be, for example, about
0.08 inch.Alternatively, the uncompressed height of tissue thickness compensation part 20020 can be for example at about 0.025 inch
Change between about 0.10 inch.
It is such as described in greater detail herein, tissue thickness compensation part 20020 can be in its proximal extremity 20026 and distal end
Different compression heights is compressed between 20025.Alternatively, tissue thickness compensation part 20020 can be entire at it
It is equably compressed under length.The compression height of tissue thickness compensation part 20020 may depend on the geometry of such as end effector 12
Shape, the characteristic of tissue thickness compensation part 20020, the tissue T of engagement and/or nail 20030.Tissue thickness compensation part 20020
Compression height can be related with the tissue space in end effector 12.Optionally, for example, when anvil block 20060 is pressed from both sides towards nail bin 20000
When tight, tissue space can be limited at the top platform surface 20011 (Figure 78) of nail bin 20000 and the tissue of anvil block 20060 connects
Between tactile surface 20061 (Figure 61).Tissue space may be, for example, about 0.025 inch or be about 0.100 inch.Tissue space can example
Such as it is about 0.750 millimeter or is about 3.500 millimeters.The compression height of tissue thickness compensation part 20020 can for example be equal to or substantially
It is upper to be equal to tissue space.When tissue T is located in the tissue space of end effector 12, the compression of tissue thickness compensation part is high
Degree can be reduced, to adapt to tissue T.Such as when tissue space is about 0.750 millimeter, the compression height of tissue thickness compensation part
It can be about 0.500 millimeter.For example, when tissue space is about 3.500 millimeters, the compression height of tissue thickness compensation part 20020
It can be about 2.5mm.In addition, tissue thickness compensation part 20020 may include minimal compressed height.For example, tissue thickness compensation part
20020 minimal compressed height can be about 0.250 millimeter.Be limited to nail bin platform surface and anvil block tissue contacting surface it
Between tissue space can for example be equal to or the uncompressed height of at least substantially equal to tissue thickness compensation part.
Referring primarily to Figure 62, tissue thickness compensation part 20020 may include include fiber 20082 fibrous nonwoven material
20080.Tissue thickness compensation part 20020 may include the material of felt or similar felt.Fiber 20082 in non-woven material 20080
It can be tightened together by any method as known in the art, including but not limited to needle point method, heat bonding, water entanglement, ultrasound
Pattern bonding, chemical adhesion and meltblowing adhesive.In addition, the layer of non-woven material 20080 can by machinery, plus thermally or chemically
It tightens together to form tissue thickness compensation part 20020.It is such as described in greater detail herein, the non-woven material 20080 of fiber
It can be compressible, tissue thickness compensation part 20020 can be made compressible.Tissue thickness compensation part 20020 may also comprise not
Compression section.For example, tissue thickness compensation part 20020 may include compressible non-woven material 20080 and uncompressed part.
Referring still primarily to Figure 62, non-woven material 20080 may include multiple fibers 20082.In non-woven material 20080
At least some fibers 20082 can be crimped fibre 20086.Crimped fibre 20086 can be for example in non-woven material 20080
It is curling, distorting, coiling, bending, deformation, spiral, circular and/or bowed.As in further detail herein
Description, crimped fibre 20086 can be formed by any suitable shape so that the deformation of crimped fibre 20086 generates load on spring
Power or restoring force.Crimped fibre 20086 can form the shape of coiling or substantially coiled type by thermoforming.Crimped fibre
20086 can be formed by non-crimped fiber 20084.For example, non-crimped fiber 20084 can be wrapped in around heated mandrel to be formed
The substantially shape of coiled type.
Tissue thickness compensation part 20020 may include homogeneous, absorbable polymer matrix.Uniform absorbable polymerization
Object matrix may include such as foam, gel and/or film.In addition, multiple fibers 20082 be dispersed among entirely uniform it is absorbable
In polymeric matrix.At least some of homogeneous, absorbable polymer matrix fiber 20082 can be such as crimped fibre
20086.As described in more detail, the homogeneous, absorbable polymer matrix of tissue thickness compensation part 2002 can be can
Compression.
Referring to Figure 65 and Figure 66, crimped fibre 20086 can random dispersion at least one of entire non-woven material 20080
In point.For example, crimped fibre 20086 can random dispersion in entire non-woven material 20080 so that non-woven material 20080
A part than the other parts of non-woven material 20080 include more crimped fibres 20086.In addition, crimped fibre 20086 can
It is gathered in such as fiber cluster 20085a, 20085b, 20085c, 20085d and 20085e in non-woven material 20080.Volume
The shape of bent fiber 20086 can cause the entanglement of fiber 20086 during the manufacture of non-woven material 20080;Crimped fibre
20086 entanglement can then cause the formation of fiber cluster 20085a, 20085b, 20085c, 20085d and 20085e.Except this it
Outside or alternatively, crimped fibre 20086 can in entire non-woven material 20080 random orientation.For example, with reference to
Figure 62, the first crimped fibre 20086a can be orientated along first direction, and the second crimped fibre 20086b can be orientated in a second direction, and
And third crimped fibre 20086c can be orientated along third direction.
Crimped fibre 20086 can systematically be distributed and/or be arranged at least part of entire non-woven material 20080.
For example, referring now to Figure 67, crimped fibre 20186 can be positioned in construction 20185, the edges plurality of crimped fibre 20186a
First direction is arranged, and other multiple crimped fibre 20186b are arranged in a second direction.Crimped fibre 20186 can be overlapped,
So that they mutually tangle or interconnect.Crimped fibre 20186 systemic can be arranged so that crimped fibre 20186a is substantially parallel
In another crimped fibre 20186a.Another crimped fibre 20186b can extend substantially transversely to some crimped fibres 20186a.
Optionally, crimped fibre 20186a can be substantially aligned with first axle Y, and crimped fibre 20186b can be substantially with second
Axis X is aligned.For example, first axle Y can be perpendicular or substantially perpendicular to second axis X.
Referring primarily to Figure 68, crimped fibre 20286 can be arranged to construction 20285.Each crimped fibre 20286 may include
The longitudinal axis being limited between the first end 20287 of crimped fibre 20286 and second end 20289.Crimped fibre 20286
It can systematically be distributed in non-woven material 20080 so that the first end 20287 of a crimped fibre 20286 is located in phase
Adjacent to the position of the second end 20289 of another crimped fibre 20286.Alternatively, fine referring now to Figure 69
Dimension construction 20385 may include the first crimped fibre 20386a being for example orientated along first direction, second be orientated in a second direction
Crimped fibre 20386b, and the third crimped fibre 20386c that is orientated along third direction.According to the present invention, crimped fibre
20286 single pattern or construction can repeat in entire non-woven material 20080.Crimped fibre can be in entire non-woven material
It is arranged in different modalities in 20080.As other alternate forms, non-woven material 20080 may include that at least one curling is fine
Tie up pattern and the crimped fibre of multiple random orientations and/or random distribution.
Referring again to Figure 62, multiple fibers 20082 in non-woven material 20080 may include at least some non-crimped fibers
20084.Non-crimped fiber 20084 and crimped fibre 20086 in non-woven material 20080 can be tangled or be interconnected.Crimped fibre
20086 and the ratio of non-crimped fiber 20084 may be, for example, about 25:1.Alternatively, crimped fibre 20086 with it is non-
The ratio of crimped fibre 20084 may be, for example, about 1:25.Alternatively, crimped fibre 20086 and non-crimped fiber
20084 ratio may be, for example, about 1:1.As described in more detail, when non-woven material 20080 has deformed, non-woven material
The quantity of crimped fibre 20086 can influence the restoring force of the generation of non-woven material 20080 in the per unit volume of material 20080.Such as
It is equally more fully described herein, the restoring force that non-woven material 20080 generates may also depend upon such as non-woven material 20080
The material and shape of middle crimped fibre 20086 and non-crimped fiber 20084, size, position and/or orientation.
The fiber 20082 of non-woven material 20080 may include polymer composition.The polymer composition of fiber 20082
It may include the polymer, absorbable polymer or combination thereof of nonabsorable.Absorbable polymer may include can biology
Absorb, biocompatible elastomeric polymer.In addition, the polymer composition of fiber 20082 may include synthetic polymer, non-
Synthetic polymer or combination thereof.The example of synthetic polymer includes but not limited to polyglycolic acid (PGA), poly- (lactic acid)
(PLA), polycaprolactone (PCL), polydioxanone (PDO) and their copolymer.For example, fiber 20082 may include 90/
10 poly- (glycolide-L- lactides) copolymers, for example, the copolymer can with brand name VICRYL (polyglactic 910) from
Ethicon, Inc. are commercially available.The example of non-synthetic polymer includes but not limited to lyophilized polysaccharides, glycoprotein, elastic egg
In vain, proteoglycans, gelatin, collagen and oxidized regenerated cellulose (ORC).Optionally, tissue thickness as described herein is similar to mend
Repay the polymer composition in part, the polymer composition amount of may include of fiber 20082 is different (such as by weight percentage)
Absorbable polymer, nonabsorable polymer, synthetic polymer and/or non-synthetic polymer.
The crimped fibre 20086 of non-woven material 20080 may include first polymer composition, and non-woven material
20080 non-crimped fiber 20084 may include different polymer compositions.For example, crimped fibre 20086 may include that synthesis is poly-
Object, such as 90/10 poly- (glycolide-L- lactides) are closed, and non-crimped fiber 20084 may include non-synthetic polymer, such as oxygen
Change regenerated cellulose.Alternatively, crimped fibre 20086 and non-crimped fiber 20084 may include identical polymerization
Compositions.
As described herein, crimped fibre 20086 and non-crimped fiber 20084 can be for example, by needle point method, heat bonding, water
It tangles, ultrasound mode bonds, chemical adhesion and meltblowing adhesive tighten together.Including synthetic fibers such as " VICRYL
The crimped fibre 20086 of (polyglactic 910) ", and the non-crimped fiber 20084 including oxidized regenerated cellulose can lead to
It crosses needle thorn and forms non-woven material 20080 together.Non-woven material 20080 may include for example, about 5% to 50% (by weight
Meter) curling " VICRYL (polyglactic 910) " fiber 20086, and be the non-volume of about 5% to 50% (by weight)
Bent oxidized regenerated cellulose (ORC) fiber 20084.Such as when non-woven material 20080 contacts tissue T, non-crimping ORC fibers
20084 can react rapidly with the blood plasma in tissue to form gel block.The formation of gel ORC block can be instantaneous or almost instantaneous
Ground is contacted with tissue.In addition, after gel ORC block formation, " VICRYL (polyglactic 910) " fiber of curling
20086 can still be distributed in entire non-woven material 20080.For example, crimped fibre 20086 can be suspended in gel ORC block.
Since gel ORC block is bioabsorbable, curling " VICRYL (polyglactic910) " fiber 20086 can be in adjacent tissue
Apply screen resilience, as described in more detail.In addition, tissue can start in " VICRYL (polyglactic 910) " fiber
And/or heal around forming nail 30030, also as described in more detail.
Referring primarily to Figure 78-Figure 81, the support section 20010 of nail bin 20000 may include warehouse 20017, top platform table
Face 20011 and multiple nail cavities 20012.Each nail cavity 20012 can limit the opening in platform surface 20011.Nail 20030 can be by can
It is located in nail cavity 20012 with removing.According to the present invention, single nail 20030 is arranged in each nail cavity 20012.Referring primarily to
Figure 82 and Figure 83, and it is similar to nail as described herein, each nail 20030 may include with first end 20035 and the second end
The base portion 20031 at end 20036.Nail leg 20032 can extend from the first end 20035 of base portion 20031, and another nail leg
20032 can extend from the second end 20036 of base portion 20031.Referring again to Figure 78-Figure 81, before deployment nail 20030, often
The base portion 20031 of a nail 20030 can be supported by staple drivers 20040, which is located in the rigid support of nail bin 20000
In part 20010.In addition, before deployment nail 20030, the leg 20032 of each nail 20030 can be at least partially contained within nail cavity
In 20012.
Nail 20030 can be deployed between initial position and firing position.For example, referring primarily to Figure 81, nail 20030 can be located
In initial position (nail 20030e, 20030f), part percussion or centre position (nail 20030c, 20030d) or firing position (nail
20030a,20030b).Driver 20040 can drive the nail between initial position and firing position.For example, each nail
20030 base portion 20031 can be supported by driver 20040.Follow closely the leg 20032 of (such as nail 20030e, 20030f in Figure 80)
It can be positioned in nail cavity 20012.When firing member or nail percussion sliding part 20050 are from the proximal extremity 20001 of nail bin 20000
When distal end 20002 translates, the inclined surface 20051 on sliding part 20050 can contact the nauropemeter on driver 20040
Face 20042, the nail 20030 being located in deployment on contacted driver 20040.Nail 20030 can be deployed in initial position
Between firing position so that leg 20032 moves across the non-woven material 20080 of tissue thickness compensation part 20020, penetrates group
The top surface 20021 for knitting thickness compensation part 20020 penetrates tissue T, and contact is located in nail bin in end effector 12
The anvil block 20060 (Figure 61) on 20000 opposites.Nail leg 20032 can be directed to the deformation of anvil block 20060, the leg of each nail 20030
20032 can capture a part for a part for non-woven material 20080 and tissue T.
In percussion configuration (Figure 82 and Figure 83), each nail 20030 can follow closely the tissue in 20030 to tissue T and capture
Thickness compensation part 20020 applies compressing force.Referring primarily to Figure 80 and Figure 81, the leg 20032 of each nail 20030 can be towards nail
20030 base portion 20031 deforms downwards, to form nail retention region 20039.Nail retention region 20039 can be tissue T and tissue
The region that thickness compensation part 20020 can be captured by percussion nail 20030.In all cases, nail retention region 20039 can limit
Between the inner surface and the inner surface of base portion 20031 for following closely 20030 of strained leg 20032.The retention area of nail 20030
20039 size may depend on a number of factors, such as the width of the diameter of the length of leg, leg, base portion and/or the journey of leg deformation
Degree.
Optionally, when non-woven material 20080 is trapped in nail retention region 20039, the quilt of non-woven material 20080
Capture portion can be compressed.The compression height for being trapped in the non-woven material 20080 in nail retention region 20039 can be according to identical
Tissue T in nail retention region 20039 and the variation in nail bin 20000.For example, in the case where tissue T is relatively thin, nail retention area
Domain 20039 can have the space for more giving non-woven material 20080, and therefore, 20080 compressed degree of non-woven material can
Can unlike when tissue T is thicker its will be compressed it is big.Such as in the case where tissue T is thicker, non-woven material 20080 can
It is compressed more, to adapt to thicker tissue T.For example, with reference to Figure 82, non-woven material 20080 can for example be cut in the first nail
It stays and is compressed to the first height in the 20039a of region, the second height is compressed in the second nail retention region 20039b, followed closely in third
It is compressed to third height in the 20039c of retention area, the 4th is compressed in the 4th nail retention region 20039d highly, and
The 5th height is compressed in 5th nail retention region 20039e.Similarly, as shown in Figure 83, non-woven material 20080 can be
It is compressed to the first height in one nail retention region 20039a, the second height is compressed in the second nail retention region 20039b,
Third height is compressed in third nail retention region 20039c, and it is high in the 4th nail retention region 20039d to be compressed to the 4th
Degree.Alternatively, the compression height of non-woven material 20080 can be uniform in entire nail bin 20010.
Optionally, non-woven material 20080 can be moved to compressed configuration by the power applied from initial uncompressed configuration.This
Outside, non-woven material 20080 can have elasticity so that screen resilience or restoring force can be generated when non-woven material 20080 is compressed.
When deformation, which can attempt to spring back from the configuration for compressing or deforming.When non-woven material 20080 attempts
When rebound, screen resilience or restoring force can be applied in the tissue being also trapped in nail retention region 30039, such as herein more in detail
Carefully describe.When the power of application is then removed, restoring force can be such that non-woven material is sprung back from the configuration of compression.It is non-woven
Material 20080 is resiliently to initial uncompressed configuration or resiliently to the configuration for being substantially similar to initial uncompressed configuration.It is non-
The deformation of weaving material 20080 can be elastic.The deformation of non-woven material can be partial elastic and partially plastic.
When a part for non-woven material 20080 is compressed in nail retention region 20039, non-woven compensating part
The crimped fibre 20086 in the part in 20039 can also be compressed or in other words be deformed.The deformation of crimped fibre 20086
Amount can be corresponding with the decrement of the captured part of non-woven material 20080.For example, with reference to Figure 63, non-woven material 20080
The nail 20030 that can be disposed captures.The nail 20030 that non-woven material 20080 is disposed compresses more, crimped fibre
20086 average deformation can be bigger.In addition, the nail that non-woven material 20080 is disposed compresses fewer, crimped fibre
20086 average deformation can be smaller.Similarly, referring to Figure 82 and Figure 83, non-woven material 20080 is compressed more wherein
Nail retention region 20039d in, the crimped fibre 20086 in nail retention region 20039d usually can deform more.In addition,
In nail retention region 20039a, non-woven material 20080 is compressed fewer, the crimped fibre in nail retention region 20039a
20086 usually can deform fewer.
The ability that non-woven material 20080 is sprung back from the configuration of deformation, that is, the screen resilience of non-woven material 20080 can use
Certainly in the screen resilience of crimped fibre 20086 in non-woven material 20080.Crimped fibre 20086 can deform with resiliencely.Curling
The deformation of fiber 20086 can be partial elastic and partially plastic.Optionally, the compression of each crimped fibre 20086 can make by
The crimped fibre 20086 of compression generates screen resilience or restoring force.For example, when fiber 20086 attempts to spring back from its compressed configuration
When, compressed crimped fibre 20086 can generate restoring force.Fiber 20086 can attempt to be restored to its initial uncompressed structure
Type or the configuration for being substantially similar to its configuration.Crimped fibre 20086 can attempt to part and be restored to its initial configuration.Optionally,
The only a part of crimped fibre 20086 can have elasticity in non-woven material 20080.When crimped fibre 20086 includes linear bullet
Property material when, the restoring force of compressed crimped fibre 20086 may depend on such as 20086 compressed quantity of crimped fibre and
The device of spring stiffness coefficient of crimped fibre 20086.The device of spring stiffness coefficient of crimped fibre 20086 can be fine at least dependent on such as curling
Orientation, material and shape and/or the size of dimension 20086.
Crimped fibre 20086 in non-woven material 20080 may include uniform device of spring stiffness coefficient.Alternatively
It selects, the device of spring stiffness coefficient of the crimped fibre 20086 in non-woven material 20080 can be variation.When with big spring
When the crimped fibre 20086 of stiffness factor is greatly compressed, crimped fibre 20086 can generate big restoring force.When with same
When the crimped fibre 20086 of the big device of spring stiffness coefficient of sample is compressed less, crimped fibre 20086 can generate smaller recovery
Power.The summation of the restoring force generated by the crimped fibre 20086 of the compression in non-woven material 20080 can be generated in tissue thickness
Merging restoring force on the entire non-woven material 20080 of compensating part 20020.Non-woven material 20080 can be trapped in tool
Have to apply in the tissue T in the percussion nail 20030 of the non-woven material 20080 of compression and merges restoring force.
In addition, the quantity of the crimped fibre 20086 of per unit volume non-woven material 20080 can influence non-woven material
20080 device of spring stiffness coefficient.For example, the negligible amounts of the crimped fibre 20086 when per unit volume non-woven material 20080
When, the screen resilience in non-woven material 20080 can be relatively low;For example, when the crimped fibre of per unit volume non-woven material 20080
When 20086 quantity is more, the screen resilience of non-woven material 20080 can be higher;For example, working as per unit volume non-woven material
20080 crimped fibre 20086 it is more when, the screen resilience of non-woven material 20080 can higher.Work as non-woven material
When 20080 screen resilience is relatively low, such as when the quantity of the crimped fibre 20086 of per unit volume non-woven material 20080 is relatively low
When, the merging restoring force being applied to by tissue thickness compensation part 20020 in captured tissue T also can be smaller.When non-woven material
Material 20080 screen resilience it is higher when, such as when per unit volume non-woven material 20080 crimped fibre 20086 quantity compared with
Gao Shi, the sum of the restoring forces being applied to by tissue thickness compensation part 20020 in captured tissue T also can be higher.
Referring primarily to Figure 64, the non-woven material 20080' of tissue thickness compensation part 20020' may include such as therapeutic agent
20088, such as drug and/or pharmaceutically active agents.The therapeutic agent 20088 of the releasable therapeutically effective amount of non-woven material 20080 '.
For example, when non-woven material 20080 ' is absorbed, therapeutic agent 20088 can be released.Therapeutic agent 20088 can be released to and flow through
Fluid on non-woven material 20080 ' or across non-woven material 20080 ', such as blood.The example of therapeutic agent 20088 can
Including but not limited to hemostat and drug, such as fibrin, fibrin ferment and/or oxidized regenerated cellulose (ORC);Anti-inflammatory agent
Object, such as Diclofenac, aspirin, naproxen, sulindac and/or hydrocortisone;Antibiotic and antimicrobial agents or
Preparation, such as triclosan, ionic silver, ampicillin, gentamicin, polymyxin B, and/or chloramphenicol;And/or anticancer agent,
Such as cis-platinum, mitomycin and/or adriamycin.Therapeutic agent 20088 may include biological agent, such as stem cell.Non-woven material
20080 ' fiber 20082 may include therapeutic agent 20088.Alternatively, therapeutic agent 20088 may be added to that non-woven
Material 20080 ' is in other words integrated into tissue thickness compensation part 20020 '.
Referring primarily to Figure 70-Figure 70 B, the tissue thickness compensation part 20520 for end effector 12 (Figure 61) may include
Multiple springs or coiled fiber 20586.Similar with crimped fibre 20086 as described herein, coiled fiber 20586 is in tissue thickness
In compensating part 20520 can be (for example) crimp, distortion, coiling, bending, deformation, it is spiral, circular and/
Or it is bowed.Coiled fiber 20586 can be wrapped in around mandrel to form the shape of coiling or substantially coiled type.Coiled fiber
20586 can in entire tissue thickness compensation part 20520 random orientation and/or random distribution.Alternatively, it coils
Fiber 20586 can systematicness arrangement and/or inhomogenous distribution in entire tissue thickness compensation part 20520.For example, with reference to figure
70, coiled fiber 20586 may include the longitudinal axis between the first end 20587 of coiled fiber 20586 and second end 20589
Line.The longitudinal axis of coiled fiber 20520 in tissue thickness compensation part 20520 can be parallel or substantially parallel.Each coiling
The first end 20587 of fiber 20520 can position and every along the first longitudinal side 20523 of tissue thickness compensation part 20520
The second end 20589 of a coiled fiber 20586 can be positioned along the second longitudinal side 20524 of tissue thickness compensation part 20520.
In such construct, coiled fiber 20586 can laterally traverse tissue thickness compensation part.Alternatively, coiling is fine
Dimension 20586 can longitudinally or diagonally traverse tissue thickness compensation part 20520.
Optionally, similar with crimped fibre 20086 as described herein, coiled fiber 20586 may include polymer composition.
Crimped fibre 20586 can be at least partially elasticity so that the deformation of crimped fibre 20586 generates restoring force.Coiled fiber
20586 polymer composition may include such as polycaprolactone (PCL) so that coiled fiber 20586 is in chlorophyll solvent
It is insoluble.Referring to Figure 70 A, spring or coiled fiber 20520 are positively retained in compensating material 20580.Compensating material 20580 can
Coiled fiber 20586 is maintained at loading position so that coiled fiber 20586 applies load on spring to compensating material 20580 and exists
Apply load on spring in compensating material 20580.Coiled fiber 20586 can be maintained at neutral position by compensating material 20580, at this
In the case of coiled fiber 20586 will not apply load on spring to compensating material 20580 or apply spring in the compensating material 20580
Load.Compensating material 20580 can be bioabsorbable, and in some cases, it may include foam, such as polyglycolic acid
(PGA) foam.In addition, compensating material 20580 can be soluble in such as chlorophyll solvent.Tissue thickness compensation part may include
Such as coiled fiber 20586 containing polycaprolactone (PCL) and the compensating material 20580 containing polyglycolic acid (PGA) foam, make
It is insoluble in chlorophyll solvent to obtain coiled fiber 20520, and compensating material 20580 is solvable in chlorophyll solvent
's.Compensating material 20580 can be at least partially elasticity so that the compression of compensating material 20580 generates restoring force.In addition,
Referring to Figure 70 B, the compensating material 20580 of tissue thickness compensation part 20520 may include therapeutic agent 20588, such as stem cell.Work as benefit
Repay the therapeutic agent 20588 of 20580 releasable therapeutically effective amount of compensating material when material 20580 is absorbed.
Similar with tissue thickness compensation part 20020 as described herein, tissue thickness compensation part 20520 can be compressible
's.For example, when 20030 (Figure 78-Figure 81) of nail are deployed to firing position from initial position, 20030 engageable tissues of nail are thick
Spend a part for compensating part 20520.According to the present invention, nail 20030 can capture the part and phase of tissue thickness compensation part 20520
Adjacent tissue T.Nail 20030 can apply captured part from compressing force to tissue thickness compensation part 20520 and tissue T so that tissue
Thickness compensation part 20520 is compressed to compression height from uncompressed height.The compression of tissue thickness compensation part 20520 can lead to it
In coiled fiber 20586 corresponding deformation.As described in more detail, the deformation of each coiled fiber 20586 can produce
Raw restoring force, which may depend on the screen resilience of coiled fiber, for example, the deflection of coiled fiber 20586 and/or coiling
The device of spring stiffness coefficient of fiber 20586.The device of spring stiffness coefficient of coiled fiber 20586 can be at least dependent on such as coiled fiber
20586 orientation, material and shape and/or size.The deformation of coiled fiber 20586 can be whole in tissue thickness compensation part 20520
Restoring force is generated in a tissue thickness compensation part 20520.Tissue thickness compensation part 20520 can be to being caught in percussion nail 20030
It obtains tissue T and applies the sum of the restoring forces generated by the coiled fiber 20586 and/or elastic compensating material 20586 that deform.
Referring primarily to Figure 71 and Figure 72, the tissue thickness compensation part 20620 for end effector 12 may include multiple bullets
Spring coil 20686.Similar with crimped fibre 20086 as described herein and coiled fiber 20586, spring coil 20686 is being organized
Can be (for example) crimping, distorting, coiling, bending, deformation, spiral, circular in thickness compensation part 20620
And/or it is bowed.Optionally, similar with fiber and coil as described herein, spring coil 20686 may include combination of polymers
Object.In addition, spring coil 20686 can be at least partially elasticity so that the deformation of spring coil 20686 generates restoring force.
Spring coil 20686 may include first end 20687, second end 20689 and longitudinal axis between the two.Referring to Figure 71, bullet
The first end 20686 of spring coil 20686 can be positioned at or near the proximal extremity 20626 of tissue thickness compensation part, and
The second end 20689 of identical springs coil 20686 can be positioned at the distal end 20625 of tissue thickness compensation part 20620
Near or so that for example spring coil 20686 longitudinally traverses tissue thickness compensation part 20620.Alternatively, disk
Tissue thickness compensation part 20620 can laterally or be diagonally traversed around fiber 20686.
Tissue thickness compensation part 20620 may include outer membrane 20680, and the outer membrane 20680 is at least partly around at least one
Spring coil 20686.Referring to Figure 71, outer membrane 20680 can surround multiple spring coils in tissue thickness compensation part 20620
20686 periphery extends.Alternatively, the bullet that outer membrane 20680 can be in fully enclosed tissue thickness compensation part 20620
Spring coil 20686 or at least one spring coil 20686.Spring coil 20686 can be maintained at end effector by outer membrane 20680
In 12.Spring coil 20686 can be maintained at loading position by outer membrane 20680 so that spring coil 20686 generates load on spring simultaneously
And external membrane 20680 applies screen resilience.Alternatively, spring coil 20686 can be maintained at neutral by outer membrane 20680
Position.Tissue thickness compensation part 20620 may also include packing material 20624.Packing material 20624 can be kept by outer membrane 20680
In the spring coil 20686 and/or around.Packing material 20624 may include therapeutic agent 20688, be controlled similar to as described herein
Treat agent.In addition, packing material 20624 can support the spring coil 20686 in tissue thickness compensation part 20620.Packing material
20624 can be compressible and be at least partially elasticity so that packing material 20624 helps to be mended by tissue thickness
The screen resilience or restoring force of the generation of part 20620 are repaid, as described in more detail.
Similar with tissue thickness compensation part as described herein, tissue thickness compensation part 20620 can be compressible.Work as nail
When 20030 (Figure 78-Figure 81) are deployed to firing position from initial position, 20030 engageable tissue thickness compensation parts 20620 are followed closely
A part.Optionally, each nail 20030 can capture a part for tissue thickness compensation part 20620 together with adjacent tissue T.Nail
20030 can apply captured part from compressing force to tissue thickness compensation part 20620 and captured tissue T so that tissue thickness
Compensating part 20620 is compressed between uncompressed height and compression height.The compression of tissue thickness compensation part 20620 can cause to protect
Hold the corresponding deformation (Figure 72) of spring coil 20686 wherein.As described in more detail, each spring coil 20686
Deformation can generate restoring force, which depends on the screen resilience of spring coil 20686, for example, spring coil 20686
The device of spring stiffness coefficient of deflection and/or spring coil 20686.The device of spring stiffness coefficient of spring coil 20686 can at least depend on
In the material and shape and/or size of such as spring coil 20686.In addition, according to time of packing material 20624 and outer membrane 20680
The compression of elastic force, packing material 20624 and/or outer membrane 20680 can also generate restoring force.At least by tissue thickness compensation part
The summation for the restoring force that deformed spring coil 20686, packing material 20624 in 20620 and/or outer membrane 20680 generate can be
Restoring force is generated in entire tissue thickness compensation part 20620.Tissue thickness compensation part 20620 can be to the quilt in percussion nail 20030
Capture tissue T applies the sum of the restoring forces generated by deformed spring coil 20686.
Optionally, referring primarily to Figure 73-Figure 75, the tissue thickness compensation part 20720 for end effector 12 may include
Multiple spring coils 20786.Similar with coiled fiber as described herein and spring, spring coil 20786 is compensated in tissue thickness
It can be (for example) crimping, distorting, coiling, bending, deformation, spiral, circular and/or bow in part 20720
Shape.Spring coil 20786 can be at least partially elasticity so that the deformation of spring coil 20786 generates restoring force.This
Outside, spring coil 20786 may include first end 20787, second end 20789 and longitudinal axis between the two.Referring primarily to
The first end 20787 of Figure 75, spring coil 20786 can be positioned at the proximal extremity 20726 of tissue thickness compensation part 20720
Near or, and the second end 20789 of spring coil 20786 can be positioned on the distal end of tissue thickness compensation part 20720
At or near 20725 so that spring coil 20786 longitudinally traverses tissue thickness compensation part 20720.Spring coil 20786 can
It is longitudinally extended along two parallel rows in tissue thickness compensation part 20720.Tissue thickness compensation part 20720 can be positioned on end and hold
In row device 12 so that sliding part 20050 (Figure 61) or cutting element 20052 can be along between the spring coils 20786 of parallel row
Slit 20015 translate.Alternatively, spring coil 20786 can laterally or diagonally traverse tissue thickness's benefit
Repay part 20720.
Referring again to Figure 75, spring coil 20786 is positively retained at or is embedded in compensating material 20780.Compensating material 20780
It can be bioabsorbable, and may include foam in some cases, such as polyglycolic acid (PGA) foam.Compensating material
20780 can have elasticity so that the deformation of compensating material 20780 generates screen resilience.Compensating material 20780 is molten in such as chlorophyll
Can be soluble in agent.For example, tissue thickness compensation part can such as spring coil 20786 including containing polycaprolactone (PCL)
With the compensating material 20780 containing polyglycolic acid (PGA) foam so that spring coil 20786 is in chlorophyll solvent can not
Molten, and compensating material 20780 is soluble in chlorophyll solvent.Compensating material 20780 can be at least partially elasticity,
So that the deformation of compensating material 20780 generates load on spring or restoring force.
Tissue thickness compensation part 20720 may include plait 20790, can be between the spring coil 20786 of parallel row
Extend.For example, with reference to Figure 75, the first plait 20790 can diagonally traverse the spring coil 20786 of two parallel rows, and
Second plait 20790 can also diagonally traverse the spring coil 20786 of two parallel rows.First and second plaits 20790
It can intersect.Plait 20790 can be crossed over many times along the length of tissue thickness compensation part 20720.Plait 20790 can be by spring
Coil 20786 is maintained in loading configuration so that spring coil 20786 is maintained at the base in tissue thickness compensation part 20720
This flat position.Spring coil 20786 can be directly attached to by traversing the plait 20790 of tissue thickness compensation part 20720.As
Another option, plait 20790 can be connected to spring coil 20786 via support element 20792,20792 edge of support element
The longitudinal axis for spring coil 20786 extends through each spring coil 20786.
As described in more detail, nail bin 20000 may include slit 20015, can receive including cutting element
20052 translational slidiing part 20050 (Figure 61).When sliding part 20050 is translated along slit 20015, sliding part 20050 can incite somebody to action
Nail 20030 is projected from the securing member chamber 20012 in nail bin 20000, and cutting element 20052 can simultaneously or almost simultaneously be cut
Disconnected tissue T.It also can be cut off in tissue thickness compensation part 20720 referring again to Figure 75 when cutting element 20052 translates
Parallel row spring coil 20786 between the plait 20790 that intersects.When plait 20790 is cut off, each spring coil
20786 can be released from its loading configuration so that each spring coil 20786 was loaded from tissue thickness compensation part 20720
Substantially flat position is restored to expanding location.Optionally, when spring coil 20786 extends, the benefit of spring coil 20786 is surrounded
It is also expansible to repay material 20780.
Optionally, when 20030 (Figure 78-Figure 81) of nail are deployed to firing position from initial position, nail 20030 is engageable
A part for tissue thickness compensation part 20720, and tissue thickness compensation part 20720 can expand in extension or trial in nail 20030
Exhibition, and compressing force can be applied to tissue T.Optionally, at least one nail 20030 can capture tissue thickness compensation part 20720
A part is together with adjacent tissue T.Nail 20030 can be to the captured part and captured tissue T of tissue thickness compensation part 20720
Apply compressing force so that tissue thickness compensation part 20720 is compressed between uncompressed height and compression height.Tissue thickness is mended
The corresponding deformation of spring coil 20786 and the compensating material 20780 remained at can be led to by repaying the compression of part 20720.Such as this
Text is more fully described, and the deformation of each spring coil 20786 can generate restoring force, which may depend on spring coil
Screen resilience, for example, the device of spring stiffness coefficient of the deflection of spring coil 20786 and/or spring coil 20786.Spring coil
20786 device of spring stiffness coefficient can be at least dependent on the orientation, material and shape and/or size of such as spring coil 20786.By
The restoring force that at least deformed spring coil 20786 and/or compensating material 30380 in tissue thickness compensation part 20720 generate
Summation can generate restoring force in entire tissue thickness compensation part 20720.Tissue thickness compensation part 20720 can be to the tissue that is captured
T and percussion nail 20030 apply the sum of the restoring forces generated by the deformed spring coil 20786 in tissue thickness compensation part 20720.
Optionally, referring primarily to Figure 76 and Figure 77, the tissue thickness compensation part 20820 for surgical end-effector 12 can
Including spring coil 20886.Similar with fiber and coil as described herein, spring coil 20886 is in tissue thickness compensation part
It can be (for example) crimping, distorting, coiling, bending, deformation, spiral, circular and/or arch in 20820
's.Spring coil 20886 may include polymer composition and can be at least partially elasticity so that spring coil 20886
Deformation generate screen resilience.In addition, spring coil 20886 may include first end 20887 and second end 20889.Referring to figure
76, first end 20887 can be positioned at or near the proximal extremity 20826 of tissue thickness compensation part 20820, and the second end
End 20889 can be positioned at or near the distal end 20825 of tissue thickness compensation part 20820.Spring coil 20886 can be from group
It knits the winding of proximal extremity 20825 of thickness compensation part 20820 or is folded into distal end 20826.
Referring again to Figure 76, spring coil 20886 is positively retained at or is embedded in compensating material 20880.Compensating material 20880
It can be bioabsorbable, and in some cases, it may include foam, such as polyglycolic acid (PGA) foam.Compensating material
20880 in such as chlorophyll solvent can be soluble.Tissue thickness compensation part can be for example including containing polycaprolactone (PCL)
Spring coil 20886 and the compensating material 20880 for containing polyglycolic acid (PGA) foam so that spring coil 20886 is in chlorophyll
It is insoluble in solvent, and compensating material 20880 is soluble in chlorophyll solvent.Compensating material 20880 can at least portion
Divide ground that there is elasticity so that the deformation of compensating material 20880 generates load on spring or restoring force.
It is similar with tissue thickness compensation part as described herein, for example, tissue thickness compensation part 20820 can be compressible
's.The compression of tissue thickness compensation part 20820 can lead to the compensating material in holding or embedded tissue thickness compensation part 20820
At least part of spring coil 20886 in 20880 deforms.As described in more detail, the deformation of spring coil 20886
Restoring force can be generated, which may depend on the deflection of such as screen resilience of spring coil 20886, spring coil 20886
And/or the device of spring stiffness coefficient of spring coil 20886.It is produced by deformed spring coil 20886 and/or deformation-compensated material 20880
The summation of raw restoring force can generate restoring force in entire tissue thickness compensation part 20820.Tissue thickness compensation part 20820 can
Sum of the restoring forces are applied to the captured tissue T in percussion nail 20030.
Referring now to Figure 84, surgical end-effector 12 may include having the tissue of at least one tubular element 30080 thick
Spend compensating part 30020.Tissue thickness compensation part 30020 is positively retained in surgical end-effector 12.As retouched in further detail herein
It states, the fastener in end effector 12 can be disposed so that fastener moves to firing position and makes tissue thickness compensation part
At least part of tubular element 30080 in 30020 deforms.Reader will be appreciated that, including at least one as described herein
The tissue thickness compensation part of tubular element can be mounted on a variety of surgical end-effectors in or in other words with a variety of surgical ends
Actuator engages, and these are within the scope of the invention.
Optionally, referring also to Figure 84, tissue thickness compensation part 30020 can be relative to the anvil block 30060 of end effector 12
Positioning.Alternatively, tissue thickness compensation part 30020 can be relative to the fastener cartridge assembly of end effector 12
(such as nail bin 30000) positions.Nail bin 30000 can coordinate the warehouse channel 30072 in the jaw 30070 of end effector 12
In.For example, tissue thickness compensation part 30020 can be releasably secured to nail bin 30000.Tissue thickness compensation part 30020
Tubular element 30080 can be positioned adjacent to the top platform surface 30011 of the rigid support portion 30010 of nail bin 30000.Tubulose
Element 30080 can be by adhesive or by wrappage (similar at least one of wrappage as described herein) (for example, figure
16) it is fixed to top platform surface 30011.Tissue thickness compensation part 30020 can be whole at one with the component including nail bin 30000
Body so that nail bin 30000 and tissue thickness compensation part 30020 are formed as individual unit construction.For example, nail bin 30000 may include
Such as first main part, such as rigid support portion 30010 and the second main part, such as tissue thickness compensation part
30020。
Referring to Figure 84-Figure 86, the tubular element 30080 in tissue thickness compensation part 30020 may include elongated portion
30082, which has extends through at least one tube chamber 30084 therein at least partly.Referring primarily to figure
86, the elongated portion 30082 of tubular element 30080 may include weaving or weave strand 30090, as described in more detail.
Alternatively, elongated portion 30082 may include solid construction, such as polymer extrudate, rather than weaving strand
30090.The elongated portion 30082 of tubular element 30080 may include thickness.The thickness of elongated portion 30082 can be entire long at it
In degree and around a diameter of substantially uniform;In other cases, which can change.Elongated portion 30082 can
For elongation so that for example the length of elongated portion 30082 is more than the diameter of elongated portion 30082.Elongated portion may include example
Such as about 1.20 inches to about 2.60 inches of length and about 0.10 inch to about 0.15 inch of diameter.Tubular element
20080 length can be such as about 1.40 inches, and the diameter of tubular element 20080 can be such as about 0.125 inch.
In addition, elongated portion 30082 can limit for example substantially circular or elliptical cross-sectional shape.Alternatively,
Cross-sectional shape may include polygonal shape, such as triangle, hexagon and/or octagon.Referring again to Figure 84, tubular element
30080 may include the first distal end 30083 and the second proximal extremity 30085.The cross-sectional shape of elongated portion 30082 can be
Narrow at first end 30083 and/or second end 30085, wherein at least one end 30083 of tubular element 30080,
30085 can be closed and/or seal.Alternatively, tube chamber 30084 can continue across the distal side of tubular element 30080
End 30083,30085 so that end 30083,30085 is open.
Tubular element 30080 may include the single central lumen for extending through elongated portion 30084 at least partly
30084.Tube chamber 30084 can extend across the whole length of elongated portion 30084.As other alternate forms, tubular element
30080 may include extending through multiple tube chambers 30084 therein.The tube chamber 30084 for extending through tubular element 30080 can be circle
Shape, semicircle, wedge shape and/or combination thereof.According to the present invention, tubular element 30080 may also include support web, can
For example modified " T " or X-shaped shape are formed in tube chamber 30084.Size, tube chamber and/or support in tubular element 30080 is fine
Dimension net can limit the cross-sectional shape of tubular element 30080.The cross-sectional shape of tubular element 30080 can in its whole length
It is consistent, or alternatively, the cross-sectional shape of tubular element 30080 can change along its length.Such as this
Text is more fully described, and the cross-sectional shape of tubular element 30080 can influence compressibility and the rebound of tubular element 30080
Power.
Tubular element 30080 may include perpendicular diameter and horizontal diameter;Its size can be according to the pipe in end effector 12
The construction of the very best part 30080, the size (tissue space for including end effector 12) of end effector 12 and nail retention region
30039 expection geometry selects.For example, the perpendicular diameter of tubular element 30080 can have with the desired height of forming nail
It closes.In such cases, the perpendicular diameter of tubular element 30080 may be selected so that when tubular element 30080 is trapped in forming
When in nail 30030, perpendicular diameter can reduce about 5% to about 20%.For example, the pipe that perpendicular diameter is about 0.100 inch
The very best part 30080 can be used for being expected the nail that forming height is about 0.080 inch to about 0.095 inch.Therefore, when tubulose member
When part 30080 is trapped in forming nail 30030, even if not capturing any tissue T wherein, tubular element 30080 it is vertical
Diameter can also reduce about 5% to about 20%.When tissue T is trapped in forming nail 30030, tubular element 30080
Compression even can bigger.Perpendicular diameter can be uniform in the whole length of tubular element 30080, or alternatively select
It selects, perpendicular diameter can vary along its length.
When tubular element 30080 is in not deformed or resilient configuration, the horizontal diameter of tubular element 30080 can be more than,
Equal to or less than the perpendicular diameter of tubular element 30080.For example, with reference to Figure 85, horizontal diameter is for example big greatly than perpendicular diameter
About three times.For example, horizontal diameter may be about 0.400 inch and perpendicular diameter may be about 0.125 inch.As other one
Kind selection, referring now to Figure 87, when tubular element 31080 is in not deformed or resilient configuration, the level of tubular element 31080
Diameter can be equal or substantially equal to the perpendicular diameter of tubular element 31080.For example, horizontal diameter may be about 0.125 inch
And perpendicular diameter is alternatively about 0.125 inch.Tubular element 30080 may include about 0.125 inch of perpendicular diameter, big
About 0.400 inch of horizontal diameter and about 1.400 inches of length.As described in more detail, when power A is applied to pipe
The very best part 30080 and/or when 31080, tubular element is deformable so that cross-sectional geometry (including horizontal and vertical diameter)
It is alterable.
Referring again to Figure 84-Figure 86, the tubular element 30080 in tissue thickness compensation part 30020 can be deformable.It is whole
A tubular element 30080 can be deformable.For example, tubular element 30080 can be from the proximal extremity of elongated portion 30082
30083 to distal end 30085 and around its entire perimeter can be deformable.Alternatively, tubular element
30080 only a part can be deformable.For example, the only intermediate length and/or tubular element 30080 of elongated portion 30082
The only a part of perimeter can be deformable.
When the contact point being applied to compressing force on the elongated portion 30082 of tubular element 30080, contact point can be inclined
It moves, the cross sectional dimensions of this changeable tubular element 30080.For example, referring again to Figure 85, tubular element 30080 may include stretching
Top apex 30086 on long part 30082 and bottom apex 30088.In the initial undeformed configuration, tubular element 30080
It may include the undeformed vertical diameter between undeformed cross-sectional dimension, including top apex 30086 and bottom apex 30088.
When compressing force A is applied to top apex 30086, tubular element 30080 is moveable to deformed configuration.In deformed configuration,
The cross sectional dimensions of pipe 30080 is changeable.For example, pipe 30086 may include between top apex 30086 and bottom apex 30088
Deformation perpendicular diameter, which is smaller than undeformed vertical diameter.Referring to Figure 87, for example, working as tubular element
30080 when never deformed configuration moves to deformed configuration, and the horizontal diameter of deformation tube 30080 can be lengthened out.Deformation tube 30080
Deformed cross-sectional dimension can be at least dependent on the position of exerted forces A, angle orientation and/or size.As described in more detail,
The deformation of tubular element 30080 can generate screen resilience or restoring force, may depend on the screen resilience of tubular element 30080.
Referring also to Figure 85, tubular element 30080 can generate screen resilience or restoring force when compressed.In such cases,
As described herein, when the contact point being applied to power A on the elongated portion 30082 of tubular element 30080, tubular element
30080 can move to deformed configuration from initial undeformed configuration.When removing applied power A, deformation tube 30080 can be from deformation
Configuration is sprung back.Deformation tube 30080 resiliently to initial undeformed configuration or it is resilient to initial undeformed configuration substantially class
As configuration.The ability that tubular element 30080 is sprung back from deformed configuration is related to the screen resilience of tubular element 30080.
Referring again to Figure 85, tubular element 30080 can apply screen resilience or restoring force.When for example by following closely 30030 (Figure 88
And Figure 89) when applying applied power A to tubular element 30080, restoring force can be generated by tubular element 30080, such as herein more
It describes in detail.The cross sectional dimensions of tubular element 30080 can be changed in the power A applied.In addition, in linear elastic material,
The restoring force of each deformed part of tubular element 30080 may depend on the deformation size and tubular element of tubular element 30080
The device of spring stiffness coefficient of 30080 part.The device of spring stiffness coefficient of tubular element 30080 can be at least dependent on such as tubulose member
Orientation, material, cross-sectional geometry and/or the size of part 30080.Tubular element in tissue thickness compensation part 30020
30080 may include uniform device of spring stiffness coefficient.Alternatively, device of spring stiffness coefficient can be along tubular element
30080 length and/or diameter change around tubular element 30080.When the tubular element with the first device of spring stiffness coefficient
When 30080 part is greatly compressed, tubular element 30080 can generate larger restoring force.When with identical first spring
When a part for the tubular element 30080 of stiffness factor is compressed less, tubular element 30080 can generate smaller restoring force.
Referring again to Figure 84, the tubular element 30080 in tissue thickness compensation part 30020 may include polymer composition.
The elongated portion 30082 of tubular element 30080 may include the polymer composition.In addition, the polymer composition may include to
Small part elastic material so that the deformation of tubular element 30080 generates restoring force.The polymer composition may include for example can not
Polymer, absorbable polymer or the combination thereof of absorption.The example of synthetic polymer includes but not limited to polyglycolic acid
(PGA), poly- (lactic acid) (PLA), polycaprolactone (PCL), polydioxanone (PDO) and their copolymer.For example, can inhale
The polymer of receipts may include bioabsorbable biocompatible elastomeric polymer.In addition, the polymer of tubular element 30080
Composition may include synthetic polymer, non-synthetic polymer or combination thereof.Optionally, it is similar to described elsewhere herein
Polymer composition, the polymer composition amount of may include of tubular element 30080 different (such as by weight percentage) can
The polymer of absorption, the polymer of nonabsorable, synthetic polymer and/or non-synthetic polymer.
Referring to Figure 84 and Figure 85, tubular element 30080 may include such as therapeutic agent 30098, such as pharmaceutically active agents or medicine
Object.Therapeutic agent 30098 is positively retained in the tube chamber 30084 of tubular element 30080.Elongated portion 30082 can encapsulate or part is sealed
Fill therapeutic agent 30098.Additionally or alternatively, the polymer composition of elongated portion 30082 may include controlling
Treat agent 30098.The therapeutic agent 30098 of 30080 releasable therapeutically effective amount of tubular element.It can be absorbed in tubular element 30080
When discharge therapeutic agent 30098.For example, therapeutic agent 30098 is releasably to flowing through on tubular element 30080 or pass through tubular element
30080 fluid, such as blood.Tubular element is pierced through as other alternate forms, such as when following closely 30030 (Figure 88 and Figure 89)
30080 and/or when in nail percussion sliding part 30050 cutting element 30052 (Figure 84) cut tubular element 30080 a part
When, releasable therapeutic agent 30098.The example of therapeutic agent 30098 may include but be not limited to hemostat and drug, such as, fibrin
Albumen, fibrin ferment and/or oxidized regenerated cellulose (ORC);Antiinflammatory medicine, such as Diclofenac, aspirin, naproxen,
Sulindac and/or hydrocortisone;Antibiotic and antimicrobial agents or antimicrobial, such as triclosan, ionic silver, ammonia benzyl
Penicillin, gentamicin, polymyxin B and/or chloramphenicol;Anticancer agent, such as cis-platinum, mitomycin and/or adriamycin;With/
Or biological agent, such as stem cell.
Referring again to Figure 84, Figure 88 and Figure 89, fastener (such as following closely 30030) can for example be disposed from nail bin 30000, be made
30030 engagement tissue thickness compensation parts 30020 must be followed closely and to 32080 applied force A of tubular element therein.As described herein,
Tubular element 30080 can be caused to deform 30080 applied force A of tubular element.It is similar with end effector 12 as described herein, nail
The rigid support portion 30010 in storehouse 30000 may include warehouse 30017, platform surface 30011 and multiple nail cavities therein
30012.Each nail cavity 30012, which can limit the opening in platform surface 30011 and follow closely 30030, can be removably positioned in nail
In chamber 30012 (Figure 104).Referring primarily to Figure 88 and Figure 89, each nail 30030 may include base portion 30031 and from base portion 30031
Two nail legs 30032 extended.Before deployment nail 30030, the base portion 30031 of each nail 30030 can be by being located in nail bin
Staple drivers 30040 (Figure 104) support in 30000 rigid support portion 30010.In addition before deployment nail 30030, often
The leg 30032 of a nail 30030 can be at least partially contained in nail cavity 30012 (Figure 104).
Optionally, as described in more detail, nail 30030 can be deployed between initial position and firing position.Example
Such as, 30050 engageable driver 30040 (Figure 104) of nail percussion sliding part so that it is at least one nail 30030 initial position with hit
Hair moves between position.Referring primarily to Figure 88, nail 30030 is moveable to firing position, wherein the leg 30032 of nail 30030 engages
The tubular element 32080 of tissue thickness compensation part 32020 penetrates tissue T and contacts and the nail in surgical end-effector 12
The anvil block 30060 (Figure 104) that storehouse 30000 is opposite and positions.Nail shapes pit 30062 in anvil block 30060 can make nail leg 30032
Bending so that by the tissue T in a part for the capture tubular element 32080 of percussion nail 30030 and nail retention region 30039
A part.As described in more detail, when nail 30030 moves between initial position and firing position, at least one nail
Leg 30032 can pierce the tubular element 32080 of tissue thickness compensation part 32020.Alternatively, nail leg 30032 can
Around the peripolesis of tubular element 32080 so that nail leg 30032 avoids piercing through tubular element 32080.With it is as described herein tight
Firmware is similar, and the leg 30032 of each nail 30030 can be cut towards the deformation downwards of base portion 30031 of nail 30030 with forming nail between the two
Stay region 30039.Nail retention region 30039 can be that a wherein part for tissue T and tissue thickness compensation part 32020 can be by firing
The region of 30030 capture of nail.In firing position, each nail 30030 to tissue T and can be trapped in the nail of nail 30030 and cut
The tissue thickness compensation part 32020 in region 30039 is stayed to apply compressing force.
Referring also to Figure 88, when tubular element 32080 is trapped in nail retention region 30039, tubular element 32080
Captured part is deformable, as described herein.In addition, tubular element 32080 can be retained according to the identical nail is for example trapped in
Thickness, compressibility and/or the density of tissue T in region 30039 and be deformed into the difference in different nail retention regions 30039
Deformed configuration.Tubular element 32080 in tissue thickness compensation part 32080 can extend longitudinally through continuous nail retention region
30039.In such construct, tubular element 32080 can be deformed into each nail retention region along a line percussion nail 30030
Different deformation configurations in 30039.Referring now to Figure 89, tubular element 33080 in tissue thickness compensation part 33020 can be along
A line percussion nail 30030 is laterally arranged in nail retention region 30039.Tubular element 33080 can be protected by soft shell 33210
It holds.In such construct, tubular element 33080 and soft shell 33210 can be deformed in each nail retention region 30039 not
Same deformed configuration.For example, in the case where tissue T is relatively thin, tubular element 33080 is lessly and thicker in tissue T compressible
In the case of, tubular element 33080 is morely to adapt to compared with thick tissue T compressible.Alternatively, tubular element
33080 deformation size can be uniform in the whole length of tissue thickness compensation part 33020 and/or width range.
Referring to Figure 90-Figure 92, the tubular element 34080 in tissue thickness compensation part 34020 may include more strands
34090.Referring primarily to Figure 90, strand 34090 can be woven or be woven into the tubulose lattice 34092 to form tubular element 34080
It is interior.The tubulose lattice 34092 formed by strand 34090 can be substantially hollow.The strand 34090 of tubular element 34080 can
For solid strand, tubulose strand and/or other another suitable shapes.For example, with reference to Figure 91, tubulose lattice 34092 it is single with
Strand 34090 can be pipe.Referring to Figure 93, strand 34090 may include extending through at least one tube chamber 34094 therein.Tube chamber
34094 number, geometry, and/or dimension can determine the cross-sectional shape of strand 34090.For example, strand 34090 may include
Circular tube chamber, semicircle tube chamber, wedge-shaped lumen and/or combination thereof.According to the present invention, strand 34090 may also include support
Web 34096 can form for example modified " T " or X-shaped shape.At least the diameter of strand 34090, extend through it is therein
Tube chamber and support web can characterize the cross-sectional shape of strand 34090.As described in more detail, each strand 34090
Cross-sectional shape pair that can influence the screen resilience generated by strand 34090 or restoring force and be generated by tubular element 34080
Answer screen resilience or restoring force.
Referring to Figure 94, the tubulose lattice 34092 of strand 34090 can be deformable.Tubulose lattice 34092 can generate or have
Help the deformability and/or screen resilience of tubular element 34080.For example, the strand 34090 of tubulose lattice 34092 can be woven in
Together so that strand 34090 can be slided and/or be bent relative to each other.When to the elongated portion of tubular element 34080
When 34082 applied force, strand 34090 therein slidably and/or bending so that tubulose lattice 34092 moves to deformed configuration.
For example, referring also to Figure 94, nail 30030 compressible tubulose lattice 34092 and the tissue T that is trapped in nail retention region 34039,
This can cause the strand 34090 of tubulose lattice 34092 to slide and/or be bent relative to each other.When tubulose lattice 34092 is compressed
When to deformed configuration, the top apex 34086 of tubulose lattice 34092 can be transported towards the bottom apex 34088 of tubulose lattice 34092
It is dynamic, to adapt to the captured tissue T in nail retention region 30039.In all cases, it is trapped in percussion nail 30030
Tubulose lattice 34092 will attempt to regain its not deformed configuration and restoring force can be applied to captured tissue T.This
Outside, it is located in the part of the tubulose lattice 34092 between nail retention region 30039 (that is, not capturing in percussion nail 30030) also
It can be deformed due to the deformation of the adjacent part of the tubulose lattice 34092 in nail retention region 30039.In tubulose lattice 34092
In the case of deformation, tubulose lattice 34092 can attempt to spring back from deformed configuration or partly spring back.Optionally, tubulose lattice
34092 part resiliently only can partly be sprung back and/or protect to the other parts of its initial configuration and tubulose lattice 34092
Hold complete compression.
Similar with the description of the tubular element of this paper, each strand 34090 can also be deformable.In addition, strand 34090
Deformation can generate restoring force, the restoring force depend on each strand 34090 screen resilience.Referring primarily to Figure 91 and Figure 92, pipe
Each strand 34090 of shape lattice 34092 can be tubulose.Alternatively, each strand of tubulose lattice 34092
34090 can be solid.As other alternate forms, tubulose lattice 30092 may include at least one tubulose strand 34090, extremely
The strand 34090 and/or combination thereof of a few solid strand 34090, at least one " X " or T shape.
Strand 34090 in tubular element 34080 may include polymer composition.The polymer composition of strand 34090
It may include the polymer, absorbable polymer or combination thereof of nonabsorable.The example of synthetic polymer includes but unlimited
In polyglycolic acid (PGA), poly- (lactic acid) (PLA), polycaprolactone (PCL), polydioxanone (PDO) and their copolymerization
Object.For example, absorbable polymer may include bioabsorbable biocompatible elastomeric polymer.In addition, strand 34090
Polymer composition may include synthetic polymer, non-synthetic polymer and/or combination thereof.Optionally, it is similar to herein
The polymer composition elsewhere, the polymer composition amount of may include of strand 34090 are different (such as by weight percentage
Meter) absorbable polymer, nonabsorable polymer, synthetic polymer and/or non-synthetic polymer.
Strand 34090 in tubular element 34080 also may include such as therapeutic agent 34098 (Figure 91), such as pharmaceutical activity
Agent or drug.The therapeutic agent 34098 of 34090 releasable therapeutically effective amount of strand.It can be discharged when tubulose strand 34090 is absorbed
Therapeutic agent 34098.For example, therapeutic agent 30098 is releasable to the fluid flowed through on strand 34090 or across strand 34090, it is all
Such as blood.As other alternate forms, such as when nail 30030 pierces through strand 34090 and/or works as nail percussion sliding part 30050
On cutting element 30052 (Figure 84) cutting tubulose lattice 34092 a part when, releasable therapeutic agent 34098.Therapeutic agent
34098 example may include but be not limited to hemostat and drug, such as fibrin, fibrin ferment and/or oxidation regeneration fiber
Plain (ORC);Anti-inflammatory drug, such as Diclofenac, aspirin, naproxen, sulindac and/or hydrocortisone;Antibiotic and
Antimicrobial agents or preparation, such as triclosan, ionic silver, ampicillin, gentamicin, polymyxin B and/or chlorine are mould
Element;Anticancer agent, such as cis-platinum, mitomycin and/or adriamycin;And/or biological agent, such as stem cell.
Referring to Figure 95 and Figure 96, tubular element 35080 may include multiple layers 35100 of strand 35090.Tubular element
35080 may include multiple layers 35100 of tubulose lattice 35092.Referring to Figure 95, tubular element 35080 may include such as strand
35090 first layer 35100a and second layer 35100b.Referring now to Figure 96, the tubular element of tissue thickness compensation part 35120
35180 may include the third layer 35100c of such as strand 35090.In addition, the different layers 35100 in tubular element 35180 can wrap
Include different materials.Each layer 35100a, 35100b, 35100c can be bioabsorbable, wherein each layer 35100a,
35100b, 35100c may include different polymer compositions.For example, first layer 35100a may include that first polymer combines
Object;Second layer 35100b may include second polymer composition;And third layer 35100c may include third polymerization compositions.
In such cases, layer 35100a, 35100b, 35100c of tubular element 35180 can be by different rates by bio-absorbable.Example
Such as, first layer 35100a can quickly absorb, and second layer 35100b is than first layer 35100a more slow trappings, and third layer
35100c is than first layer 35100a and/or second layer 35100b more slow trappings.Alternatively, first layer 35100a
Can slow-absorbing, second layer 35100b is faster absorbed than first layer 35100a, and third layer 35100c is than first layer
35100a and/or second layer 35100b faster absorb.
Similar with strand 34090 as described herein, the strand 35090 in tubular element 35180 may include drug 35098.
Referring again to Figure 95, in order to control the elution or release of drug 35098, include the first layer of the strand 35090 of drug 35098a
35100a can be with first rate by bio-absorbable, and includes that the second layer 35100b of the strand 35090 of drug 30098b can be with
Second rate is by bio-absorbable.For example, first layer 35100a can quickly be absorbed to allow drug 35098a rapid initial releases, and
And second layer 35100b can be compared with slow trapping to allow drug 30098b controlled releases.In the strand 35090 of first layer 30100a
Drug 35098a may differ from the drug 35098b in the strand 35090 of second layer 35100b.For example, in first layer 35100a
Strand 35090 may include that the strand 35090 in oxidized regenerated cellulose (ORC) and second layer 35100b may include solution, should
Solution includes hyaluronic acid.In such cases, the releasable oxidized regenerated cellulose of the initial absorption of first layer 35100a is to help
Help control bleeding, and the subsequent absorption of second layer 35100b includes releasably the solution of hyaluronic acid to help to inhibit tissue attached
It.Alternatively, layer 35100a, 35100b may include identical drug 35098a, 35098b.For example, referring again to
Strand 35090 in Figure 96, layer 35100a, 35100b and 35100c may include anticancer agent, such as cis-platinum.In addition, first layer
35100a can quickly be absorbed to allow cis-platinum rapid initial release, second layer 35100b can be compared with slow trapping to allow cis-platinum by controlled release
Put, and third layer 35100c can most slow trapping to allow the more extended controlled release of cis-platinum.
Referring to Figure 97 and Figure 98, tissue thickness compensation part 36020 may include overmold material 36024.Overmolding material
Material 36024 can be formed in 36080 outside of tubular element, 36080 inside of tubular element or 36080 inner side and outer side of tubular element
The two.Referring to Figure 97, overmold material 36024 can be coextruded in both 36080 inner side and outer side of tubular element, and tubulose
Element 36080 may include the tubulose lattice 36092 of strand 36090.It is similar with polymer composition as described herein, overmolding
Material 36024 may include such as polyglycolic acid (PGA), poly- (lactic acid) (PLA) and/or any other is suitable bioabsorbable
Biocompatible elastomeric polymer.In addition, overmold material 36024 can be non-porous so that overmold material 36024
Form the impermeable layer of fluid in tubular element 36080.Overmold material 36024 can limit the tube chamber passed through
36084。
If further discussed above, the strand 36090 in tubular element 36080 and/tubulose lattice 36092 may include treating
Agent 36098.Referring also to Figure 97 and Figure 98, non-porous overmold material 36024 can include drug in interior lumen 36084a
36098.Alternatively or additionally, non-porous overmold material 36024 can wrap in intermediary canal 36084b
Drug containing 36098, the intermediary canal 36084b of the tubulose lattice 36092 such as comprising the strand 36090 containing drug.With it is above-mentioned
It is similar, tubular element 36080 can relative in nail bin 30000 nail cavity 30012 and cutting element 30052 position (Figure 84).Nail
30030 deployment and/or the translation of cutting element 30052 can pierce through non-porous overmold material 36024 or make its rupture, make
The drug 36098 that be accommodated at least one tube chamber 36084 of tubular element 30080 can be discharged from tube chamber 30084 by obtaining.Referring to
Figure 99, tubular element 37080 may include non-porous film 37110.Non-porous film 37110 can be at least partly around tubulose lattice 37092
Or the first layer 37100a and second layer 37100b of tubulose lattice 30092 are to provide and overmold material as described herein
The impermeable covering of 36024 similar fluids.
As described herein, tubular element may include bioabsorbable material, therapeutic agent, more strands, tubulose lattice, pipes
At least one of the layer of shape lattice, overmold material, non-porous film or combinations thereof.For example, with reference to Figure 100, tubular element
The 38080 more stocks that may include overmold material 38024 and positioned across the central lumen 38084 of tubular element 38080
Line 38090.Strand 38090 may include therapeutic agent 38098.Alternatively, for example, with reference to Figure 101, tubular element
39080 may include such as overmold material 39024 and the treatment being located in the central lumen 39084 of tubular element 39080
Agent 39098.Optionally, at least one of tubular element 39080 and overmold material 39024 may include fluid treatment agent
39098。
Mainly referring again to Figure 84, tubular element 30080 can be fixed relative to the rigid support portion 30010 of nail bin 30000
Position.Tubular element 30080 can 30010 longitudinal register of neighbouring rigid support portion.Tubular element 30080 can be arranged essentially parallel to or
With in rigid support portion 30010 longitudinal slit or cavity 30015 be aligned.Tubular element 30080 can be with longitudinal slit 30015
Alignment a so that part for tubular element 30080 is Chong Die with a part for longitudinal slit 30015.In such cases, nail percussion
Cutting element 30052 on sliding part 30050 can cut off tubulose member when cutting edge 30052 is translated along longitudinal slit 30015
A part for part 30080.Alternatively, tubular element 30080 can be longitudinal positioning of the first of longitudinal slit 30015
On side or the second side.As other alternate forms, tubular element 30080 can be relative to the rigid support portion of nail bin 30000
30010 positioning so that tubular element 30080 laterally or diagonally traverses at least part of rigid support portion 30010.
See, for example, Figure 102, tissue thickness compensation part 40020 may include multiple tubular elements 40080.Tubular element
40080 may include for example different length, cross-sectional shape and/or material.In addition, tubular element 40080 can be relative to nail bin
30000 rigid support portion 40010 and position so that the tubulose axis of tubular element 40080 is parallel to each other.Tubular element
40080 tubulose axis can be longitudinally aligned so that the first tubular element 40080 is positioned in another tubular element 40080.
Alternatively, parallel tubular elements 40080 can longitudinally traverse such as nail bin 30000.As other alternative shape
Formula, parallel tubular elements 40080 can laterally or diagonally traverse nail bin 30000.Alternatively, non-parallel tubulose
Element 40080 can be angled with respect to each other orientation so that its tubulose axis intersects each other and/or not parallel.
Referring to Figure 102-Figure 105, tissue thickness compensation part 40020 can have there are two tubular element 40080;First tubulose member
Part 40080a can be longitudinally positioned on the first side of the longitudinal slit 30015 in rigid support portion 30010, and the second tubulose
Element 40080b can be longitudinally positioned in the second side of longitudinal slit 30015.Each tubular element 40080 may include strand
40090 tubulose lattice 40092.Nail bin 30000 may include six row nail cavity 30012 in total, wherein for example three row nail chamber 30012 is fixed
Position is on every side of longitudinal slit 30015.In such cases, it may not be necessary to translate in nail percussion sliding part 30050
Cutting edge 30052 cuts off a part for tubular element 40080.
Similarly, referring now to Figure 106-Figure 107, tissue thickness compensation part 41020 may include being longitudinally arranged in nail bin
Two tubular elements 41080a, 41080b in 30000.Similar to the above, the nail 30030 in three row nail chamber 30012 can
Engage a tubular element 41080a and another engageable tubulose of nail 30030 in different three row nail chambers 30012
Element 41080b.Referring also to Figure 106-Figure 107, the nail 30030 disposed can across the cross section of tubular element 40080 not
With engagement tubular element 40080 at position.As described herein, the screen resilience elasticity and correspondence applied by tubular element 41080 is extensive
Multiple power may depend on the cross-sectional shape etc. of tubular element 41080.It is located at the arch section of tubular element 41080
Or nail 30030 in neighbouring nail retention region 30039 is than being located in the nail retention region 30039 near non-arch section
Nail 30030 be subjected to bigger restoring force.Similarly, the nail retention region being located in the non-arch section of tubular element 41080
Nail 30030 in 30039 can be subjected to than 30030 bodies of nail by being located at or near the arch section of tubular element 30080
The smaller restoring force of restoring force tested.In other words, large number of due to that may be captured along the nail 30030 of such part
The arch section of elastic material, tubular element 41080 has bigger spring stiffness than the non-arch section of tubular element 41080
Coefficient.Optionally, therefore, referring primarily to Figure 107, the restoring force generated by tissue thickness compensation part 41020 can be in tubular element
Bigger and the smaller near nail 30030b near nail 30030a and 30030c in 30080a.Correspondingly, it is mended by tissue thickness
The restoring force for repaying the generation of part 41020 can be near the nail 30030d and 30030f in tubular element 30080b than following closely near 30030e
Bigger.
Referring again to Figure 102-Figure 105, the cross section geometric form of the optional strand 40090 for including tubulose lattice 40092
Shape, in order to provide the correspondence restoring force required screen resilience elasticity and applied by tubulose lattice 40092.For example, referring again to figure
103, the strand 40090a being located in the arch section of tubular element 40080 may include X-shaped cross-section, and be located in tubulose
Strand 40090b in the non-arch section of element 40080 may include tubular cross-section.Including different cross-sectional geometries
Strand 40090a can be weaved with 40090b together with to form tubulose lattice 40092.Alternatively, strand 40090a
Such as adhesive can be used to be attached to each other with 40090b.Referring to Figure 104 and Figure 105, the strand 40090 in tubular element 40080
Different cross-sectional geometries can make the restoring force being subjected in the nail retention region 30039 of nail bin 30000 optimize.It can
Select specific cross-sectional geometry so that the resilience constant in the nail retention region 30039 of nail bin substantially balance or
It is equal.
Referring to Figure 108, tubular element 41080a, 41080b of tissue thickness compensation part 41120 can pass through adjacent part
41126 tighten together.Although translation cutting element 30052 can pass through between tubular element 41080a and 41080b,
Cutting element 30052 may be needed to cut off at least part of adjacent part 41126.Adjacent part 41126 may include soft material
Material, such as foam or gel are easy translated cutting element 30052 and cut off.Adjacent part 41026 can compensate tissue thickness
Part 41120 is releasably secured to surgical end-effector 12.Adjacent part 41126 can be fixed to rigid support portion 30010
Top platform surface 30011 so that it is adjacent after discharging tubular element 41080a, 41080b from surgical end-effector 12
Part 41126 remains in surgical end-effector 12.
Referring to Figure 109-Figure 110, tissue thickness compensation part 42020 may include multiple tubular elements 42080 so that for example manage
The quantity of the very best part 42080 is identical as the line number of nail cavity 30012 in nail bin 30000.Nail bin 30000 may include six row nail cavities
30012 and tissue thickness compensation part 42020 may include six tubular elements 42080.Each tubular element 42080 can be with a line
30012 substantial registration of nail cavity.It, can from each of row nail 30030 when nail 30030 is projected from a line nail cavity 30012
Pierce through identical tubular element 42080 (Figure 110).The deformation of one pipe 42080 can have the deformation of adjacent tubes 42080 minimum
It influences or does not influence.Therefore, tubular element 42080 can apply in the nail retention region 30039 across 30030 width of nail bin
Substantially discrete and customization screen resilience.Identical tubular element 35080 is engaged in the nail 30030 fired from multirow nail cavity 30012
In the case of (Figure 107), the deformation of tubular element 35080 less can customize.For example, tubular element 35080 is in the first row
Deformation in nail retention region 30039 can influence the change in nail retention region 30039 of the tubular element 35080 in another row
Shape.It translates cutting edge 30052 and can avoid cut-out tubular element 42080.Alternatively, referring to Figure 111, tissue thickness
Compensating part 43020 may include six or more tubular elements 43080, such as seven tubular elements 44080.In addition, tubular element
43080 can symmetrically or non-symmetrically be arranged in end effector 12.When 43080 longitudinal direction of odd number tubular element and it is arranged symmetrically
When in end effector 12, translation cutting element 30052 can cut off the intermediate tube champion being covered on vertical passage 30015
Part.
Referring to Figure 112, tissue thickness compensation part 44020 may include central tubular element 44080b, at least partly with
Longitudinal slit 30015 in the rigid support portion 33010 of nail bin 30000 is aligned.Tissue thickness compensation part 44020 may also include
At least one peripheral tubular element 44080a, 44080c on 30015 side of longitudinal slit.For example, tissue thickness compensates
Part 44020 may include three tubular elements 44080:First peripheral tubular element 44080a can be longitudinal positioning of nail bin 30000
On first side of longitudinal slit 30015, central tubular element 44080b can be positioned substantially in longitudinal slit 30015 and/or
It is aligned with longitudinal slit 30015, and the second peripheral tubular element 44080c can be longitudinal positioning of the second of longitudinal slit 30015
On side.Central tubular element 44080b may include that relative to perpendicular diameter be the horizontal diameter substantially extended.Central tube champion
Part 44080b and/or any other tubular element can be Chong Die with multirow nail cavity 30012.Referring also to Figure 112, for example, central tubular
Element 44080b can be Chong Die with four nail rows of nail cavity 30012 and each peripheral tubular element 44080a, 44080c can be with list
Row nail cavity 30012 is overlapped.Alternatively, central tubular element 44080b can for example with less than four row nail cavities 30012
Overlapping, for example, two row nail cavities 30012.In addition, peripheral tubular element 44080a, 44080c can be with more than 30012 weight of a line nail cavity
It is folded, such as two row nail cavities 30012.Referring now to Figure 113, the central tubular element 44180b of tissue thickness compensation part 44120 can
Include therapeutic agent 44198 in the tube chamber 44184 of central tubular element 44180b.Optionally, central tubular element 44180b and/
Or at least one peripheral tubular element 44080a, 44080c may include therapeutic agent 44198 and/or any other suitable treatment
Agent.
Referring to Figure 114, tissue thickness compensation part 44220 may include shell 44224, the shell can with it is as described herein overlapping
Injected plastics material 32024 is similar.Multiple tubular elements 44080 are held in place by shell 44224 in end effector 12.Shell
44224 can be coextruded with tubular element 44080.Tubular element 44080 may include the tubulose lattice 44092 of strand 44090.It is similar
In herein, the polymer composition, shell 44224 may include such as polyglycolic acid (PGA), poly- (lactic acid) (PLA) elsewhere
And/or any other suitable bioabsorbable biocompatible elastomeric polymer.In addition, shell 44224 can be non-porous
So that shell 44224 for example forms the impermeable layer of fluid in tissue thickness compensation part 44220.Further such as this paper
It discusses, the strand 44090 in tubular element 44080 and/or tubulose lattice 44092 may include therapeutic agent 44098.Non-porous shell
44224 can include therapeutic agent 44098 in tissue thickness compensation part.As described herein, tubular element 44080 can be relative to nail cavity
30012 and cutting element 30052 be positioned in nail bin 30000.The deployment of nail 30030 and/or the translation of cutting element 30052
Non-porous shell 44224 can be pierced through or make its rupture so that therapeutic agent 44198 wherein included can be from tissue thickness compensation part
It is discharged in 44020.
Referring to Figure 115, tissue thickness compensation part 44320 may include central tubular element 44380b, the central tubular element
Including tubulose lattice 44392.Tubulose lattice 44392 can have nonwoven part or gap 44381, the nonwoven part or
Gap is substantially aligned with the longitudinal slit of rigid support portion 30,010 30015.In this case, tubular element 44380b
The woven portion of tubulose lattice 44092 is not Chong Die with longitudinal slit 30015.Therefore, cutting in nail percussion sliding part 30052 is translated
Cutting element 30052 can overlapping of the translation of slit 30015 without the woven portion of cut-out tubulose lattice 44392 along longitudinal direction.Although adjacent
The nail 30030c and 30030d that gap 44381 in nearly tubular element 44380b positions can be received from 44392 structure of tubulose lattice
Less support, but other feature structure can be that these nails 30030 provide support and/or in its nail retention region 30039
Other restoring force is provided.For example, as described in more detail, tubular element, supporting part, spring and/or pillar in addition
Material can for example be positioned in the places at least one of the inside and outside tubular element 44380b near gap 44381.
Referring now to Figure 116-Figure 119, tissue thickness compensation part 45020 may include laterally traversing the more of nail bin 30000
A tubular element 45080.Tubular element 45080 can be positioned so that perpendicular to nail cavity 30012 row and/or nail bin 30000 it is rigid
The longitudinal axis of property support section 30010.Referring to Figure 116, the longitudinal direction that tubular element 45080 can traverse in nail bin 30000 is narrow
Slot 30015 so that the cutting element 30052 in nail percussion sliding part 30050 can be narrow along longitudinal direction in nail percussion sliding part 30050
Tubular element 45080 is cut off when slot 30015 translates.Alternatively, referring now to Figure 117, tissue thickness compensation part
46020 may include two groups of tubular elements laterally traversed 46080.First group of tubular element 46080a laterally traversed can determine
On the first side of longitudinal slit 30015, second group of tubular element 46080b laterally traversed can be positioned on longitudinal slit for position
In 30015 the second side.In such construct, cutting element 30052 can pass through between two groups of tubular elements 46080, and
A part for tubular element 46080 is not cut off.Alternatively, when at least one other tubular element 46080 not
When traversing longitudinal slit 30015 and not cut off by cutting element 30052, cutting element 30052 can cut off traverse it is longitudinal narrow
At least one tubular element 46080 of slot 30015.
When tubular element 45080 laterally traverses nail bin 30000, referring to Figure 118 and Figure 119, nail 30030 is engageable every
At least one of a nail retention region 30039 tubular element 45080.In such construct, each tubular element 45080 can edge
The length of nail bin 30000 provides discrete restoring force.For example, referring primarily to Figure 119, and thinner tissue thickness is organized wherein
The tubular element 45080 that the distal end of compensating part 45020 is positioned about is compared, and thicker tissue thickness is organized to compensate wherein
The tubular element 45080 that the proximal extremity of part 45020 is positioned about can greatly be compressed.Therefore, with can be by closer to tissue
The restoring force that the tubular element 46080 of the distal end positioning of thickness compensation part 45020 generates is compared, and is mended closer to tissue thickness
The restoring force of bigger can be provided by repaying the tubular element 45080 of the proximal extremity positioning of part 45020.In addition, referring also to Figure 119, one
The deformation of a pipe 45080 can have minimum influence for the deformation of adjacent tubes 45080 or not influence.Therefore, tubular element
45080 can apply substantially discrete and customization screen resilience in the nail retention region 30039 of the length along nail bin 30030.?
In the case that the multiple nails 30030 fired from single row of nail cavity 30012 engage identical tubular element 35080, tubular element 35080
Deformation less can customize.For example, the deformation of the tubular element 35080 in a nail retention region 30039 can influence the tubulose
Deformation of the element 35080 in another nail retention region 30039.
As other alternate forms, referring to Figure 120-Figure 125, the tubular element 47080 of tissue thickness compensation part 47020
Nail bin 30000 can diagonally be traversed.Tubular element 47080 can traverse the longitudinal slit 30015 in nail bin 30000 so that nail
The cutting element 30052 fired on sliding part 30050 can be when slit 30015 translates nail percussion sliding part 30052 along longitudinal direction
Cut off the tubular element 47080 diagonally traversed.Alternatively, tissue thickness compensation part 47020 may include two groups
The tubular element 47080 diagonally traversed.First group of tubular element 47080 diagonally traversed can be positioned on longitudinal slit
On 30015 the first side, second group of tubular element 47080 diagonally traversed can be positioned on the second side of longitudinal slit 30015
On.In such construct, cutting element 30052 can pass through between two groups of tubular elements 47080, and can not cut off any
Tubular element 47080.
Referring still to Figure 120-Figure 123, the tubular element 47080 diagonally traversed can be positioned in nail bin 30000, make
Gap is obtained to be limited between tubular element 47080.It is captured in the nail retention region 30039 of forming nail 30030 when such as passing through
Tissue T when applying compressing force to adjacent tubular elements 47080, the gap between adjacent tubular elements can be tubular element
47080 horizontal extension provides space.Tubular element 47080 can be connected by material membrane or material piece 47024 across gap.Material
Tablet can be positioned in the platform surface 30011 of rigid support portion 30010 and/or the tissue contact side of tubular element 47080
At least one on.
Referring to Figure 124 and Figure 125, at least one tubular element 47080 diagonally traversed can be relative in nail bin 30000
Nail cavity 30012 position so that tubular element 47080 is located in the leg 30032 for the nail 30030 disposed from multirow nail cavity 30012
Between.When nail 30030 moves to firing position from initial position, as described in more detail, nail leg 30032 can keep fixed
Position is around tubular element 47080.In addition, for example, nail can deform so that nail leg 30032 surrounds the week of tubular element 47080
It wraps up on side.In such construct, nail 30030 can move to percussion or shaping position, without piercing through tubular element 47080.Nail
Leg 30032 can prevent from unintentionally discharging the therapeutic agent 47098 remained at around the movement of tubular element 47080.Each pipe
The very best part 47080 may depend on nail cavity 30012 relative to the selected angle orientation of the longitudinal slit 30015 of nail bin 30000 and exist
Position in nail bin 30000.For example, tubular element 47080 can relative to nail bin 30000 longitudinal slit 30015 at about 40
Angle positioning is spent in five (45).Alternatively, the longitudinal slit that tubular element 47080 can for example relative to nail bin 30000
30015 at the degree angle positioning of 15 (15) to 75 (75).
Similar to the description of the disclosure in the whole text, multiple tubular elements in tissue thickness compensation part can be for example, by bonding
Agent, wrappage, band, overmold material, compensating material and/or any other suitable connection adhesive or structure connect
It connects.Referring to Figure 126-Figure 128, soft shell 48024 can surround or encapsulate the tubular element in tissue thickness compensation part 48020
48080.Soft shell 48024 can limit the tubular element 48080 in end effector 12, and can make each tubular element
48080 are held in place, such as longitudinally aligned with a line nail cavity 30012.For example, tissue thickness compensation part 48020 may include six
Tubular element 48080.Soft shell 48024 can be sufficiently deformable and flexible, to limit the tubulose wherein wrapped up member
Part 48020, while allowing the deformation and rebound of tubular element 48080.In addition, soft shell 48024 can stretch tight tightly around tubulose
Element 48080, and can keep engaging with tightening for tubular element when tubular element 48080 deforms and/or springs back.
Referring to Figure 127, before deployment nail 30030, anvil block 30060 can be pivoted or be rotated downwards, to compress anvil block 30060
Tissue thickness compensation part 48020 between nail bin 30000 and tissue T.The compression of tissue thickness compensation part 48020 may include soft
Property shell 48024 and wherein tubular element 48020 corresponding compression.When tubular element 48020 deforms, soft shell 48024
It can similarly deform.Tubular element 48020 can equably compress on the entire width of nail bin 30000, and soft shell
48024 can undergo the similar homogeneous compaction on entire tubular element 48080.Referring to Figure 128, when anvil block 30060 is in nail 30030
When being opened after the deployment of nail bin 30000, tubular element 48080 can spring back from compressed configuration or partly spring back (Figure 127).
According to the present invention, tubular element 48080 can be sprung back so that tubular element 48080 returns to its initial undeformed configuration.Tubulose
Element 48080 can partly be sprung back so that tubular element 48080 partly returns to its initial undeformed configuration.For example, pipe
The deformation of the very best part 48080 can be partial elastic and partially plastic.When tubular element 48080 is sprung back, soft shell 48024
It can keep tightening with each tubular element 48080 and engage.Tubular element 48080 and soft shell 48024 can recoil in this way
Degree, the degree makes tubular element 48080 and tissue T fill nail retention region 30039, while tubular element 48080 exists
Apply restoring force appropriate in tissue T therein.Referring to Figure 129, in other cases, including six are maintained at soft shell
The tissue thickness compensation part 48120 of tubular element 48180 in 48124 can for example be positioned in the anvil block of end effector 12
On 30060.
Referring to Figure 130-Figure 133, tissue thickness compensation part 49020 may include tubular element 49080, and the tubular element is along anvil
The longitudinal axis longitudinal register of seat 30060.Tissue thickness compensation part 49020 can be consolidated by compressible compensating material 49024
Surely the anvil block 30060 of end effector 12 is arrived.In addition, compressible compensating material 49024 can surround or encapsulate tubular element
49080.Similar to description herein, tubular element 49080 may include at least one therapeutic agent 49098, which can pass through
Following manner discharges:The various components of absorptive tissue thickness compensation part 49020, the nail 30030 by being fired by nail bin 30000
And/or cutting element 30052 pierces through tubular element 49080.
Referring to Figure 131, nail bin 30000 may include the nail being located in nail cavity 30,012 30030, wherein in deployment nail 30030
Before, the tissue thickness compensation part 49020 of anvil block 30060 and attachment thereon can be pivoted and be compressed towards nail bin 30000 and catch
Obtain tissue T between the two.The tubular element 49080 of tissue thickness compensation part 49020 can be by pivotal anvil 30060 along nail bin
30000 length equably deforms (Figure 131).Referring to Figure 132 and Figure 133, nail percussion sliding part 30050 can be along nail bin 30000
In longitudinal slit 30015 translate and engage each driver 30040 for the lower section of nail 30030 being located in nail cavity 30010,
The driver 30040 wherein each engaged can fire or project nail 30030 from nail cavity 30012.When anvil block 30060 discharges tissue
When pressure on T and tissue thickness compensation part 49020, tissue thickness compensation part 49020 (including tubular element 49080 and can press
The compensating material 49024 of contracting) resilient configuration (Figure 132 and figure can be recoiled to from compressed configuration (Figure 131) rebound or partly
133).Resiliently to such degree, the degree keeps tissue thick for tubular element 49080 and compressible compensating material 49024
It spends compensating part 49020 and tissue T fills nail retention region 30039, while restoring force is applied to by tissue thickness compensation part 49020
In captured tissue T.
Referring to Figure 124-Figure 126, two tissue thickness compensation parts 50020a, 50020b can be positioned in the end of surgical instruments
In portion's actuator 12.For example, the first tissue thickness compensation part 50020a can be attached to the nail bin 30000 in lower jaw 30070,
And minor microstructure thickness compensation part 50020b can be attached to anvil block 30060.The first tissue thickness compensation part 50020a can be wrapped
Multiple tubular elements 50080 are included, multiple tubular element is longitudinally arranged and is maintained in the first compensating material 50024a.Extremely
A few tubular element 50080 may include therapeutic agent 50098, be similar to therapeutic agent as described herein.First compensating material
50024a can be deformable or substantially rigid.In addition, the first compensating material 50024a can make tubular element 50080 relative to
Nail channel 30000 is held in place.For example, the first compensating material 50024a can make each tubular element 50080 keep following closely with a line
Chamber 30012 is longitudinally aligned.Minor microstructure thickness compensation part 50020b may include the first compensating material 50024a, the second compensating material
50024b and/or third compensating material 50024c.Second compensating material 50024b and third compensating material 50024c can be variable
It is shape or substantially rigid.
Anvil block 30060 can pivot and apply compressive force to tissue thickness compensation part 50020a, 50020b and anvil block
Tissue T between 30060 and nail bin 30000.In some cases, the first tissue thickness compensation part 50020a and minor microstructure are thick
It is not compressible to spend compensating part 50020b.Alternatively, the first tissue thickness compensation part 50020a and/or
At least one of two tissue thickness compensation part 50020b components can be compressible.Referring now to Figure 135 and Figure 136, work as nail
30030 from nail bin 30000 when firing, and each nail 30030, which can pierce through, to be maintained in the first tissue thickness compensation part 50020a
Tubular element 50080.As shown in Figure 135, the therapeutic agent 50098 being maintained in tubular element 50080 can pierce through pipe in nail 30030
It is released when the very best part 50080.In release, therapeutic agent 50098 can coat nail leg 30032 and around percussion nail 30030
Tissue T.When nail 30030 is fired from nail bin 30000, nail 30030 also can pierce minor microstructure thickness compensation part 50020b.
Referring to Figure 137-Figure 140, tissue thickness compensation part 51020 may include laterally traversing tissue thickness compensation part
51020 at least one tubular element 51080.For example, with reference to Figure 137, tissue thickness compensation part 51020 can be relative to nail bin
30000 positioning so that the first end 51083 of the tubular element 51080 laterally traversed can be positioned in the of nail bin 30000
Near one longitudinal direction side, and the second end 51085 of the tubular element 51080 laterally traversed can be positioned in nail bin 30000
Second longitudinal side near.For example, tubular element 51080 may include capsule shape.As shown in Figure 138, tubular element 51080
It can be perforated between first end 51083 and second end 51085, and in some cases, tubular element 51080 can be
It is perforated at or near the center 51087 of tubular element 51080.For example, tubular element 51080 may include polymer composition,
Such as bioabsorbable biocompatible elastomeric polymer.In addition, referring again to Figure 137, tissue thickness compensation part 51020
It may include multiple tubular elements 51080 laterally traversed.For example, 13 tubular elements 51080 can be laterally arranged in
In tissue thickness compensation part 51020.
Referring again to Figure 137, tissue thickness compensation part 51020 may also include at least partly around tubular element 51080
Compensating material 51024.Compensating material 51024 may include bioabsorbable polymer, such as lyophilized polysaccharide, glycoprotein,
Elastin laminin, proteoglycans, gelatin, collagen and/or oxidized regenerated cellulose (ORC).Compensating material 51024 can make tubular element
51080 are held in place in tissue thickness compensation part 51020.In addition, compensating material 51024 can be fixed nail bin 30000
The top platform surface 30011 of rigid support portion 30010 so that compensating material 51020 is firmly positioned in end effector
In 12.Compensating material 51024 may include at least one drug 51098.
Referring still to Figure 137, the tubular element 51080 of lateral register can be positioned relative to translation cutting element 30052, be made
Tubular element 51080 can be cut off by obtaining cutting element 30052.It is cut off at or near the perforation that cutting element 30052 can be wherein
Tubular element 51080.When tubular element 51080 is cut to two halves, the cut-off part of tubular element 51080 can be swollen or
Extension, as shown in Figure 139.For example, tubular element 51080 may include hydroaropic substance 51099, which can be in tubulose
It discharges and/or exposes when element 51080 is cut off.In addition, when hydroaropic substance 51099 contacts the body fluid in tissue T, it is hydrophilic
Property substance 51099 can attract the fluid, this can cause tubular element 51080 be swollen or extension.When tubular element 51080 expands
Zhan Shi can deviate or be adapted to the tubular element 51080 of swelling around the compensating material 51024 of tubular element 51080.
For example, when compensating material 51024 includes gelatin, the gelatin can be deviated to adapt to the tubular element 51080 of swelling.Now
Referring to Figure 140, the extension of tubular element 51080 and the offset of compensating material 51024 can lead to tissue thickness compensation part 51020
Corresponding extension.
Similar to other tissue thickness compensation parts that the disclosure is discussed in the whole text, tissue thickness compensation part 51020 can pass through
The power deformation or compression applied.In addition, tissue thickness compensation part 51020 can be fully flexible so that it is passing through
Screen resilience is generated when the power deformation of application, and then can be sprung back when removing applied power or partly be sprung back.Optionally,
When tissue thickness compensation part 51020 is captured in nail retention region 30039, nail 30030 can make tissue thickness compensation part
51020 deformations.For example, nail 30030 can make the tubular element of the tissue thickness compensation part 51020 captured in percussion nail 30030
51080 and/or compensating material 51024 deform.Optionally, the non-capture portion of tissue thickness compensation part 51020 can also be cut because of nail
It stays the deformation in region 30039 and deforms.In deformation, tissue thickness compensation part 51020 can attempt to spring back from deformed configuration.
Optionally, before such rebound can be happened at the hydrophilic extension of tubular element 51080, the hydrophily of tubular element 51080 expands
While exhibition and/or after the hydrophilic extension of tubular element 51080.When tissue thickness compensation part 51020 attempts to spring back,
It can apply restoring force in the tissue in being also trapped in nail retention region 30039, as described in more detail.
Optionally, in tissue thickness compensation part 51020 in tubular element 51080 and/or compensating material 51024 at least one
Person may include therapeutic agent 51098.When the tubular element 51080 comprising therapeutic agent 51098 is cut off, it is included in tubular element
Therapeutic agent 51098 in 51080 can be released.In addition, when compensating material 51024 includes therapeutic agent 51098, therapeutic agent
51098 can discharge when bioabsorbable compensating material 51024 is absorbed.Tissue thickness compensation part 51020 can provide treatment
The rapid initial release of agent 51098 is the controlled release of therapeutic agent 51098 later.For example, when the pipe for including therapeutic agent 51098
When the very best part 51080 is cut off, tissue thickness compensation part 51020 can be provided along cutting line from tubular element 51080 to tissue T
The rapid initial release of therapeutic agent 51098.In addition, when bioabsorbable 51024 quilt of compensating material for including therapeutic agent 51098
When absorption, tissue thickness compensation part 51020 can provide the extended controlled release of therapeutic agent 51098.It is flowed into therapeutic agent 51098
Before compensating material 51024, when at least some of therapeutic agent 51098 can keep shorter one section in tubular element 51080
Between.Alternatively, at least some of therapeutic agent 51098 is positively retained in tubular element 51080 until tubulose member
Part 51080 is absorbed.The therapeutic agent 51098 and compensating material 51024 discharged from tubular element 51080 can be identical.
Alternatively, such as tubular element 51080 and compensating material 51024 may include different therapeutic agents or different control
Treat agent combination.
Referring still to Figure 140, end effector 12 can almost simultaneously or fast successive cut tissue T and percussion nail
30030 enter in the tissue T of cut-out.In this case, nail 30030 can have been turned off adjacent tissue T's in cutting element 30052
It is deployed in tissue T immediately after tubular element 51080.In other words, nail 30030 can be in the swelling of tubular element 51080
And tissue thickness compensation part 51020 is engaged after the extension of tissue thickness compensation part 51020 immediately, or simultaneously carry out.
After nail 30030 is entered by percussion in tissue T, tissue thickness compensation part 51020 can continue to increase or extend.It is followed closely in deployment
When 30030, nail 30030 can pierce through tubular element 51080.In this case, cut-off tubular element is remained at
Therapeutic agent 51098 in 51080 can be discharged from tubular element 51080, and can cover percussion nail 30030 in some cases
Leg 30031.
Referring to Figure 141, tissue thickness compensation part 51020 can be manufactured for example by molding technology.According to the present invention, frame or
Mold 51120 may include first longitudinal side 51122 and second longitudinal side 51124.Side 51124 may include one or more longitudinally in each
A recess 51130, one or more of recesses can respectively receive the first end 50183 or the of tubular element 51080
Two ends 50185.The first end 50183 of tubular element 51080 can be positioned in the first recess in first longitudinal side 51122
In 51130a, and the second end 50183 of tubular element 51080 can be positioned in second longitudinal side 51124 it is second recessed
In mouth 51130b so that tubular element 51080 laterally traverses frame 51120.Recess 51180 may include semi-circular grooves, should
Semi-circular grooves can be bonded the first end 50183 or second end 50185 of wherein tubular element 51080 securely.First
Recess 51130a can be positioned so that directly on the opposite of the second recess 51130b, and tubular element 51080 can be positioned so that it is vertical
Directly in or be at least substantially orthogonal to the longitudinal axis of frame 51120.Alternatively, the first recess 51130a can be from
Second recess 51130b offsets so that tubular element 51080 is angularly positioned relative to the longitudinal axis of frame 51120.As
Other alternate forms, at least one tubular element 51080 can be longitudinal positioning of in frame 51120 so that tubular element exists
Extend between the cross side 51126,51128 of frame 51120.In addition, for example, at least one tubular element can be positioned angularly
Between two recesses on the cross side 51126,51128 of frame and/or the recess on cross side 51126 and longitudinal direction side
In the frame between recess on 51124.Frame 51120 may include support lugn 51136, and the support lugn is sustainable to be located in
Tubular element 51080 in frame 51120.
For example, frame 51120 may include recess 51130 to accommodate 12 tubular elements 51080.Frame recess 51130
It can be filled by tubular element 51080, and alternatively, and not all recess 51130 can be filled.Optionally,
At least one tubular element 51080 can be positioned in frame 51120.At least half of recess 51130 can receive tubular element
51080.Once tubular element 51080 is positioned in frame 51120, compensating material 51024 can be added to frame
51120.When being added to frame 51120, compensating material 51024 can be fluid.For example, compensating material 51024 can be inclined
It notes in frame 51120 and can surround and be positioned at the flowing of tubular element 51080 therein.Referring to Figure 142, the compensation material of flowing
Material 51024 can surround the tubular element 51080 supported by the recess 51130 in frame 51120 and flow.In compensating material 51024
Solidification, or after at least curing sufficiently can will be including compensating material 51024 and tubular element 51080 referring now to Figure 143
Tissue thickness compensation part 51020 is removed from frame 51120.Tissue thickness compensation part 51020 can be trimmed.For example, can incite somebody to action
Extra compensating material 51024 is removed from tissue thickness compensation part 51020 so that the longitudinal direction side of compensating material is substantially flat
Smooth.In addition, referring to Figure 144, the first end 50183 and second end 50185 of tubular element 51080 can be pressed together,
Or be closed, with sealed tubular element 51080.It can make the end before tubular element 51080 is placed in frame 51120
It is closed.Alternatively, trimming process can crosscut end 51083,51085 and hot stack process can be used for sealing
And/or it is closed the end 51083,51085 of tubular element 51080.
Referring again to Figure 141, rigid pins 51127 can be positioned in each tubular element 51080.For example, rigid pins
51127 can extend across the longitudinal direction tube chamber of tubular element 51080.Rigid pins 51127 can extend over each tubular element
51080 so that rigid pins 51127 can be positioned in the recess 51130 in frame 51120.For example, with rigid pins
In 51127 embodiment, when compensating material 51204 is poured into frame 51120 and when the compensating material 51024 of flowing is enclosed
When being flowed around tubular element 51080, rigid pins 51127 can support tubular element 51080.Once compensating material 51024 cures, is hard
Change and/or be lyophilized, or cure sufficiently, harden and/or be lyophilized, you can by tissue thickness compensation part 51020 from frame 51120
It removes, and rigid pins 51127 can be removed from the longitudinal direction tube chamber of tubular element 51080.Then such as drug can be used to fill out
Fill tubular element 51080.It, can be to for example including the end of tubular element 51080 after filling tubular element 51080 with drug
51083,51085 tissue thickness compensation part 51020 is trimmed.Tissue thickness compensation part 51020 can be for example punched, and/
Or for example pass through heat and/or pressure seal.
As described herein, tissue thickness compensation part 52020 may include multiple tubular elements 51080.Referring now to Figure 145,
Tubular element 51080 may include different material properties, size and geometry.For example, the first tubular element 51080a can be wrapped
First thickness and the first material are included, and the second tubular element 51080b may include second thickness and the second material.Optionally, group
At least two tubular elements 51080 knitted in thickness compensation part 52020 may include identical material.Alternatively,
Each tubular element 51080 in tissue thickness compensation part 5202 may include different materials.Similarly, tissue thickness compensation part
At least two tubular elements 51080 in 52020 may include identical geometry.Alternatively, tissue thickness
Each tubular element 51080 in compensating part 52020 may include different geometries.
Referring now to Figure 20 8- Figure 21 1, tissue thickness compensation part 51220 may include laterally traversing tissue thickness compensation part
51220 at least one tubular element 51280.Referring to Figure 20 8, tissue thickness compensation part 51220 can be relative to end effector
12 anvil block 30060 positions.For example, tissue thickness compensation part 51220 can be fixed the anvil block 30060 of end effector 12
Fixation surface 30061.Referring primarily to Figure 20 9, for example, tubular element 51280 may include capsule shape.For example, tubular element
51280 may include polymer composition, such as bioabsorbable biocompatible elastomeric polymer.
Referring again to Figure 20 8, tissue thickness compensation part 51220 may also include at least partly around tubular element 51280
Compensating material 51224.For example, compensating material 51224 may include bioabsorbable polymer, such as lyophilized polysaccharide, sugared egg
White class, elastin laminin, proteoglycans, gelatin, collagen and/or oxidized regenerated cellulose (ORC).It is similar as above, compensating material
51024 can be such that tubular element 51280 is held in place in tissue thickness compensation part 51220.In addition, compensating material 51224 can quilt
Fixation surface 30061 fixed to anvil block 30060 so that compensating material 51220 is firmly positioned in end effector 12.It mends
It repays material 51224 and may include at least one drug.
Referring still to Figure 20 8, the tubular element 51280 of lateral register can be relative to the cutting in translational slidiing part 30250
Element 30252 positions so that translatable cutting element 30252 can cut off tubular element 51280.For example, cutting element
30252 can cut off tubular element 51280 at or near 51280 center of each tubular element.When tubular element 51280 is cut to
When two halves, the cut-off part of tubular element 51280 can be swollen or extend, as shown in Figure 20 8.Referring primarily to Figure 21 0, tubulose
Element 51280 may include hydroaropic substance 51099, the hydroaropic substance can be discharged when tubular element 51280 is cut off and/or
Exposure.In addition, referring now to Figure 21 1, when hydroaropic substance 51099 contacts the body fluid in tissue T, hydroaropic substance 51099
Fluid can be attracted, this can cause tubular element 51280 to be swollen or extend.When tubular element 51280 extends, around tubulose member
The compensating material 51224 of part 51280 can deviate or be adapted to the tubular element 51280 of swelling.For example, working as compensating material
51224 include gelatin when, the gelatin can deviate with adapt to swelling tubular element 51280.Referring again to Figure 20 8, tubulose
The extension of element 51280 and the offset of compensating material 51224 can lead to the corresponding extension of tissue thickness compensation part 51220.
Similar to other tissue thickness compensation parts that the disclosure is discussed in the whole text, tissue thickness compensation part 51220 can pass through
The power deformation or compression applied.In addition, tissue thickness compensation part 51220 can be fully flexible so that it is passing through
Screen resilience is generated when the power deformation of application, and then can be sprung back when removing applied power or partly be sprung back.In addition, working as
When tissue thickness compensation part 51220 is trapped in nail retention region 30039 (Figure 88), nail 30030 can be such that tissue thickness compensates
Part 51220 deforms.For example, nail 30030 can make the tubulose member of the tissue thickness compensation part 51220 captured in percussion nail 30030
Part 51280 and/or compensating material 51224 deform.Optionally, the non-capture portion of tissue thickness compensation part 51220 also can be because of nail
Deformation in retention area 30039 and deform.In deformation, tissue thickness compensation part 51220 can attempt to return from deformed configuration
Bullet.Optionally, before such rebound can be happened at the hydrophilic extension of tubular element 51280, the hydrophily of tubular element 51280
While extension and/or after the hydrophilic extension of tubular element 51280.When tissue thickness compensation part 51220 attempts to spring back
When, restoring force can be applied in the tissue in being also trapped in nail retention region 30039, as described in more detail.
Referring to Figure 146-Figure 149, tissue thickness compensation part 52020 may include laterally traversing tissue thickness compensation part
One or more tubular elements 52080 of 52020 (being similar at least one tissue thickness compensation part as described herein).Tissue is thick
Degree compensating part 52020 may include multiple tubular elements 52080 laterally traversed.Tissue thickness compensation part 52020 may also include
One or more material pieces 52024, the material piece keep or retain at least one of tissue thickness compensation part 52020 tubulose member
Part 52080.One or more material pieces 52024 can be positioned in the above and or below of tubular element 52080, and can jail
Admittedly keep each tubular element 52080 in tissue thickness compensation part 52020.Referring primarily to Figure 146, tissue thickness compensation part
It may include the first material piece 52024a and the second material piece 52024b.Tubular element 52080 can be positioned in the first material piece
Between 52024a and the second material piece 52024b.In addition, referring still to Figure 146, material piece 52024b can be fixed nail bin
The top platform surface 30011 of 30000 rigid support portion so that tissue thickness compensation part 52020 is firmly positioned in end
In portion's actuator 12.Alternatively, one or more material pieces 52024 can be fixed anvil block 30060 or change sentence
Words, which are said, to be maintained in end effector 12.
Referring primarily to Figure 147, tissue thickness compensation part 52020 can be porous and/or permeable.For example, material piece
52024 may include multiple holes 52026.Hole 52026 can be substantially circular.Hole 52036 can be visible in material piece 52024
's.Alternatively, hole 52036 can be microcosmic.Referring still to Figure 147, tubular element 52080 may also comprise multiple
Hole 52026.Referring to Figure 148, tissue thickness compensation part 52120 may include material piece 52124, which includes multiple non-circular
Hole 52126.For example, hole 52126 may include diamond shape and/or fluting shape.Alternatively, referring to Figure 149, tissue
Thickness compensation part 52220 may include tubular element 52280, which includes permeable tubulose lattice 52292.For example,
Material piece 52224 may include bioabsorbable biocompatible elastomeric polymer and may include drug.
At least one tubular element 52080 can be swollen or extend, as shown in Figure 150 A- Figure 150 D.For example, with reference to figure
150A, tubular element 52080 can be positioned in the first material piece 52024a and the second material in tissue thickness compensation part 52020
Among piece 52024b.When tissue thickness compensation part 52020 contacts tissue T, as shown in Figure 150 B, tissue thickness compensation part
52020 can extend.For example, tubular element 52080 may include be exposed within tissue T and/or on fluid when extend
Hydroaropic substance 52099.In addition, material piece 52024 and tubular element 52080 can be permeable, as described herein so that
Fluid penetrable tissue thickness compensation part 52020 from tissue T is hydrophilic in fluid contact tubular element 52080 to allow
Property substance 52099.When tubular element 52080 extends, the material piece 52024 around tubular element 52080 can be deviated or be adjusted
It is whole with adapt to swelling tubular element 52080.Similar to the various tissue thickness compensation parts that are discussed in the whole text of the present invention, extension
Tissue thickness compensation part 52020 can be deformed by the power (compressing force such as applied by percussion nail) applied or compression, such as
Shown in Figure 150 C.In addition, tissue thickness compensation part 52020 can be fully flexible so that it becomes in the power by being applied
Screen resilience is generated when shape, and then can be sprung back when removing applied power.Referring now to Figure 150 D and Figure 150 E, tissue is thick
Degree compensating part 52020 can recoil to different configurations in different nail retention regions 30039, suitably to adapt to captured group
Knit T.
Referring to Figure 151-Figure 156, tissue thickness compensation part 53020 may include multiple vertically oriented tubular elements 53080.
Optionally, each tubular element 53080 may include tubulose axis, which is substantially perpendicular to the rigidity of nail bin 30000
The top platform surface 30011 of support section 30010.In addition, the first end of each tubular element 53080 can for example neighbouring top
Portion's platform surface 30011 positions.Tubular element 53080 may be, for example, deformable and may include elastomer polymer.Optionally
Ground, as shown in Figure 152, tubular element 53080 can be compressed when the tissue T being sewn captures in nail retention region 30039.
Tubular element 53080 may include elastic material so that when tubular element 53080 attempts to spring back from deformed configuration, tubular element
53080 deformation generates restoring force.The deformation of tubular element 53080 can be at least partly elasticity and at least partly plasticity.Pipe
The very best part 53080 can serve as spring under the power applied, and can not fasten.Referring to Figure 153, tubular element 53080
Can be substantially cylinder-shaped.Referring to Figure 154, tubular element 53180 may include buckling region 53112.When to tubular element 53180
When applying compressing force, it can fasten or deform at buckling region 53112.Tubular element 53180 can flexibly and/or modeling
It deforms to property, is then designed to fasten suddenly at buckling region 53112 under the tightening force being pre-selected.
Referring primarily to Figure 155, the first tubular element 53080 can be positioned at the first end of nail cavity 30012, and another
One tubular element 53080 can be positioned at the second end of nail cavity 30012.As shown in Figure 153, tubular element 53080 can
Including extending through tube chamber 53084 therein.Referring again to Figure 152, when nail 30030 moves to firing position from initial position
When, each nail leg 30032 can pass through the tube chamber 53084 of each tubular element 53080.Alternatively, main ginseng
See that Figure 156, vertically oriented tubular element 54080 can be disposed in tissue thickness compensation part 54020 so that tubular element
54080 adjacent to each other or contacts.In other words, tubular element 54080 can be clustered or concentrate in together.Tubular element 54080
It can systematically be disposed in tissue thickness compensation part 54020;However, in other cases, tubular element 54080 can by with
Machine is arranged.
Referring again to Figure 151, Figure 155 and Figure 156, tissue thickness compensation part 53020 may also comprise material piece 53024, should
Material piece makes tubular element 53080 keep or be retained in tissue thickness compensation part 53020.Material piece 53024 can be positioned in
The above and or below of tubular element 53080, and each tubulose in tissue thickness compensation part 53020 can be firmly held
Element 53080.Tissue thickness compensation part 53020 may include the first and second material pieces 53024.Tubular element 53080 can be determined
Position is between the first and second material pieces 53024.In addition, material piece 53024 can be fixed the rigid support portion of nail bin 30000
The top platform surface 30011 divided so that tissue thickness compensation part 53020 is firmly positioned in end effector 12.As
Another option, material piece 53024 can be fixed anvil block 30060 or be in other words maintained in end effector 12.Material
Tablet 53024 can be sufficiently deformable so that when spring 55080 of the material piece 53024 in tissue thickness compensation part deforms
Deformation.
Referring to Figure 157 and Figure 158, tissue thickness compensation part 55020 may include at least one spring 55080, the spring
It is fully flexible so that it can generate screen resilience in deformation.Referring primarily to Figure 157, tissue thickness compensation part 55020
It may include multiple springs 55080, such as three row springs 55080.Spring 55080 can systematically and/or be randomly arranged in group
It knits in thickness compensation part 55020.For example, spring 55080 may include elastomer polymer.The shape of spring 55080 allows it
Deformation.Spring 55080 can be deformed into deformed configuration from initial configuration.For example, when a part of quilt of tissue thickness compensation part 55020
When capture is in nail retention region 30039, within nail retention region 30039 and/or the spring 55080 of surrounding can deform.Example
Such as, spring 55080 can be fastened or be collapsed under the compressing force applied for percussion nail 30030, and spring 55080 can generate it is extensive
Multiple power, the restoring force depend on the device of spring stiffness coefficient of distortion spring 55080 and/or the deflection of spring 55080.Spring
55080 can serve as sponge under the compressing force applied by percussion nail 30030.In addition, spring 55080 may include compensating material, such as
The disclosure is more fully described in the whole text.
Tissue thickness compensation part 55020 also may include one or more material pieces 55024, which keeps or reservation group
Knit at least one of thickness compensation part 55020 spring 55080.Material piece 55024 can be positioned in the top of spring 55080
And/or lower section, and the spring 55080 in tissue thickness compensation part 55020 can be firmly held.Tissue thickness compensation part
55020 may include the first material piece 55024a and the second material piece 55024b.Tubular element 52080 can be positioned in the first material
Between piece 55024a and the second material piece 55024b.Referring primarily to Figure 158, tissue thickness compensation part 55020 may also include third
Material piece 55024c, the third material piece is adjacent to the first material piece 55024a or the second material piece 55024b positioning.Optionally, until
A few material piece 55024 can be fixed the top platform surface 30011 of the rigid support portion of nail bin 30000 so that group
Thickness compensation part 55020 is knitted to be firmly positioned in end effector 12.Alternatively, at least one material piece
55024 can be fixed anvil block 30060 or in other words be maintained in end effector 12.
Referring now to Figure 158, when nail 30030 is fired from nail bin 30000 (Figure 156), nail 30030 can engage tissue thickness
Spend compensating part 55020.Percussion nail 30030 can retain the part capture of tissue T and tissue thickness compensation part 55020 in nail
In region 30039.Spring 55080 can be deformable so that tissue thickness compensation part 55020 is captured by percussion nail 30030
When compress.Spring 55080 can be positioned between the percussion nail 30030 in tissue thickness compensation part 55020.Alternatively
Selection can capture at least one spring 55080 in nail retention region 30039.
Referring to Figure 159, tissue thickness compensation part 60020 may include at least two compensation layers 60022.Tissue thickness compensation part
60020 may include multiple compensation layers 60022, and multiple compensation layer can stack in top of each other, positioned side by side or their group
It closes.As described in more detail, the compensation layer 60022 of tissue thickness compensation part 60020 may include for example different geometric forms
Shape and/or material property.In addition, as described in more detail, pit and/or channel may be present in the adjacent compensation layer stacked
Between 60022.For example, tissue thickness compensation part 62020 may include six compensation layers 62022a, 62022b, 62022c,
62022d, 62022e, 62022f, six compensation layers adjacent on top of each other can stack (Figure 174).
Referring to Figure 160, Figure 161 and Figure 163-Figure 168, tissue thickness compensation part may include the first compensation layer 60122a and
Two compensation layer 60122b.First compensation layer 60122a can be stacked the top of the second compensation layer 60122b is adjacent.It is adjacent to stack
Compensation layer 60122 can be separated by Separation or pit 60132.Referring primarily to Figure 160, tissue thickness compensation part 60120 also may be used
Including at least one cantilever beam or support being located between the first compensation layer 60122a and the second compensation layer 60122b
60124.Support element 60124 can position the first compensation layer 60122a relative to the second compensation layer 60122b so that compensation layer
60122 are separated by Separation 60132.As described in more detail, support element 60124 and/or compensation layer 60122a,
The deformation of 60122b can for example reduce Separation 60132.
The supporting beam of tissue thickness compensation part may include multiple geometries and size.For example, supporting beam can be simple I
Ellbeam, single-bend support beam 60124 (Figure 160) placed in the middle, eccentric single-bend support beam 60224 (Figure 161), elliptical support beam
60324 (Figure 163), multi-bend support beam 60424 (Figure 164), and/or symmetrical double cantilever support beams 60524 (Figure 165).In addition,
Referring now to Figure 160, Figure 166 and Figure 167, for example, supporting beam 60624 can be thinner than at least one compensation layer 60122 (Figure 166),
Supporting beam 60724 can be thicker than at least one compensation layer 60122 (Figure 167) and/or supporting beam 60124
Repay the substantially the same thickness of layer 60122 (Figure 160).Material, geometry and/or the size of supporting beam 60124 for example can shadows
Ring the deformability and screen resilience elasticity of tissue thickness compensation part 60120.
Referring still to Figure 160, for example, the compensation layer 60122 of tissue thickness compensation part 60120 and supporting beam 60124 can wrap
Include different materials, such as structured material, biomaterial and/or electric material.For example, at least one compensation layer 60122 can
Including polymer composition.Polymer composition may include at least partly elastic material so that compensation layer 60122 and/or branch
The deformation of support beam 60124 can generate screen resilience.The polymer composition of compensation layer 60122 may include nonabsorable polymer,
Absorbable polymer or combination thereof.For example, absorbable polymer may include bioabsorbable biocompatibility bullet
Elastomer polymer.In addition, the polymer composition of compensation layer 60122 may include synthetic polymer, non-synthetic polymer or they
Combination.The example of synthetic polymer include but not limited to polyglycolic acid (PGA), poly- (lactic acid) (PLA), polycaprolactone (PCL),
Polydioxanone (PDO) and their copolymer.The example of non-synthetic polymer includes but not limited to polysaccharide, glycoprotein
Class, elastin laminin, proteoglycans, gelatin, collagen and oxidized regenerated cellulose (ORC).Optionally, it is similar to herein institute elsewhere
The polymer composition stated, the polymer composition amount of may include of compensation layer 60122 different (such as by weight percentage)
Absorbable polymer, the polymer of nonabsorable, synthetic polymer and/or non-synthetic polymer.Optionally, tissue thickness is mended
The each compensation layer 60022 repaid in part 60120 may include different polymer compositions, or alternatively, at least
Two compensation layers 60122 may include identical polymer composition.
Referring again to Figure 159, for example, at least one compensation layer 60022 may include therapeutic agent 60098, such as drug or medicine
Object activating agent.The therapeutic agent 60098 of 60022 releasable therapeutically effective amount of compensation layer.Therapeutic agent 60098 can be in compensation layer 60022
It is discharged when being absorbed.The example of therapeutic agent 60098 may include but be not limited to hemostat and drug, such as, fibrin, blood coagulation
Enzyme and/or oxidized regenerated cellulose (ORC);Antiinflammatory medicine, such as Diclofenac, aspirin, naproxen, sulindac and/
Or hydrocortisone;Antibiotic and antimicrobial agents or antimicrobial, such as triclosan, ionic silver, ampicillin, celebrating
Big mycin, polymyxin B, and/or chloramphenicol;And/or anticancer agent, such as cis-platinum, mitomycin and/or adriamycin.For example, controlling
It treats agent 60098 and may include biological agent, such as stem cell.Optionally, each compensation layer in tissue thickness compensation part 60020
60022 may include different therapeutic agents 60098, or alternatively, and at least two compensation layers 60022 may include identical
Therapeutic agent 60098.For example, the compensation layer 60022 comprising therapeutic agent 60098 (such as biological agent) can for example be wrapped in two
Between structured compensation layer 60022, described two structured compensation layers include polymer composition, such as polyglycolic acid (PGA)
Foam.According to the present invention, compensation layer 60022 can also include such as conductive material, such as copper.
Referring again to Figure 174, the compensation layer 62022 in tissue thickness compensation part 62020 can have different geometries.
When layer 62022 is adjacently located in tissue thickness compensation part 62020, compensation layer 62022 can be formed between layer 62022 to
A few three dimensional catheter 62032.For example, when the second compensation layer 62022b for including channel is positioned in substantially flat third
When the top of compensation layer 62022c, the channel of third compensation layer 62022c and flat surfaces can limit three dimensional catheter between the two
62032a.Similarly, for example, when the 5th compensation layer 62022e for including channel is positioned in the 4th compensation including corresponding channel
When the lower section of layer 62022d, the channel, which can be formed, to be limited by the channel in neighbouring compensation layer 62022d, 62022e stacked
Three dimensional catheter 62032b.When fluid flows through tissue thickness compensation part 62020, conduit 62032 can guide therapeutic agent and/or body
Liquid.
Referring to Figure 170, tissue thickness compensation part 61020 may include compensation layer 61022, such as layer 60122a and 21022b,
The layer can receive the nail 30030 disposed from nail bin 20000 (Figure 169).When nail 30030 moves to percussion position from initial position
When setting, the geometry of at least one compensation layer 61022 can guide nail leg 30032 to firing position.Optionally, at least one
Compensation layer 61022 may include extending through hole 61030 therein, and mesoporous 61030 can be arranged in nail 30030 from nail bin
The nail leg 30032 for having disposed nail 30030 is received when being fired in 20000 (Figure 169), as described in more detail.As another
Outer a kind of selection, referring again to Figure 174, for example, nail leg 30032 can pierce through at least one compensation layer, such as compensation layer
62022f, and can through hole 62030 be received at least one compensation layer, such as compensation layer 62022a.
Referring primarily to Figure 170, tissue thickness compensation part 60120 may include on one of compensation layer 61022a, 61022b
At least one support tabs 61026.Support tabs 61026 can protrusion enter and be limited to Separation between adjacent compensation layer
61032, the gap 61032 between such as the first compensation layer 61020a and the second compensation layer 61020b.Support tabs 61026 can be from
Longitudinal lateral process of first compensation layer 61022a.In addition, support tabs 61026 can along longitudinal direction side length extend or only along one
Part extends.Optionally, at least one support tabs 61026 can be from two longitudinal lateral process of compensation layer 61022a, 61022b.
In addition, compensation layer 61022a, 61022b of adjacent positioned may include corresponding support tabs 60126 so that from the first compensation layer
The support tabs 60126 that 60122a extends can at least partly with the support tabs 60126 that extend from the second compensation layer 60122b
Alignment.Referring again to Figure 168, tissue thickness compensation part 60820 may include the limitation between adjacent compensation layer 60122a, 60122b
Device plate 60828.For example, restrictor plate 60828, which can be positioned on, is defined in the first compensation layer 60122a and the second compensation layer 60122b
Between gap 60132 in.As described in more detail, support tabs 61026 and/or the controllable branch of restrictor plate 60828
The deformation and/or deflection of support member 60124 and/or compensation layer 60122a, 60122b.
As described herein, the compensation layer 60022 of tissue thickness compensation part 60020 may include different materials, geometry
And/or size.Such tissue thickness compensation part 60020 can be assembled by a variety of manufacturing technologies.Referring primarily to Figure 159, tissue is thick
Degree compensating part 60022 can be manufactured by lithographic printing, stereolithography (SLA) or silk-screen printing technique.For example, cubic light is scribed
Tissue thickness compensation part 60020 can be formed by making technique, wherein each compensation layer 60022 includes different material and/or geometric form
Feature structure.For example, the ultraviolet light in stereo lithography machine can draw the geometry of the first compensation layer 60022 so that including
First compensation layer 60022 of one material, geometry and/or size is cured by ultraviolet light.Ultraviolet light then can draw second
The geometry of compensation layer 60022 so that the second compensation layer 60022 including the second material, geometry and/or size passes through
Ultraviolet light cures.According to the present invention, stereo lithography machine can draw compensation layer 60022, draw compensation side by side on top of each other
Layer 60022 draws compensation layer 60022 with combination thereof.In addition, compensation layer 60022 can be plotted as so that pit 60132
It is present between adjacent compensation layer 60022.Since stereo lithography machine can be formed with the very thin of unique geometry
Layer, therefore the tissue thickness compensation part 60020 manufactured by stereolithography processes may include extremely complex 3 dimensional coil geometry.
Referring to Figure 169, tissue thickness compensation part 60920 can be positioned in the end effector 12 of surgical instruments 10 (Fig. 1).
Tissue thickness compensation part 60920 can be positioned relative to the nail bin 20000 of end effector 12.For example, tissue thickness compensation part
60920 can be releasably secured to nail bin 20000.At least one compensation layer 60922 of tissue thickness compensation part 60920 can be adjacent
Top platform surface 20011 (Figure 79) positioning of nearly nail bin 20000.For example, the second compensation layer 60922b can by adhesive or
It is fixed to top platform surface 20011 by wrappage (similar at least one of wrappage as described herein) (Figure 16).
Tissue thickness compensation part 60920 can be integral with nail bin 20000 so that 60920 shape of nail bin 20000 and tissue thickness compensation part
As individual unit construction.For example, nail bin 20000 may include the first main part, such as (figure of rigid support portion 20010
79) and the second main part, such as tissue thickness compensation part 60920.
Referring still to Figure 169, tissue thickness compensation part 60920 may include the compensation of the first compensating part part 60920a and second
Part part 60920b.First compensating part part 60920a can be positioned in the first longitudinal side of nail bin 20000, and the second compensation
Part part 60920b can be positioned in the second longitudinal side of nail bin 20000.Optionally, when tissue thickness compensation part 60920 is opposite
When nail bin 20000 positions, the longitudinal slit 20015 (Figure 78) in rigid support portion 20010 (Figure 78) can be in the first compensation
Extend between part part 60920a and the second compensating part part 60920b.For example, when in nail percussion sliding part 20050 (Figure 78)
When cutting element 20052 translates across end effector 12, cutting element 20052 may pass through the first compensating part part 60920a and
Longitudinal slit 20015 between second compensating part part 60920b, the part without cutting off tissue thickness compensation part 60920.
Alternatively, cutting element 20052 can cut off a part for tissue thickness compensation part 60920.
Referring now to Figure 162, tissue thickness compensation part 63020 can fit in the end effector of circular surgical apparatus
In 12'.Tissue thickness compensation part 62030 may include circular first compensation layer 63022a and circular second compensation layer
63022b.Second compensation layer 63022b can be positioned on the circular top platform surface 20011 ' of round nail bin 20000 ', wherein
Second compensation layer 63022b may include the geometry of the geometry corresponding to platform surface 20011 '.For example, platform surface
20011 ' may include stepped portion, and the second compensation layer 63022b may include corresponding stepped portion.Tissue thickness compensation part
It may also include, for example, at least one support element 63024 and/or support tabs that extend around tissue thickness compensation part 63020
63026。
Referring again to Figure 170, percussion nail 30030 can engage tissue thickness compensation part 60920.The disclosure in the whole text as described in
As, percussion nail 30030 can capture the part and tissue T of tissue thickness compensation part 60920, and apply compressive force to
Tissue thickness compensation part 60920.In addition, referring primarily to Figure 171-Figure 173, tissue thickness compensation part 60920 can be deformable.
Optionally, as described herein, the first compensation layer 60920a can be separated by Separation 60932 and the second compensation layer 60920b.
Referring to Figure 171, before compression organization thickness compensation part 60920, gap 60932 may include the first distance.When for example by hitting
When compressing force A is applied to tissue thickness compensation part 60920 and tissue T by 30030 (Figure 170) of hair nail, support element 60924 can become
Shape.Referring now to Figure 172, single bent support beam 60924 can be bent at compressing force A so that the first compensation layer 60920a and
Separation 60932 between two compensation layer 60920b is reduced to second distance.Referring primarily to Figure 173, the first compensation layer
60922a and the second compensation layer 60922b can also be deformed at compressing force A.Support tabs 60926 can control compensation layer 60920
Deformation.For example, support tabs 60926 can prevent from mending by supporting its longitudinal direction side when compensation layer 60920 is in contact with each other
Repay the overbending of layer 60920.Support tabs 60926 can be also bent at compressing force A or archwise.Or conduct in addition to this
Another option, when compensation layer 60920 and/or the contact restrictor plate 60128 of support tabs 60926, herein more in detail
The restrictor plate 60128 (Figure 168) carefully described can limit the deformation of compensation layer 60920.
In addition, being similar to various tissue thickness compensation parts as described herein, tissue thickness compensation part 60920 can be in deformation
Generate screen resilience or restoring force.The restoring force that the tissue thickness compensation part of deformation generates can depend, at least partially, on tissue thickness
Orientation, size, material and/or the geometry of compensating part 60920, and the tissue thickness deformed by the power applied compensate
The amount of part 60920.In addition, at least part of tissue thickness compensation part 60920 can have elasticity so that tissue thickness compensation part
60920 generate load on spring or restoring force when being deformed by percussion nail 30030.Support element 60924 may include elastic material and/
Or at least one compensation layer 60922 may include elastic material so that tissue thickness compensation part 60920 has elasticity.
Referring now to Figure 175, the end effector of surgery suturing appliance may include the first jaw and the second jaw, wherein the
At least one of one jaw and the second jaw can be movable with respect to each other.For example, it includes nail bin that end effector, which can have,
First jaw in channel 19070 and the second jaw including anvil block 19060, wherein anvil block 19060 can be towards and/or far from nail bins
Channel 19070 pivots.Staple cartridge channel 19070 can receive nail bin 19000, lead to for example, it can be removably retained in nail bin
In road 19070.Nail bin 19000 may include warehouse 19010 and tissue thickness compensation part 19020, wherein tissue thickness compensation part
19020 can be removably attached to warehouse 19010.Referring now to Figure 176, warehouse 19010 may include 19012 He of multiple nail cavities
The nail 19030 being located in each nail cavity 19012.In addition, nail 19030 can be by the staple drivers that are located in warehouse 19010
19040 supports, wherein sliding part and/or firing member can for example be advanced through nail bin 19000 to be lifted up nail cavity 19012
Interior staple drivers 19040 project nail 19030 as shown in Figure 177, and from nail cavity 19012.
Referring primarily to Figure 175 and Figure 176, tissue thickness compensation part 19020 may include elastic component 19022 and encapsulation elasticity
The container 19024 of component 19022.Container 19024 can be sealed and can be limited the cavity comprising internal gas, the inside gas
Body has the pressure different from ambient atmosphere pressure.The pressure of internal gas can be more than the pressure of ambient atmosphere, and as another
A kind of outer selection, the pressure of internal gas can be less than the pressure of ambient atmosphere.Container 19024 includes big less than surrounding wherein
In the embodiment of the strong pressure of air pressure, the side wall of container 19024 can encapsulate vacuum.In this case, the vacuum can be with
Container 19024 is caused to deform, collapse and/or graduation, wherein the elastic component 19022 being located in container 19024 can be elastic
It is compressed in container 19024.When extracting vacuum on container 19024, elastic component 19022 can be deflected down or be deformed simultaneously
And it can be held in place by the side wall of container 19024 under compression or vacuum sealing state.
Elastic component 19022 and container 19024 are made of biocompatible materials.Optionally, for example, elastic component
19022 and/or container 19024 can be made of bioabsorbable material (such as PLLA, PGA and/or PCL).Elastic component
19022 can be made of elastic material.Elastic component 19022 may also comprise structural resiliency.For example, elastic component 19022 can be
The form of hollow tube.
Further described above, tissue thickness compensation part 19020 can against or neighbouring warehouse 19010 platform
Surface 19011 positions.Referring now to Figure 177, when nail 19030 is fired at least partly, appearance can be pierced through by following closely 19030 leg
Device 19024 makes its rupture.Container 19024 may include central part 19026, which can be positioned on warehouse 19010
The top of cutting slit 19016 so that when cutting element 19080 be advanced into cutting be located in nail bin 19000 and anvil block 19060 it
Between tissue T when, the central part 19026 of the also cleavable container 19024 of cutting element 19080, to pierce through container 19024 or
Make its rupture.In either case, once container 19024 has ruptured, then the internal gas in container 19024 can with around
The air of tissue thickness compensation part 19020 obtains balance, and allows 19022 resilient expansion of elastic component, to reacquire or
The configuration of its not deformed and/or non-graduation is reacquired at least partly.In this case, elastic component 19022 can will be inclined
Set the tissue T that power is applied in the nail 19020 for being trapped in deformation.More particularly, by being limited in anvil block 19060
After the forming surface deformation of pit 19062, the leg for following closely 19030 can be by least part of tissue T and elastic component 19022
Capture is in nail 19030 so that when container 19024 ruptures, tissue thickness compensation part 19020, which can compensate, is trapped in nail
The thickness of tissue T in 19030.For example, when the tissue T being trapped in nail 19030 is relatively thin, it is trapped in the nail 19030
Interior elastic component 19022 can be extended to fill the gap in nail 19030, and enough compressing forces are applied to tissue T.
Correspondingly, when the tissue T being trapped in nail 19030 is thicker, the elastic component 19022 being trapped in the nail 19030 can
It keeps compression to think that the relatively thick tissue in nail 19030 concedes space, and same, enough compressing forces is applied to tissue T.
When container 19024 is pierced, as described above, elastic component 19022 can attempt to extension to be elastically returned to it
Initial configuration.In some cases, a part of of the elastic component 19022 being trapped in nail 19030 possibly can not return
To its initial not deformed shape.In this case, elastic component 19022 may include spring, which can apply compressing force
To the tissue T being trapped in nail 19030.According to the present invention, elastic component 19022 can simulate Hookean spring, wherein by bullet
Property component 19022 apply compressing force with amount or apart from Linear proportional, elastic member 19022 be maintained at nail 19030 in
Deflection.Alternatively, elastic component 19022 can simulate nonlinear spring, wherein being applied by elastic component 19022
Compressing force not with amount or apart from Linear proportional, elastic member 19022 be maintained at nail 19030 intrinsic deflections.
Referring primarily to Figure 178 and Figure 179, nail bin 19200 may include tissue thickness compensation part 19220, which mends
Repay the container 19222 that part can include one or more sealings wherein.Each in container 19222 can be sealed and can be wrapped
Containing internal gas.The pressure of internal gas in sealing container 19222 can be more than atmospheric pressure, and in sealing container 19222
The pressure of internal gas can be strong with subatmospheric.The pressure subatmospheric of internal gas in container 19222 is strong
In the case of, container 19222 can be described as including vacuum.Optionally, one or more containers 19222 can be wrapped or be included in
In oversheath, case, wrappage and/or film 19224, for example, wherein tissue thickness compensation part 19220 can be positioned in warehouse
19010 19011 top of platform surface.For example, each container 19222 can be by having circle or at least substantially circular cross section
The pipe of (for example, with closed end and open end) is made.Vacuum can be extracted on the open end of pipe, and sufficient when reaching in pipe
When enough vacuum, open end can be closed and seal.For example, pipe can be made of such as polymer material, the open end of middle pipe
It can be heated to be closed and seal the open end.Under any circumstance, the vacuum in each container 19222 can inwardly pull pipe
Side wall and make tubular elastic deform and/or graduation.Container 19222 is shown as in Figure 179 at least partly graduation
State.
When following closely 19030 in its non-firing position, as shown in Figure 179, tissue thickness can be positioned in by following closely 19030 top
Spend 19220 lower section of compensating part.For example, nail 19030 can be positioned in its respective nail cavity 19012 so that nail 19030 not with appearance
Device 19222 contacts, until the non-firing position shown in Figure 179 of nail 19030 moves to its firing position shown in Figure 180.Group
Knitting the wrappage 19224 of thickness compensation part 19220 can protect container 19220 not pierced through prematurely by nail 19030.Referring now to
Figure 180, when nail 19030 is fired at least partly, container 19222 can be pierced through or make its rupture by following closely 19030 leg.At this
In the case of kind, internal gas in container 19222 can obtain balance with the air around container 19222, and resilient expansion with
Reacquire or reacquire at least partly the configuration of its undeformed and/or non-graduation.In this case, it is pierced
Container 19222 bias force can be applied to the tissue in the nail 19030 for being trapped in deformation.More particularly, passing through limit
It is scheduled on after the forming surface deformation of the pit 19062 in anvil block 19060, the leg for following closely 19030 can be by tissue T and container
19222 at least part capture is in nail 19030 so that when container 19222 ruptures, container 19222, which can compensate, is caught
Obtain the thickness of the tissue T in nail 19030.For example, when the tissue T being trapped in nail 19030 is relatively thin, it is trapped in the nail
Container 19222 in 19030 can be extended to fill the gap in nail 19030, and at the same time enough compressing forces are applied to
Tissue T.Correspondingly, when the tissue T being trapped in nail 19030 is thicker, the container 19222 that is trapped in the nail 19030
Compression can be kept to think that the relatively thick tissue in nail 19030 concedes space, and at the same time enough compressing forces are applied to tissue T.
When container 19222 is pierced, as described above, container 19222 can attempt to extension to be elastically returned to it initially
Configuration.The part of container 19222 being trapped in nail 19030 possibly can not return to its initial not deformed shape.At this
In the case of kind, container 19222 may include spring, which can apply compressive force to the tissue T being trapped in nail 19030.
According to the present invention, container 19222 can simulate Hookean spring, wherein the compressing force applied by container 19222 and amount or range line
Property it is proportional, wherein container 19222 be maintained at nail 19030 intrinsic deflections.Alternatively, container 19222 can simulate
Nonlinear spring, wherein the compressing force applied by container 19222, not with amount or apart from Linear proportional, wherein container 19222 is protected
It holds and is following closely 19030 intrinsic deflections.Container 19222 at which under its sealed configuration when can be hollow and empty.As other one
Kind selects, each limited cavity in container 19222, and may also include at least one drug wherein included.For example,
Container 19222 may include at least one drug, which can be released and/or bio-absorbable.
The container 19222 of tissue thickness compensation part 19220 can be arranged in any suitable manner.As shown in Figure 178, limit
The nail cavity 19012 being scheduled in warehouse 19010, and the nail 19030 being located in nail cavity 19012 can be arranged in line.As shown, example
Such as, nail cavity 19012 can be arranged to the row of six vertical linears;However, using any suitably-arranged side of nail cavity 19012
Formula.Also as shown in Figure 178, tissue thickness compensation part 19220 may include six containers 19222, wherein each in container 19222
It is a to be aligned with a line nail cavity 19012, or the side of being positioned on.Each in nail 19030 in a line nail cavity 19012 can
Pierce through identical container 19222.In some cases, some followed closely in 19030 nail leg can not pierce through the appearance being positioned on
Device 19222;However, in the case where container 19222 limits continuous inner cavity, for example, can be filled by least one of nail 19030
Ground is divided to pierce through cavity, the atmospheric pressure around the pressure and container 19222 to allow inner chamber gas obtains balance.Referring now to
Figure 185, tissue thickness compensation part may include such as container, such as container 19222', can be transverse to the direction of staple line 19030
Extend.For example, container 19222 ' can extend across multiple nails row.Referring now to Figure 186, tissue thickness compensation part 19220 " can wrap
Include multiple containers 19222 ", along perpendicular to or be at least substantially orthogonal to staple line 19030 direction extend.For example, container
19222 " some can be pierced through by nail 19030, and other can not be pierced through by nail 19030.It " can be horizontal for example, container 19222
Extend across or across cutting path, wherein cutting element can crosscutting container 19222 " and make its rupture.
Optionally, as described above, tissue thickness compensation part such as tissue thickness compensation part 19220 for example may include multiple
Sealing container, such as container 19222.As also described above, each of sealing container 19222 may include independent internal gas.
Container 19222 can have different internal pressures.For example, the first container 19222 may include the inner vacuum with first pressure,
And second container 19222 may include the inner vacuum with the second different pressures.For example, deformation or the graduation of container 19222
Amount may depend on the vacuum pressure of internal gas wherein included.For example, compared with the container 19222 with smaller vacuum, tool
There is the container 19222 of relatively large vacuum that can deform or the amount of graduation bigger.The cavity of container can be segmented as two or more
Independent seal cavity, wherein each independent seal cavity may include independent internal gas.For example, some nails in nail row
For example the first cavity in a reservoir can be limited with being arranged as piercing through, while other nails followed closely in row can be constructed and arranged
To pierce through the second cavity limited in a reservoir.In this case, the nail in going wherein especially is being followed closely from one end of nail row
It is sequentially fired in the embodiment of the other end, as described above, one of cavity can have been kept when another cavity ruptures
It is whole and its internal gas can be maintained.For example, the first cavity there can be internal gas, there is the first vacuum pressure, and the
Two cavitys can have internal gas, have the second different vacuum pressures.According to the present invention, keep complete cavity that can maintain it
Internal pressure, until container is by bio-absorbable, to form timing pressure release.
Referring now to Figure 181 and Figure 182, tissue thickness compensation part such as tissue thickness compensation part 19120 is for example attachable
To anvil block 19160.Similar as above, tissue thickness compensation part 19120 may include container 19124 and be positioned at multiple bullets therein
Property component 19122.Also similar as above, container 19124 can limit the cavity comprising internal gas, which, which has, is less than
Or the pressure more than the atmospheric pressure around tissue thickness compensation part 19120.Internal gas in container 19124 includes vacuum
In the case of, container 19124 and be positioned at elastic component 19122 therein can be by the vacuum and container in container 19124
The pressure difference between atmospheric pressure outside 19124 and deform, collapse and/or graduation.In use, anvil block 19160 can be transported
Closed position is moved, wherein anvil block is positioned relative to nail bin 19100, and the tissue engagement surface wherein on container 19124
19121 can engage the tissue T being located among tissue thickness compensation part 19120 and nail bin 19100.In use, structure is fired
Part 19080 can be promoted towards distal side with percussion nail 19030, as described above, and at the same time cutting tissue T.Tissue thickness compensation part
19120 may also include middle section 19126, which can be aligned with the cutting slit being limited in anvil block 19160, wherein
When firing member 19080 is advanced through tissue thickness compensation part 19120 towards distal side, firing member 19080 can pierce through container
19124 or make its rupture.In addition, similar as above, firing member 19080 can be lifted up staple drivers 19040 and hit
Hair nail 19030 so that nail 19030 can contact anvil block 19160 and be deformed to its deformed configuration, as shown in Figure 183.Work as nail
19030 when being fired, and nail 19030 can pierce through tissue T and then pierce through container 19124 or make its rupture so that be located in container
Elastic component 19122 in 19124 can extend at least partly, as described above.
Further described above, tissue thickness compensation part can be made of biocompatible materials.Biocompatibility
Material (such as foam) may include tackifier, surfactant, filler, crosslinking agent, pigment, dyestuff, antioxidant and other
Stabilizer and/or combination thereof, to provide required characteristic for material.Biocompatible foam may include surfactant.Table
Face activating agent can be applied to material surface and/or be dispersed in material.It is not intended to be limited to any specific theory, is applied to
The surfactant of biocompatible materials can reduce the surface tension of the fluid of contact material.For example, surfactant can
To reduce the surface tension of the water of contact material, to accelerate water to penetrate into material.Water can serve as catalyst.Surfactant can be with
Improve the hydrophily of material.
Surfactant may include anion surfactant, cationic surfactant and/or non-ionic surface active
Agent.The example of surfactant includes but not limited to polyacrylic acid, methyl cellulose (methalose), methylcellulose, ethyl
Cellulose, propyl cellulose, hydroxyethyl cellulose, carboxymethyl cellulose, polyoxyethylene cetyl ether, polyoxyethylene laural base
Ether, polyoxyethylene octyl ether, NONIN HS 240, polyoxyethylene oleyl ether, polyoxyethylene sorbitan Dan Yue
Cinnamic acid ester, polyoxyethylene stearyl base ether, ethylene nonyl phenyl ether, dialkylphenoxypoly (ethyleneoxy) ethyl alcohol and pool Lip river
Sha Mu and combination thereof.Surfactant may include the copolymer of polyethylene glycol and polypropylene glycol.Surfactant can wrap
Include non-phospholipid surfactants.Non-phospholipid surfactants can provide antibacterial stability and/or other materials is dispersed in bio-compatible
In property material.
Tissue thickness compensation part may include at least one drug.Tissue thickness compensation part may include natural material as described herein
One or more of material, non-synthetic materials, and/or synthetic material.Tissue thickness compensation part may include biocompatible foam,
The biocompatible foam includes gelatin, collagen, hyaluronic acid, oxidized regenerated cellulose, polyglycolic acid, polycaprolactone, gathers
Lactic acid, polydioxanone, polyhydroxyalkanoatefrom, Poliglecaprone and combination thereof.Tissue thickness compensation part may include
Film, the film include at least one drug.Tissue thickness compensation part may include that Biodegradable films, the Biodegradable films include extremely
A kind of few drug.Drug may include liquid, gel and/or powder.Drug may include anticancer agent, such as cis-platinum, mitomycin and/
Or adriamycin.
Tissue thickness compensation part may include biodegradation material, to provide at least one medicine when biodegradation material is degraded
The controlled elution of object.When biodegradation material contacts activator such as activating solution, biodegradation material can degrade, Ke Yifen
Solution, or lose structural intergrity.For example, activating solution may include saline solution or any other electrolyte solution.Biodegradable material
Material can contact activating solution by routine techniques, and the technology includes but not limited to spraying, dipping and/or brushing.In use,
For example, surgeon can will include the end effector and/or nail bin of tissue thickness compensation part (it includes at least one drugs)
It immerses in activating solution, the activating solution includes salting liquid, such as sodium chloride, calcium chloride, and/or potassium chloride.Tissue thickness compensates
Part can discharge drug when tissue thickness compensation part is degraded.Drug can be quickly from the feature of the elution of tissue thickness compensation part
Initial eluting rate and at a slow speed persistently eluting rate.
According to the present invention, tissue thickness compensation part for example can be by may include that the biocompatible materials of oxidant are constituted.Oxygen
Agent can be organic peroxide and/or inorganic peroxide.The example of oxidant may include but be not limited to hydrogen peroxide, peroxide
Change urea, calper calcium peroxide and peromag and SODIUM PERCARBONATE.Oxidant may include peroxy oxidant and the oxidation of hypohalogenous acids alkali
Agent, such as hydrogen peroxide, hypochlorous acid, hypochlorite, hypocodites and percarbonate.Oxidant may include alkali metal chlorine
Hydrochlorate, hypochlorite and perborate, such as sodium chlorite, sodium hypochlorite and sodium perborate.Oxidant may include vanadate.Oxygen
Agent may include ascorbic acid.Oxidant may include active oxygen generator.According to the present invention, organization bracket may include bio-compatible
Property material, the biocompatible materials include oxidant.
Biocompatible materials may include liquid, gel and/or powder.For example, oxidant may include particle and/or nanometer
Particle.For example, oxidant can be ground into particle and/or nano particle.It can be by the way that oxidant be suspended in a polymer solution
And oxidant is made to be attached in biocompatible materials.Oxidant can be attached to biocompatible materials during lyophilized technique
In.After freeze-drying, oxidant could attach to the cell wall of biocompatible materials, at the time of contact with tissue interaction.Oxygen
Agent cannot be chemically bonded to biocompatible materials.Percarbonate dry powder can be embedded in biocompatible foam, with logical
It crosses slow release oxygen and long-term biological effects is provided.Percarbonate dry powder can be embedded in the polymer fiber in non-woven structure
It is interior, to provide long-term biological effects by slow release oxygen.Biocompatible materials may include oxidant and drug, such as strength
Mycin and ascorbic acid.
Biocompatible materials may include quick release oxidant and/or at a slow speed sustained release oxidant.Oxidant is from life
The feature of the elution of object compatibility material can be quickly initial eluting rate and continue eluting rate at a slow speed.When oxidant contacts body fluid
When (such as water), oxidant produces oxygen.The example of body fluid may include but be not limited to blood, blood plasma, peritoneal fluid, myelencephalon
Liquid, urine, lymph, synovia, vitreous humor, saliva, gastrointestinal cavity content and/or bile.It is not intended to be limited to any specific
Theory, oxidant can reduce cell death, enhance organizational vitality and/or maintain to be broken in cutting and/or sewing process
The mechanical strength of bad tissue to tissue.
Biocompatible materials may include at least one particle and/or nano particle.Biocompatible materials may include this
One or more of natural material, non-synthetic materials and synthetic material described in text.Biocompatible materials may include average
A diameter of about 10nm to about 100nm and/or about 10 μm to about 100 μm, such as 45-50nm and/or 45-50 μm of particle.Biology
Compatibility material may include that biocompatible foam, the biocompatible foam include at least one particle being embedded
And/or nano particle.Particle and/or nano particle cannot be chemically bonded to biocompatible materials.Particle and/or nano particle
The controlled release of drug can be provided.Particle and/or nano particle may include at least one drug.For example, particle and/or nanometer
Particle may include hemostat, antimicrobial and/or oxidant.Tissue thickness compensation part may include biocompatible foam, institute
State biocompatible foam include hemostat (it includes oxidized regenerated cellulose), antimicrobial (it include fortimicin and/
Or gentamicin) and/or oxidant (it includes percarbant).For example, particle and/or nano particle can provide up to three
The controlled release of it drug.
Particle and/or nano particle can be embedded in biocompatible materials in the fabrication process.For example, biocompatibility
Polymer (such as PGA/PCL) can contact solvent (such as dioxane) to form mixture.Biofacies can be ground
Capacitive polymer is to form particle.It can be contacted with mixture to form suspension with or without the dry particl of ORC particles.It should
Suspension can be lyophilized to form biocompatible foam, which includes with the dry particl being embedded
And/or the PGA/PCL of ORC particles.
For example, tissue thickness compensation part disclosed herein or layer can be made of absorbable polymer.For example, tissue is thick
Spending compensating part can be constituted by the following substances:Foam, film, fibrous woven materials, fiber non-woven PGA, PGA/PCL (poly- (ethyl alcohol
Sour -co- caprolactone)), PLA/PCL (poly- (lactic acid -co- polycaprolactone)), PLLA/PCL, PGA/TMC (poly- (glycolic -co- three
Carbonate)), it is PDS, PEPBO or other absorbable polyurethane, polyester, makrolon, polyorthoester, polyanhydride, poly-
Esteramides, and/or polyoxy acid ester.According to the present invention, tissue thickness compensation part can be by such as PGA/PLA (poly- (glycolic -co-s
Lactic acid)) and/or PDS/PLA (poly- (to dioxanone -co- lactic acid)) compositions.According to the present invention, tissue thickness compensation part
It can be made of such as organic material.For example, tissue thickness compensation part can by carboxymethyl cellulose, mosanom, cross-linked-hyaluronic acid,
And/or oxidized regenerated cellulose is constituted.According to the present invention, tissue thickness compensation part may include ranging from 3-7 Shore As (Xiao 30-50
Family name OO) hardometer, wherein maximum rigidity be such as 15 Shore As (65 Shore OO).Tissue thickness compensation part can be for example in 3 ft lbfs
It is subjected to 40% compression under load, 60% compression is subjected under the load of 6 ft lbfs, and/or 80% is subjected under the load of 20 ft lbfs
Compression.One or more gases (such as air, nitrogen, carbon dioxide and/or oxygen) can for example blast and/or be included in group
It knits in thickness compensation part.Tissue thickness compensation part can include the globule for constituting tissue thickness compensation part, the globule packet wherein
Include the material stiffness between about 50% and about 75%.
According to the present invention, tissue thickness compensation part may include such as hyaluronic acid, nutritional ingredient, fibrin, blood coagulation
Enzyme, the blood plasma rich in blood platelet, salicylazosulfapyridine (- 5ASA+ sulfadiazine diazo bonds)-pro-drug-
Colon bacteria (azo reductase), aminosalicylic acid (have for sustained release different pro-drugs configure 5ASA),(5ASA+ Utech-S coatings-pH>7 (coating dissolvings)),(5ASA+ ethylcellulose coats-be based on
The slow release of time/pH),(5ASA+ Utech-L coatings-pH>6), Olsalazine (5ASA+5ASA-colon
Bacterium (azo reductase)), Balsalazide (5ASA+4 aminobenzoyl-B- alanine)-colon bacteria (azo reductase)), make
Grain mesalazine, Lialda (mesalazine delay and controlled-release formulation), (herbal mixture, HMPL-004 (can press down HMPL-004
TNF-α processed, Interleukin -1β and core-κ B activation herbal mixture), (interference T lymphocytes enter intestines to CCX282-B
The oral chemokine receptor antagonist of mucous membrane), it is rifaximin (non-absorbability broad-spectrum antibiotic), infliximab, small
Mouse chimeric antibody (directly against the monoclonal antibody of TNF-α, is approved for mitigating suffer from hyporeactive to conventional therapy
Sign/symptom of the adult/pediatric patient of moderate/severe tube chamber and fistula type Crohn disease and maintain clinical remission), A Damu
(monoclonal antibody of anti-tnf-alpha is approved for mitigating sign/symptom of Crohn disease, Yi Jiyong for monoclonal antibody, people's total IgG 1
In induction and maintain to conventional therapy underaction, or as do not tolerate infliximab suffer from moderate/severe activity
The clinical remission of the adult patient of Crohn disease), match trastuzumab, the anti-TNF FAB ' of humanization (be connected to the list of polyethylene glycol
Monoclonal antibody fragment is approved for mitigating sign/symptom of Crohn disease, and for inducing and maintaining to conventional therapy
The reaction of hyporeactive adult patients with moderate/severe disease), natalizumab, the first non-TNF-α inhibitor (batch
The mutatis mutandis biologic artifact in Crohn disease), Humanized monoclonal IgG4 antibody (directly against α -4 integrins, obtain FDA
Approval is for inducing and maintaining to confirm to have inflammation and to the treatment of conventional Crow grace and TNF-α inhibitor underaction or can not be resistant to
The clinical response of the patient with moderate/severe disease of the treatment of conventional Crow grace and TNF-α inhibitor and alleviation), may give
Surely there are the concomitant immunity conditioning agent, imuran 6-MP (purine synthetic inhibitor-pro-drug), first of infliximab
Aminopterin (in conjunction with dihyrofolate reductase (DHFR) enzyme, participate in the synthesis of tetrahydrofolic acid, inhibit the synthesis of all purine), not
Purine alcohol and the treatment of sulphur purine, PPI, for acid suppression to protect the H2 of healing line, clostridium difficile (C-Diff)-flagyl, ten thousand
(excrement transposition is handled ancient mycin;Probiotics;Intracavitary normal flora is educated again), and/or rifaximin (bacterial overgrowth processing
(especially hepatic encephalopathy);It does not absorb and works to intracavitary bacterium in the gastrointestinal tract).
As described herein, for example, tissue thickness compensation part can compensate be trapped in it is being projected from nail bin and/or comprising
The variation of the thickness of the tissue in nail in staple line.In other words, certain nails in staple line can capture the thicker of tissue
Point, and other nails in staple line can capture the thinner part of tissue.In this case, tissue thickness compensation part can be in nail
Different height or thickness is presented, and apply compressive force to the tissue being trapped in nail regardless of captured tissue be it is thick or
It is thin.According to the present invention, tissue thickness compensation part can compensate for the variation of tissue hardness.For example, certain nails in staple line can capture
The highly compressible part of tissue, and other nails in staple line can capture the compressibility smaller ones of tissue.This
In the case of, for example, tissue thickness compensation part can be smaller in the interior presentation of nail (it has captured the tissue with relatively low compressibility)
Height or higher hardness, and correspondingly, can be presented in nail (it has captured the tissue with higher compressibility) larger
Highly or compared with soft.Under any circumstance, for example, no matter tissue thickness compensation part whether compensate tissue thickness variation and/
Or the variation of tissue hardness, it is referred to alternatively as " Tissue compensating part " and/or " compensating part ".
The devices disclosed in the present invention may be designed to being processed after a single use, or they may be designed to can
It is used for multiple times.However, in either case, described device can be repaired, to be reused after use at least once.It repaiies
It can include any combination of the following steps again:Dismounting described device and then cleaning are replaced particular elements and are then filled again
Match.In particular, described device can be disassembled, and it selectively can replace or take out in any combination the arbitrary number of described device
Purpose particular elements or part.Cleaning and/or replace particular elements after, described device can at the repair facility or
It is ressembled by operating team before will carrying out surgical operation then to use.Those skilled in the art will be understood that, fill
The reparation set can utilize it is a variety of for dismantling, the technology for cleaning/replace and ressemble.The uses of these technologies and gained
It is repaired device within the scope of the present invention.
Preferably, invention as described herein will be handled before surgery.First, new or used device is obtained
Tool, and instrument is cleaned if necessary.Then it carries out disinfection to instrument.In a kind of disinfection technology, the instrument is set
In the container for being closed and sealing, such as in plastics or TYVEK bag.Then the container can be penetrated by being placed in container and instrument
Radiation field in, such as γ radiation, x- rays or high energy electron.The bacterium on instrument and in container is killed in radiation.Then will
Instrument after disinfection is stored in sterile chamber.Instrument is kept sterile by the sealing container, should until being opened in medical facilities
Until container.
Any patent, patent disclosure or other public materials incorporated herein by reference in its entirety or in part only exist
Incorporated material not be incorporated to this in existing definition of the present invention, statement or the conflicting range of other public materials
Text.As a result, at the necessary level, substitution is herein incorporated by reference any by disclosure clearly described in this article
Conflicting material.It is any be stated to be herein incorporated by reference but with existing definition as described herein, statement or other are public
Punching will only not generated between the incorporated material and the existing public material by opening conflicting any material of material or part thereof
It is incorporated herein under prominent degree.
Although being described the present invention as exemplary design, it is also possible in the spirit and scope of the disclosure
It is interior that the present invention will be further modified.Therefore present patent application be intended to cover using general principles any modification,
Purposes or adaptive version.In addition, present patent application is intended to cover come from known in fields of the present invention or is used to have practical framework
The interior pattern away from the disclosure.
Claims (10)
1. a kind of fastener cartridge assembly for surgical instruments, the fastener cartridge assembly include:
Support section, the support section include securing member chamber;
Non-woven compensating part, the non-woven compensating part are positioned relative to the support section, wherein the non-woven compensating part
Including being scattered in the non-woven compensating part more non-crimped fibers everywhere and Duo Gen crimped fibres, and the wherein described curling
Fiber is thermoformed to keep the shape of substantially coiled type;With
Fastener, the fastener can move between initial position and firing position, wherein when the fastener is in it
When initial position, the fastener is positioned at least partially in the securing member chamber, and wherein when the fastener is at it
When being moved between initial position and its firing position, the fastener can compress the non-woven compensating part;
The wherein described crimped fibre includes elastic material, and the wherein described crimped fibre is suitable for described in the fasteners compress
It is deformed when non-woven compensating part.
2. fastener cartridge assembly according to claim 1, wherein the fastener includes:
Base portion;
First leg, first leg extend from the base portion;With
Second leg, second leg extend from the base portion, wherein when the fastener moves to its firing position, institute
Stating the first leg and second leg can be towards the base curve;
Wherein when the fastener moves to its firing position, the fastener is in first leg and second leg
At least one of the part of the non-woven compensating part is captured between the base portion.
3. fastener cartridge assembly according to claim 2, further includes:
Slit, the slit extend through at least part of the support section;With
Firing member, the firing member can translate in the slit, wherein the firing member can be in the percussion
Component engages the base portion of the fastener when translating so that the fastener is projected from the securing member chamber.
4. fastener cartridge assembly according to any one of the preceding claims, wherein the non-woven compensating part passes through bonding
Agent is releasably attached to the platform of the support section.
5. according to the fastener cartridge assembly described in any one of preceding claims 1-3, wherein the crimped fibre is in entire institute
State random dispersion and random orientation in non-woven compensating part.
6. according to the fastener cartridge assembly described in any one of preceding claims 1-3, wherein the crimped fibre includes synthesis
Bioabsorbable material.
7. according to the fastener cartridge assembly described in any one of preceding claims 1-3, wherein the crimped fibre includes being selected from
The material of group including following substance:Poly- (dioxanone) (PDO), polylactic acid (PLA), are gathered in oneself at polyglycolide (PGA)
Ester (PCL), makrolon and their copolymer.
8. according to the fastener cartridge assembly described in any one of preceding claims 1-3, wherein the non-woven compensating part is needle
Thorn and include hemostatic material.
9. a kind of end effector assembly for surgical instruments, the end effector assembly include:
Anvil block;
According to the fastener cartridge assembly described in any one of preceding claims 1-8.
10. end effector assembly according to claim 9, wherein the non-woven compensating part described in the fasteners compress
A part when, the non-woven compensating part can be detached from the end effector assembly.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/433,144 | 2012-03-28 | ||
US13/433,144 US9277919B2 (en) | 2010-09-30 | 2012-03-28 | Tissue thickness compensator comprising fibers to produce a resilient load |
PCT/US2013/034011 WO2013148773A1 (en) | 2012-03-28 | 2013-03-27 | Tissue thickness compensator comprising fibers to produce a resilient load |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104334095A CN104334095A (en) | 2015-02-04 |
CN104334095B true CN104334095B (en) | 2018-11-13 |
Family
ID=52408625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380028097.0A Active CN104334095B (en) | 2012-03-28 | 2013-03-27 | Including fiber to generate the tissue thickness compensation part of elastic load |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6279546B2 (en) |
CN (1) | CN104334095B (en) |
BR (1) | BR112014024197B1 (en) |
MX (1) | MX358136B (en) |
RU (1) | RU2640004C2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10603039B2 (en) * | 2015-09-30 | 2020-03-31 | Ethicon Llc | Progressively releasable implantable adjunct for use with a surgical stapling instrument |
US10085745B2 (en) * | 2015-10-29 | 2018-10-02 | Ethicon Llc | Extensible buttress assembly for surgical stapler |
US10357248B2 (en) * | 2015-10-29 | 2019-07-23 | Ethicon Llc | Extensible buttress assembly for surgical stapler |
CN105483851B (en) * | 2015-11-25 | 2020-03-24 | 中国纺织科学研究院有限公司 | Superfine polyglycolide fiber, mechanical preparation method and device thereof, application and patch |
CN110313953B (en) * | 2019-07-30 | 2024-10-11 | 康奇舒宁(苏州)医疗科技有限公司 | Flat pad device in disposable endoscopic cutting anastomat nail bin assembly |
CN113398325B (en) * | 2021-06-11 | 2023-04-21 | 叶川 | Fibrous membrane for enhancing screw stability and inducing bone regeneration and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6330965B1 (en) * | 1997-09-23 | 2001-12-18 | United States Surgical Corporation | Surgical stapling apparatus |
EP2008595A2 (en) * | 2007-06-27 | 2008-12-31 | Tyco Healthcare Group LP | Buttress and surgical stapling apparatus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814057A (en) * | 1994-06-03 | 1998-09-29 | Gunze Limited | Supporting element for staple region |
US5702409A (en) * | 1995-07-21 | 1997-12-30 | W. L. Gore & Associates, Inc. | Device and method for reinforcing surgical staples |
KR100221212B1 (en) * | 1996-08-19 | 1999-09-15 | 앨. 토드 그레고리 | Wrap material with additive delivery system |
ATE375755T1 (en) * | 1997-03-31 | 2007-11-15 | Igaki Iryo Sekkei Kk | SEWING THREAD HOLDING DEVICE FOR MEDICAL TREATMENT |
JP4398716B2 (en) * | 2003-12-24 | 2010-01-13 | 呉羽テック株式会社 | Highly stretchable nonwoven fabric provided with a clear embossed pattern and method for producing the same |
-
2013
- 2013-03-27 JP JP2015503491A patent/JP6279546B2/en active Active
- 2013-03-27 RU RU2014143252A patent/RU2640004C2/en not_active IP Right Cessation
- 2013-03-27 BR BR112014024197-0A patent/BR112014024197B1/en active IP Right Grant
- 2013-03-27 MX MX2014011672A patent/MX358136B/en active IP Right Grant
- 2013-03-27 CN CN201380028097.0A patent/CN104334095B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6330965B1 (en) * | 1997-09-23 | 2001-12-18 | United States Surgical Corporation | Surgical stapling apparatus |
EP2008595A2 (en) * | 2007-06-27 | 2008-12-31 | Tyco Healthcare Group LP | Buttress and surgical stapling apparatus |
Also Published As
Publication number | Publication date |
---|---|
BR112014024197B1 (en) | 2022-05-10 |
MX358136B (en) | 2018-08-06 |
RU2014143252A (en) | 2016-05-20 |
JP6279546B2 (en) | 2018-02-14 |
MX2014011672A (en) | 2015-02-13 |
CN104334095A (en) | 2015-02-04 |
JP2015512721A (en) | 2015-04-30 |
RU2640004C2 (en) | 2017-12-25 |
BR112014024197A2 (en) | 2017-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104394781B (en) | Tissue thickness compensation part including the structure for producing elastic load | |
CN104349800B (en) | Tissue thickness compensation part including controlled release and expansion | |
CN104321024B (en) | Tissue thickness compensator comprising a plurality of layers | |
CN104334096B (en) | Include the tissue thickness compensation part of multiple capsules | |
CN104321023B (en) | Tissue thickness compensation part including at least one medicine | |
CN104321021B (en) | Expansible tissue thickness compensation part | |
CN104321022B (en) | Tissue thickness compensator comprising a plurality of medicaments | |
CN104363838B (en) | The tissue thickness compensation part being made up of multiple material | |
CN104411255B (en) | Visual tissue thickness compensation part with improvement | |
JP6328667B2 (en) | Staple cartridge including a compressible portion | |
CN104582592B (en) | Tissue stitching instrument with the thickness compensation part for combining hydrophilic agent | |
CN104321025B (en) | Tissue thickness compensation part including elastic component | |
CN104334098B (en) | Tissue thickness compensator comprising capsules defining a low pressure environment | |
CN104334093B (en) | Device and method for tissue thickness's compensating material to be attached to surgery suturing appliance | |
CN104334095B (en) | Including fiber to generate the tissue thickness compensation part of elastic load | |
CN104379066B (en) | Tissue thickness compensator comprising channels | |
CN104349726B (en) | Tissue thickness compensation part and its manufacture method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |